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Chapter 1 
 
Toward the Synthesis of (+)-Peloruside A 
 
1.1 Lewis Acids in Organic Synthesis  
 
The importance of Lewis acids to the field of organic chemistry cannot be 
overstated. For decades, chemists have studied and observed the interactions of Lewis 
acids with Lewis bases to understand of the diverse reactivity of these compounds. 
Their diligence has led to a vast collection of reactions that are indispensable to 
modern-day synthetic chemists. Understandably, reactions that form new C-C bonds 
are of greatest utility to practitioners of organic synthesis. As such, the Lewis acid-
mediated addition of carbon nucleophiles to carbonyls continues to be an 
indispensible process used in organic synthesis.
1
 Even after intense study, the role of 
Lewis acids continues to expand and evolve as chemists devise new ways to render 
them catalytically active and increase the chemo-, regio, and stereoselectivities of the 
reactions in which they participate. 
The low cost and availability of aluminum Lewis acids make them attractive 
and of substantial interest to the synthetic community. The traditional aluminum 
halides such as AlCl3 and AlBr3 have broad applications, but are most widely known 
for their ability to promote Friedel-Crafts reactions.
2
 When the halides bound to the 
                                                 
1
 Yamamoto, H.; Editor Lewis Acids in Organic Synthesis, Volume 2, 2000. 
2
. Olah, G. A.; Editor; Friedel-Crafts and Related Reactions, Volumes 1-4, Wiley-Interscience: New 
York, 1963-1965. 
2 
 
aluminum are replaced by alkoxide ligands, a significant reduction in Lewis acidity 
occurs and a corresponding alteration in the type of reactivity they promote is 
observed. Arguably, the most famous application of an aluminum alkoxide Lewis 
acid in organic synthesis is the Al(Oi-Pr)3 promoted Meerwein-Ponndorf-Verley 
reaction (Scheme 1.1).
3
  
 
Scheme 1.1 The Meerwein-Ponndorf-Verley Reaction 
 
Bulky Aluminum Lewis Acids 
Aluminum alkoxide Lewis acids of this type often exist as complex, extended 
structures in solution.
4
 This intermolecular network decreases the Lewis acidity of the 
aluminum and introduces a variable that can lead to unpredictable outcomes when 
used in synthesis.  When appropriately modifying the alkoxide ligands with very 
bulky substituents, monomeric structures are known to exist.  This unique 
combination of increased Lewis acidity at the metal center and decreased accessibility 
has led to an abundance of interesting and previously unknown selectivities in various 
reactions. Yamamoto and coworkers have developed a class of these bulky 
aluminum-based Lewis acids where sterically hindered aluminum phenoxides are 
                                                 
3
 Wilds, A. L. Org. React. 1944, 2, 178. 
4
 Elschenbroich, C.; Salzer, A.; Eds. Organometallics, VCH, Weinheim, 1992, Ch. 7.2. 
3 
 
used for inducing remarkable reactivities, specifically in reactions involving additions 
to carbonyls (Figure 1.1).
5
  
 
 
Figure 1.1 Bulky Aluminum Based Designer Lewis Acids 
 
In general, these reagents are easily prepared in situ from the reaction of 
Me3Al with the appropriate phenol and are typically used without further purification.  
For example, aluminum tris(2,6-diphenylphenoxide) (ATPH, 1.2.2) is prepared by 
adding Me3Al (1 equiv) to a solution of 2,6-diphenylphenol 1.2.1, (3 equiv) in toluene 
at room temperature with the rigorous exclusion of air and moisture (Scheme 1.2).
6
   
The exception to this protocol is in the preparation of exceedingly bulky Lewis acids, 
such as aluminum tris(2,6-di-tert-butyl-4-methylphenoxide) 1.2.6 (ATD).
7
 In order to 
achieve this highly congested environment, 3 equivalents of the phenol 1.2.3 are 
added to LAH in ether. After liberation of H2 and removal of Li[AlH2(OC6H3t-Bu,-
2,6)2] 1.2.4 by fractional crystallization, the resulting [AlH(OC6H3t-Bu,-2,6)2,(OEt2)] 
                                                 
5
 Saito, S.; Yamamoto, H. Chem. Comm. 1997, 1585. 
6
 Saito, S.; Shiozawa, M.; Ito, M.; Yamamoto, H. J. Am. Chem. Soc. 1998, 120, 813. 
7
 Healy, M. D.; Barron, A. R. Angew. Chem., Int. Ed. Engl. 1992, 31, 921. 
4 
 
1.2.5 is refluxed in toluene with an additional equivalent of phenol to provide the 
desired Lewis acid (Scheme 1.2).  
 
Scheme 1.2 The Preparation of ATPH and ATD 
 
Perhaps the most useful of Yamamoto’s designer aluminum Lewis acids is 
ATPH. The remarkable selectivities observed when it is used are hypothesized to be 
due to its unique structure and bulk. Crystal structures of ATPH bound to DMF reveal 
a pseudo C-3 symmetric, cup-shaped cavity with a propeller-like ligand array around 
the central aluminum atom (Figure 1.2). This unusual motif encapsulates the oxygen 
of a bound carbonyl and creates an extremely hindered environment at sites proximal 
to the binding site.  
5 
 
 
Figure 1.2  X-Ray Crystal Structure of ATPH from Ref 8a 
Some of the more notable uncommon reactions that ATPH promotes include 
discrimination of structurally or electronically similar substrates, 1,4-addition of 
nucleophiles to α,β-unsaturated carbonyl compounds, promotion of stereoselective 
Claisen rearrangements, and exo-selective Diels-Alder reactions.
5
 Of most interest to 
our group however, is its ability to access to δ-hydroxy-α,β-unsaturated esters via the 
vinylogous aldol reaction of α,β-unsaturated esters and aldehydes (Scheme 1.3).8  
 
Scheme 1.3 Some Interesting Selectivities when ATPH is used in Various 
Reactions 
 
                                                 
8
 (a) Saito, S.; Shiozawa, M.; Ito, M.; Yamamoto,H. J. Am. Chem. Soc. 1998, 120, 813. (b) Saito, S.; 
Shiozawa, M.; Yamamoto, H. Angew. Chem., Int. Ed. 1999, 38, 1769. (c) Saito, S.; Shiozawa, M.; 
Nagahara, T.; Nakadai, M.; Yamamoto, H. J. Am. Chem. Soc. 2000, 122, 7847. (d) Saito, S.; Nagahara, 
T.; Shiozawa, M.; Nakadai, M.; Yamamoto, H. J. Am. Chem. Soc. 2003, 125, 6200. (e) Takikawa, H.; 
Ishihara, K.; Saito, S.; Yamamoto, H. Synlett 2004, 732. 
6 
 
1.2  The Yamamoto Vinylogous Aldol Reaction 
 
The aldol reaction is a versatile carbon-carbon bond forming transformation 
that is widely used and of great importance in organic synthesis.
9
 However, the 
control of the mixed aldol reaction between two different carbonyl compounds which 
present several possible sites for enolization is a challenging problem for synthetic 
chemists. Such reactions are normally carried out by converting the carbonyl 
compound, which is to serve as a nucleophile, to an enolate. This reactive nucleophile 
is then added to and allowed to react with the second carbonyl compound (Scheme 
1.4).  
 
Scheme 1.4 Typical Procedure for Aldol Reactions 
 
The extension of this reaction to its vinylog (i.e., the vinylogous aldol 
reaction) is well known, and in its simplest form, proceeds via a dienolate and an 
aldehyde.
10
  The product, a δ-hydroxy-α,β-unsaturated carbonyl compound, is rich in 
functionality, and as this bond construction occurs in an uncommon position (between 
                                                 
9
 For recent reviews on the aldol reaction, see: (a) Modern Aldol Reactions; Mahrwald, R., Ed.;Wiley-
VCH:Weinheim, 2004. (b) Paterson, I. Total Synthesis of Polyketides using Asymmetric Aldol 
Reactions. In Asymmetric Synthesis, 2nd ed.; Christmann, M., Brase, S., Eds.; Wiley-VCH Verlag 
GmbH & Co.: Weinheim, Germany, 2008; pp 293-298. 
10
 (a) Casiraghi, G.; Battistini, L.; Curti, C.; Rassu, G.; Zanardi, F. Chem. Rev. 2011, 11, 3076. (b) 
Denmark, S.E.; Heemstra, J.R.; Beutner, G. L. Angew. Chem., Int. Ed. 2005, 44, 4682. 
7 
 
the γ- and δ-carbons of the product), it offers novel strategic disconnections in 
synthetic planning (Scheme 1.5).  
 
Scheme 1.5 The Vinylogous Aldol Reaction 
 
Generating exclusively the γ-adduct 1.5.3 is a challenge to organic chemists. 
For example, when an α,β-unsaturated carbonyl such as cyclopentenone is treated 
with a thermodynamic, equilibrating base such as KOt-Bu it produces dienolate 1.6.2 
(Scheme 1.6). When that enolate is trapped with an electrophile, the corresponding α-
adduct 1.6.3 is the major product of the reaction. When that same α,β-unsaturated 
carbonyl is treated with a kinetic, non-equilibrating base such as LDA, enolate 1.6.5 
is generated. Trapping of 1.6.5 with an electrophile primarily results in the production 
of α’-adduct 1.6.6 (Scheme 1.6).  
 
 
Scheme 1.6 Enolization/Trapping Strategies of Cyclopentenone 
8 
 
ATPH-Mediated Vinylogous Aldol Reaction 
In recent years, this reaction has gained significant attention from the organic 
community, and an important advance was described by Hisashi Yamamoto with the 
use of the very bulky Lewis acid, aluminum tris(2,6-diphenylphenoxide) (ATPH).
8
  
ATPH is used in reactions of lithium enolates and aldehydes, and it is thought to bind 
to both the dienolate and the aldehyde components of the reaction. Due to its bulk, it 
prevents reaction at the α-carbon of the dienolate, thereby forcing the reaction to 
occur at the distal γ-carbon (Scheme 1.7). Remarkably, Yamamoto has used ATPH to 
direct reactivity to the terminal carbon in substrates as large as hexaenolates derived 
from pentaenoates.  
 
Scheme 1.7 The Yamamoto Vinylogous Aldol Reaction 
 
As a representative optimized example of Yamamoto’s procedure, pre-
complexation of methyl crotonate 1.8.2 (2.0 equiv) and benzaldehyde 1.8.1 (1.0 
equiv) with ATPH (3.3 equiv) was followed by treatment with a solution of LTMP 
(2.3 equiv) in THF at -78 ºC under an argon atmosphere. After stirring of the mixture 
at this temperature for 30 min, quenching with aq. NH4Cl, and purification by column 
chromatography on silica gel, aldol adduct 1.8.3 with exclusive E-configuration at the 
olefin was obtained in 97% yield (Scheme 1.8).  
9 
 
 
 
Scheme 1.8 Yamamoto Vinylogous Aldol Reaction of Benzaldehyde and Methyl 
Crotonate 
 
Yamamoto found that this reaction proceeds well in most cases where α,β-
unsaturated aldehydes, ketones, and esters are used as coupling partners in the 
vinylogous aldol reaction with aldehydes. The exception to this is the case where α,β-
unsaturated esters are used in the reaction with unbranched and enolizable aldehydes. 
For example, attempted vinylogous aldol reaction between methyl crotonate and 
valeraldehyde provides the desired product in a disappointing yield of only 22%. This 
is likely the result of the formation of a mixture of enolates which leads to a complex 
mixture of products and low yields of the desired compound (Table 1.1). 
 
10 
 
 
Table 1.1 Scope of the Yamamoto Vinylogous Aldol Reaction  
 
An additional requirement of the Yamamoto protocol is that the components 
must all be combined prior to the addition of the base. Attempts to conduct the 
reaction in a stepwise fashion wherein the enolate is first formed and the aldehyde 
then added provide significantly diminished yields (Scheme 1.9).  
 
 
Scheme 1.9 Unsuccessful Stepwise Yamamoto Vinylogous Aldol  
 
 
11 
 
The Intramolecular Yamamoto Vinylogous Aldol Reaction  
 
One can imagine the utility of an intramolecular reaction in the construction of 
macrolide-containing natural products. Some possible intramolecular vinylogous 
aldol retrosynthetic bond disconnections are shown in Figure 1.3. Possible target 
molecules include arenolide, RK-397, peloruside A, and laulimalide, all of which 
show interesting biological activities and structural motifs.  
 
 
 
Figure 1.3 Possible Target Molecules Utilizing an Intramolecular Vinylogous 
Aldol Reaction 
 
Mark Mitton-Fry and Joe Abramite, former graduate students in the 
Sammakia lab, hypothesized that if the aldehyde and α,β-unsaturated carbonyl 
compound must both be present and pre-complexed to ATPH prior to the addition of 
base, the method could be extended to the macroaldolization of crotonate esters to 
12 
 
rings of various size. Medium-membered rings of this nature are generally more 
difficult to make than their smaller or larger counterparts due to both entropic and 
enthalpic energy barriers they incur. Some of the more popular methods for medium-
membered ring formation include macrolactonization and ring-closing metathesis, but 
these often provide moderate yields and are unable to create any new asymmetric 
carbons in the molecule. Abramite, however, demonstrated an intramolecular 
variation of the Yamamoto vinylogous aldol reaction using crotonate esters and non-
enolizable aldehydes for the construction of 10- to 14-membered macrolides in good 
yields (up to 90%) and excellent remote diastereoselection (~20:1 dr) (Table 1.2).
11
  
 
 
 
Table 1.2 The Intramolecular Vinylogous Aldol Reaction 
 
We wished to demonstrate the utility of the intramolecular vinylogous aldol 
reaction for the construction of macrolides in the context of natural products 
                                                 
11
 Abramite, J. A.; Sammakia, T. Org. Lett. 2007, 9, 2103. 
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synthesis. We therefore targeted the polyoxygenated 16-membered macrolide 
peloruside A for synthesis. This compound was chosen because it appeared to be 
amenable to efficient synthesis using the intramolecular vinylogous aldol method 
developed by Dr. Abramite, and because it displays potent antimitotic activity with 
low nanomolar activity against several cancer cell lines.
12
  
 
1.3 Isolation, Characterization, and Biological Activity of (+)-Peloruside A 
 
Isolation and Characterization 
 
Peloruside A 1.4.1 is a polyoxygenated 16-membered macrolide natural 
product that was isolated from a marine sponge, Mycale hentscheli, found off the 
coast of New Zealand by Northcote and coworkers in 2000.
13
  The absolute 
configuration was determined by Debrabander and coworkers in their total synthesis 
of the antipode, (-)-peloruside A.
14
  
                                                 
12
 (a) Hood, K. A.; West, L. M.; Rouwe, B.; Northcote, P. T.; Berridge, M. V.; Wakefield, S. J. 
Cancer Res. 2002, 62, 3356. (b) Gaitanos, T. N.; Buey, R. M.; Diaz, J. F.; Northcote, P. T.; Teesdale-
Spittle, P.; Andreu, J. M.; Miller, J. H. Cancer Res. 2004, 64, 5063. (c) Miller, J. H.; Rouwe, B.; 
Gaitanos, T. N.; Hood, K. A.; Crume, K. P.; Baeckstroem, B. T.; La Flamme, A. C.; Berridge, M. V.; 
Northcote, P. T. Apoptosis. 2004, 9, 785. (d) Page, M.; West, L.; Northcote, P.; Battershill, C.; Kelly, 
M. J. Chem. Ecol. 2005, 31, 1161. 
13
 West, L. M.; Northcote, P. T.; Battershill, C. N. J. Org. Chem. 2000, 65, 445. 
14
 Liao, X.; Wu, Y.; De Brabander, J. K. Angew. Chem., Int. Ed. 2003, 42, 1648-1652. 
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Figure 1.4 (+)-Peloruside A 
 
Biological Activity 
 
In the isolation paper, Northcote and coworkers reported that (+)-peloruside A 
is cytotoxic against P388 murine leukemia cells at approximately 10 ng/mL (18 nM).  
Shortly thereafter, Miller and coworkers demonstrated that (+)-peloruside A is indeed 
a potent cytotoxin at low nanomolar concentrations (4-15 nM), inducing biochemical 
changes consistent with apoptosis in a variety of mammalian cell lines.
12
 It is 
proposed to have a mode of action that involves stabilizing microtubules during 
mitosis. This stabilization induces tubulin polymerization, causing cells to arrest at 
the G2-M boundary of the cell cycle leading to apoptosis. Several drugs on the market 
including paclitaxel, vincristine, vinorelbine, vinblastine and many others in clinical 
trials take advantage of this tubulin-stabilizing strategy for cancer chemotherapy 
because of the rapid growth and division of cancer cells.  
Peloruside was found to be not aﬀected by the mutations that are known to 
aﬀect the activity of the paclitaxel.15 Additionally, competition binding experiments 
                                                 
15
 Giannakakou, P.; Gussio, R.; Nogales, E.; Downing, K. H.; Zaharevitz, D.; Bollbuck, B.; Poy, G.; 
Sackett, D.; Nicolaou, K. C.; Fojo, T. PNAS, 2000, 97, 2904. 
15 
 
revealed that it does not bind to the taxane site in β-tubulin. In line with these results, 
peloruside was found to synergize with other taxane site drugs in both polymerizing 
puriﬁed tubulin and cellular activity.16  
 
Figure 1.5 Proposed Binding Site of (+)-Peloruside A from Ref. 16 
  
In addition to the antimitotic activity, recent studies have shown that 
peloruside protects cultured neurons against okadaic acid induced tau 
phosphorylation.
17
 The loss of tau function caused by misfolding, 
hyperphosphorylation, and sequestration of tau into insoluble aggregates, leads to 
axonal transport deﬁcits with neuropathological consequences. These results suggest 
that peloruside may also be considered a potential candidate for the treatment of 
tauopathies such as Alzheimers.  
                                                 
16
 Altmann, K. H. Curr.Opin. Chem. Biol. 2001, 5, 424. 
17
 Ballatore, C.; Brunden, K. R.; Huryn, D. M.; Trojanowski, J. Q.; Lee, V. M.-Y.; Smith, A. B. J 
Med. Chem, 2012. 
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1.4  Previous Syntheses of (+)-Peloruside A  
  
(+)-Peloruside A’s combination of potent biological activity and complex 
structure has led to intense interest by the synthetic organic community with six total 
syntheses reported to date.
18
 One of the challenges associated with the synthesis of 
peloruside A is the construction of the macrocycle, and all previous total syntheses 
have utilized a macrolactonization for this purpose. While macrolactonization has 
become a reliable method for the synthesis of medium- to large-membered rings, it 
can at times provide modest yields and there can be strategic advantages to other 
methods of macrocycle formation. Herein, we will briefly describe the most recent 
strategies used by the Evans, Hoye, and Jacobsen groups.  
 
The Evans Synthesis 
The Evans retrosynthetic analysis of (+)-peloruside A relies on the two 
highlighted aldol disconnections illustrated in Scheme 1.10. Based on prior work in 
the group, they anticipated that the C3 and C15 stereocenters would favorably 
influence the stereochemical outcome of these two major bond constructions.  
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 (a) Liao, X.; Wu, Y.; De Brabander, J. K. Angew. Chem., Int. Ed. 2003, 42, 1648. (b) Jin, M.; 
Taylor, R. E. Org. Lett. 2005, 7, 1303–1305. (c) Ghosh, A. K.; Xu, X.; Kim, J.-H.; Xu, C.-X. Org. Lett. 
2008, 10, 1001. (d) Evans, D. A.; Welch, D. S.; Speed, A. W. H.; Moniz, G. A.; Reichelt, A.; Ho, S. J. 
Am. Chem. Soc. 2009, 131, 3840. (e) Hoye, T. R.; Jeon, J.; Kopel, L. C.; Ryba, T. D.;Tennakoon,M. 
A.;Wang,Y. Angew. Chem., Int. Ed. 2010, 49, 6151. (f) McGowan, M. A.; Stevenson, C. P.; Schiffler, 
M. A.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2010, 49, 6147. 
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Scheme 1.10 Evans Retrosynthesis of (+)-Peloruside A 
  
The Evans synthesis of (+)-peloruside A commences with the protection of 
(S)-pantolactone 1.11.1 as a benzyl ether. Formation of the Weinreb amide is 
achieved by subjecting the lactone to a Lewis acid mediated nucleophilic ring 
opening with MeON(H)Me·HCl. Protection of the resulting free alcohol as a TES 
ether provides 1.11.2 in a 70% yield over  three steps. Ketone 1.11.3 is prepared in a 
97% yield after alkenyl lithium addition to the Weinreb amide. A highly 
diastereoselective zinc borohydride reduction of 1.11.3 is followed by TBS protection 
of the resulting hydroxyl group. Finally, oxidative cleavage of the alkene with ozone 
provides synthon 1.11.4 in an 80% yield over three steps (Scheme 1.11). 
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Scheme 1.11 Evans Forward Synthesis of (+)-Peloruside A (Part I) 
 
 The synthesis of ketone coupling partner 1.12.3 commenced with an aldol 
reaction of oxazolidinone 1.12.1 and a protected β-keto aldehyde to give alcohol 
1.12.2 in 64% yield. Methylation of the free alcohol was achieved with methyl 
Meerwein and subsequent deprotection of the ketal under acidic conditions gave the 
desired ketone 1.12.3 in a 54% yield over three steps (Scheme 1.12). 
 
 
 
Scheme 1.12 Evans Forward Synthesis of (+)-Peloruside A (Part II) 
 
 
 The aldol union of aldehyde 1.11.4 and ketone 1.12.3 was achieved in a 
highly diastereoselective fashion with 9-BBNOTf to give ketone 1.13.1 in an 82% 
yield. Subsequent 1,3-anti reduction of the ketone, regioselective protection of the 
least hindered alcohol as a TBS ether, methylation of the remaining alcohol, and a 
series of simultaneous deprotections and oxidations of the benzyl and TES ethers 
provided keto-aldehyde 1.13.2 in a 56% yield over  five steps. A 1,5-anti aldol 
reaction produced ketone 1.13.3 in a high yielding and diastereoselective manner. 
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Protection of the alcohol as a silyl ether bearing a hydride enabled internal delivery of 
the hydride to give a 1,3-anti diisopropyl silylene. The silylene was then removed 
with TBAF and the desired alcohol was regioselectively methylated. Finally, the 
PMB ether was removed with DDQ to give a 58% yield of advanced intermediate 
1.13.4 over 5 steps. To complete the synthesis, the chiral auxiliary was cleaved to 
give the carboxylic acid which was utilized in a macrolactonization to provide the 
desired macrocycle. A global deprotection with HCl resulted in formation of the 
natural product 1.4.1 in 45% yield over 3 steps (Scheme 1.13).   
 
 
 
Scheme 1.13 Evans Forward Synthesis of (+)-Peloruside A (Part III) 
 
 
The Hoye Synthesis 
The Hoye group desired to apply a diastereoselective kinetic lactonization of a 
pseudo-symmetric azelaic acid derivative 1.14.2 and to capitalize on the versatility of 
relay ring-closing metathesis (RRCM) reactions. In their retrosynthetic analysis, they 
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hoped to affect a late-stage aldol coupling between the aldehyde acceptor 1.14.1 and 
methyl ketone donor 1.14.3. They planned to install the hindered Z-trisubstituted 
alkene in through RRCM of the silaketal 1.14.4. They envisioned the main aldehyde 
fragment 1.14.1 to arise from the C2-symmetric azelaic ester precursor 1.14.2.  
 
Scheme 1.14 Hoye Retrosynthesis of (+)-Peloruside A 
 
The synthesis of the first coupling fragment in the Hoye synthesis is presented 
in Scheme 1.15. Tetrol 1.15.2 was prepared from the ethylene ketal of dimethyl 
acetone dicarboxylate 1.15.1 by first utilizing a one-pot DIBAL-H reduction of both 
esters to give the intermediate 1,5-dialdehyde. Subsequent in situ double HWE 
homologation and Sharpless asymmetric dihydroxylation provided the desired 
compound 1.15.2. Exposure to catalytic aqueous HI then promoted ketal metathesis 
by engagement of the C2 and C8 hydroxy groups to give a spirocyclic ketal as a 
single diastereomer. Installation of the methyl ethers found at C3 and C7 in 
peloruside A was achieved with Meerwein’s salt to provide 1.15.3. Transketalization 
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of 1.15.3 with ethanedithiol, MOM-ether protection of the C2/C8 diol, dithiolane 
removal, transesterification Otera’s catalyst smoothly and finally, use of hydrogen gas 
over Raney nickel provided a convenient route to C1-symmetric alcohol 1.15.4. 
Subsequent tetramethylguanidine promoted lactonization gave high levels of 
diastereoselectivity. Chemoselective reduction of the lactone was achieved with L-
Selectride to provide a lactol, which was treated with prenyl bromide/indium. This 
sequence installed the gem-dimethylated C10 moiety, while simultaneously inducing 
relactonization. Removal of the two MOM groups, PMP acetal formation, and 
reprotection of the OH as a MOM ether gave 1.15.5. A series of functional/protecting 
group manipulations followed by the reinstatement of the C1 methyl ester and C11 
aldehyde generation by ozonolysis completed the synthesis of 1.15.6 (Scheme 1.15).  
 
 
Scheme 1.15 Hoye Forward Synthesis of (+)-Peloruside A (Part I) 
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To prepare the key RRCM substrate, 1.16.1 and 1.16.2 were sequentially 
loaded onto Ph2SiCl2. RRCM with Grubb’s 2
nd
 Generation catalyst proceeded to give 
1.16.3 in 38% yield over 2 steps. Efficient elaboration of 1.16.3 into the differentially 
protected diol derivative 1.16.4 was straightforward with desilylation and sequential 
TBS and PMB installations on the primary and secondary hydroxy groups, 
respectively.  A modified Blaise reaction, wherein the reagent formed in situ from 
allyl 2-bromoacetate Zn
0
/Cp2TiCl2 converted the nitrile into an intermediate β-
aminoenoate, the hydrolysis of which was achieved to afford the β-ketoester. The 
allyl ester was finally decarbalkoxylated with [Pd(PPh3)4] (HCO2H, Et3N) to give 
ketone 1.16.4 in a 36% yield over 6 steps (Scheme 1.16). 
 
 
Scheme 1.16 Hoye Forward Synthesis of (+)-Peloruside A (Part II) 
 
Conversion to the natural product was achieved by first coupling of 1.16.4 and 
1.15.6 via a 1,5-anti aldol under conditions developed by Patterson to give 1.17.1 in a 
64% yield. Reduction of the C13 ketone with Me4NBH(OAc)3 proceeded to give the 
1,3-anti-diol which was then regioselectively methylated with Meerwein’s salt. 
Installation of a MOM ether at C11, removal of both PMB ethers, and saponification 
of the ester gave acid 1.17.2 in a high yielding manner.  Yamaguchi 
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macrolactonization of the C15 alcohol followed by oxidation of the free C9 alcohol to 
the ketone was achieved with the Dess–Martin periodinane. Finally, the silyl and 
MOM ether protecting groups were sequentially removed by treatment first with 
HF·pyridine and then with 4N aqueous HCl to provide (+)-peloruside A in a 16% 
yield over 4 steps (Scheme 1.17). 
 
 
 
Scheme 1.17 Hoye Forward Synthesis of (+)-Peloruside A (Part III) 
 
The Jacobsen Synthesis  
 
In the Jacobsen group’s synthetic plan, they wished to use their method of 
obtaining enantioenriched epoxides to serve as the key building blocks for the 
stereochemically complex macrocyclic framework. Like all previous total syntheses, 
they would employ a macrolactonization to form the macrocycle. Dissection of the 
seco-ester form of peloruside A into fragments of roughly equal size and complexity 
suggested aldehyde 1.18.2 and enone 1.18.3 as potentially useful late-stage 
intermediates. A second key strategic feature is a chiral-catalyst-controlled 
diastereoselective hetero-Diels–Alder reaction for the construction of intermediate 
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1.18.6. These fragments were envisioned to be prepared from enantioenriched 
epoxides which would control most of the developing stereocenters within the 
molecule (Scheme 1.18).  
 
Scheme 1.18 Jacobsen Retrosynthesis of (+)-Peloruside A 
 
 The Jacobsen synthesis of (+)-peloruside A began with a highly 
enantioselective Co-salen-catalyzed Payne rearrangement of meso-epoxy diol 1.19.1.  
Protection as the primary silyl ether in situ and subsequent alkylation of the 
secondary alcohol provided the bis-protected epoxide 1.19.2 in 56% yield over 3 
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steps. Epoxide 1.19.2 was subjected to a one-pot vinyl cuprate addition/methylation, 
followed by ozonolysis to provide aldehyde 1.19.3 in 66% overall yield. In an 
analogous manner, enantiopure aldehyde 1.19.6 was obtained from racemic epoxide 
1.19.4 employing a sequence of a hydrolytic kinetic resolution, vinylation, alkylation, 
and ozonolysis (Scheme 1.19). 
 
 
Scheme 1.19 Jacobsen Forward Synthesis of (+)-Peloruside A (Part I) 
 
 Aldehyde 1.19.3 and diene 1.20.1 were engaged in a chiral chromium-
catalyzed hetero-Diels–Alder reaction to give 1.20.2 in good yield and 
diastereoselectivity. Hydrogenation of 1.20.2 took place distereoselectively to provide 
1.20.3 in 69% yield and 10:1 dr. Oxidation of the lactol and opening of the resulting 
lactone with N,O-dimethylamine HCl afforded Weinreb amide 1.20.4 which was 
protected as a TBS ether. Addition of isopropenylmagnesium bromide occurred with 
26 
 
cleavage of the acetate ester, which was then reprotected as the TBS ether to provide 
aldol coupling partner 1.20.5 (Scheme 1.20). 
 
 
 
 
Scheme 1.20 Jacobsen Forward Synthesis of (+)-Peloruside A (Part II) 
 
 
 
In Jacobsen’s approach to aldehyde 1.21.5, epoxide 1.21.1 was prepared in 
high ee then opened stereospecifically and regioselectively at the propargylic 
position. The resulting primary alcohol was protected as the TIPS ether to provide 
alkyne 1.21.2 in 72% yield over two steps. Silyl ether 1.21.2 was further elaborated to 
vinyl bromide 1.21.3 by a one-pot hydroboration/bromination/elimination/silyl 
deprotection sequence. Protection of the resultant primary alcohol as the benzyl ether 
provided compound 1.21.3 in 69% yield. Alcohol 1.21.4 was obtained in 5:1 dr and 
isolated in 64% yield by lithiation of 1.21.3 and its subsequent addition to aldehyde 
1.19.6.  The free alcohol of 1.21.4 was then protected as the PMB ether. The primary 
alcohol was selectively deprotected under aqueous acidic conditions and then 
oxidized with the Dess–Martin periodinane to provide aldehyde 1.21.5 in 58% yield 
over the three steps (Scheme 1.21). 
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Scheme 1.21 Jacobsen Forward Synthesis of (+)-Peloruside A (Part III) 
 
 
To begin the completion of the natural product, enone 1.20.5 and aldehyde 
1.21.5 were coupled using a reductive aldol reaction. The primary TBS ether was then 
removed selectively using buffered HF·pyridine and the resulting alcohol was 
oxidized into aldehyde 1.22.1 in 38% yield over the three steps. Aldehyde 1.22.1 was 
then oxidized into the corresponding acid, and then subjected to DDQ to cleave the 
PMB ether and afford the macrolactonization precursor. The seco-acid was subjected 
to Yamaguchi conditions to provide the desired macrolactone. Finally, the benzyl 
protecting group was removed by transfer hydrogenolysis, and a subsequent global 
removal of the remaining protecting groups with aqueous HCl afforded (+)-peloruside 
A in 30% yield over the final 5 step sequence (Scheme 1.22). 
 
 
 
Scheme 1.22 Jacobsen Forward Synthesis of (+)-Peloruside A (Part IV) 
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1.5 Our Approach to the Total Synthesis of (+)-Peloruside A 
 
 
As aforementioned, one of the many challenges associated with the synthesis 
of peloruside A is the construction of the macrocycle, and all previous total syntheses 
have utilized a macrolactonization for this purpose. While macrolactonization has 
become a reliable method for the synthesis of medium- to large-membered rings, it 
can at times provide modest yields, and there can be strategic advantages to other 
methods of macrocycle formation. Our lab has recently described the application of 
the Yamamoto vinylogous aldol reaction for the synthesis of medium-membered 
rings using non-enolizable aldehydes.
11
 These reactions proceed in good to excellent 
yields and with high levels of remote stereocontrol, and we wished to demonstrate the 
utility of this method in the context of natural product synthesis. The vinylogous aldol 
reaction, in one of its incarnations, produces an α,β-unsaturated ester, the alkene of 
which can be subjected to functionalization, and we targeted peloruside A for 
synthesis as this compound contains functionality that can be installed from the 
product of such an intramolecular vinylogous aldol reaction. 
 
 
Retrosynthetic Analysis 
  
 We recognize that the most straightforward way of preparing the macrocycle 
in peloruside A via an intramolecular vinylogous aldol reaction would be to use 
aldehyde 1.23.2 as a cyclization precursor. After cyclization, the resulting alkoxide 
would potentially then cyclize onto the ketone to form the pyran functionality present 
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in the natural product. However, in both inter- and intramolecular cases, the 
Yamamoto vinylogous aldol reaction fails when the aldehyde coupling partner is 
unbranched and enolizable at the α-carbon. Clearly, the proposed aldehyde precursor 
bears an incompatible motif and another strategy needed to be developed to avoid this 
limitation (Scheme 1.23).  
 
 
Scheme 1.23 Our Direct Retrosynthetic Analysis of (+)-Peloruside A 
 
 In order to avoid the use of an enolizable aldehyde in the macroaldolization 
step, Joe Abramite developed a strategy in which non-enolizable furfural derivative 
1.24.3 would be utilized. Upon cyclization, this would provide a furyl alcohol 1.24.2 
which could be subjected to the Achmatowicz oxidative rearrangement to provide a 
pyranone 1.24.1. This contains all the handles necessary to install the requisite 
functionality in the natural product (Scheme 1.24).  
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Scheme 1.24 Our Modified Retrosynthetic Analysis of (+)-Peloruside A 
 
Our retrosynthetic analysis of (+)-peloruside A continues in Scheme 1.25 
where crotonate ester 1.25.1 is envisioned to come from four commercially available 
fragments.  As shown, the transformations required to convert these into to the -
hydroxy ketone 1.25.2, include a 1,3-anti reduction and selective functionalization of 
the C11-C13 diol.  A disconnection at the C11-C12 linkage provides ketone 1.25.3 
and aldehyde 1.25.4, which can be joined in a 1,5-anti aldol reaction.  Ketone 1.25.3 
can then prepared from a diastereoselective ene reaction between isobutylene and the 
aldehyde derived from protected (-)-ethyl lactate.  A palladium catalyzed -arylation 
reaction of substrates derived from methyl isobutyrate and 5-bromo-2-furoic acid 
would then give aldehyde 1.25.4 (Scheme 1.25). 
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Scheme 1.25 Our Modified Retrosynthetic Analysis of (+)-Peloruside A (continued) 
 
Model System Studies 
 
 Before embarking on the synthesis of (+)-peloruside A, Joe Abramite 
understood that an easily-prepared model system should be developed to test the key 
features of the synthetic plan. Therefore, intramolecular vinylogous aldol precursor 
1.26.1 was prepared. Unfortunately, standard conditions developed by Abramite 
32 
 
provided only 20% of the desired macrocycle 1.26.2. This material was isolated and 
subjected to the Achmatowicz oxidative rearrangement, which encouragingly 
provided a quantitative yield of pyranone 1.26.3. Isolation of the major side products 
in the Yamamoto intramolecular vinylogous aldol step indicated that enolization 
through the furan and subsequent addition to the aldehyde had occurred to provide 
dimeric products (Scheme 1.26).    
 
 
 
Scheme 1.26 Intramolecular Vinylogous Aldol Reaction of Model System 1.26.1 
 
To test the hypothesis that there was an undesired competitive enolization 
process occurring through the furan, a representative intermolecular reaction between 
methyl crotonate and 5-methyl furfural was examined. The results of this experiment 
were indeed in accordance with the hypothesis. Precomplexation of ATPH with the 
furfural does not block a bulky kinetic base like LTMP from deprotonating at its 
methyl terminus. The resulting extended enolate is free to add to other aldehydes in 
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solution, leading to the observed mixture of products. Although an undesired result in 
the current application, it is of note that this is a unique example of the utility of 
ATPH and is under further development (Scheme 1.27). 
 
Scheme 1.27 Enolization through a Furan with ATPH 
 
 The enolization of the furan and subsequent low yielding cyclization of 1.26.1 
could have potentially thwarted efforts toward the natural product by this method. 
However, examination of the proposed cyclization precursor 1.24.3 reveals that the 
offending site of enolization bares gem-dimethyl substitution. Because there are no 
enolizable protons in this position, the undesired reaction pathways could be avoided 
and it still could potentially be a successful method of preparing peloruside A.  
A more representative model system 1.28.1 was, therefore, synthesized by Joe 
Abramite that bears an analogous gem-dimethyl substituent in the enolizable position. 
Upon application of the standard intramolecular vinylogous aldol reaction conditions, 
the desired macrocycle 1.28.2 was isolated in 87% yield, albeit in a relatively low 2:1 
diastereoselectivity; however, we envisioned that increasing the rigidity and amount 
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of substitution along the backbone might improve the diastereoselectivity in the 
actual system (Scheme 1.28).  
 
 
 
Scheme 1.28 Revised Model System for (+)-Peloruside A  
 
Total Synthesis of (+)-Peloruside A 
 
To begin the synthesis of (+)-peloruside A, Joe Abramite prepared aldehyde 
1.29.3 in a sequence that I later repeated, as described below. 5-Bromo-2-furoic acid 
1.29.1 was reduced with BH3•THF to provide the corresponding alcohol which was 
protected as the TBS ether to provide bromofuran 1.29.2 in 94% yield over two steps 
(Scheme 1.29). Methyl isobutyrate was then subjected to α-arylation with bromofuran 
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1.29.2 under Hartwig’s conditions19 (Pd(dba)2, P(t-Bu)3, and Cy2NLi) then reduced 
with DIBAL-H to provide aldehyde 1.29.3. This aldehyde was then coupled to ketone 
1.30.4 using a 1,5-anti-aldol reaction,
20
 as shown in Scheme 1.31. 
 
 
Scheme 1.29 Preparation of Aldehyde 1.29.3 
 
Ketone 1.30.3 was prepared from (-)-ethyl lactate by protection as the benzyl 
ether (benzyl trichloroacetimidate, catalytic TfOH), and reduction (DIBAL-H) to 
provide aldehyde 1.30.1 (Scheme 1.30). Subjection of this aldehyde to a chelation-
controlled ene-reaction using 2-methyl propene as described by Mikami
21
 selectively 
provided alcohol 8 (>30:1 dr). Protection as the PMB ether (NaH, PMBCl) and 
oxidative cleavage (OsO4, NaIO4, 2,6-lutidine)
22
  provided methyl ketone 1.30.4 
ready for coupling with aldehyde 1.29.3.  
 
                                                 
19
 Jørgensen, M. Lee, S. Liu, X. Wolkowski, J. P.; Hartwig, J. F. J. Am. Chem. Soc. 2002, 124, 
12557. 
20
 Paterson, I.; Gibson, K. R.; Oballa, R. M. Tetrahedron Lett. 1996, 37, 8585. 
21
 Mikami, K.; Loh, T. P.; Nakai, T. Tetrahedron: Asym. 1990, 1, 13. 
22
 Yu, W.; Mei, Y.; Kang, Y.; Hua, Z.; Jin, Z. Org. Lett. 2004, 6, 3217. 
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Scheme 1.30 Preparation of Ketone 1.30.3 
 
The coupling of aldehyde 1.29.3 and methyl ketone 1.30.3 was accomplished 
using Evans’ conditions (n-Bu2BOTf, i-Pr2NEt)
23
 to provide 1.31.1 in 87% yield and 
7:1 diastereoselectivity (Scheme 1.31). Anti-selective hydroxyl-directed reduction 
(Me4NBH(OAc)3)
24
 of 1.31.1 provided diol 1.31.2 which was protected as the 
diisopropyl silylene  (1.31.3). Compound 1.31.3 was then treated with methyl lithium 
in the presence of HMPA followed by methyl iodide to provide 1.31.4 bearing a 
methyl ether at C-13 and a diisopropyl methyl silyl ether at C-11 as a single 
constitutional isomer to the limits of 
1
H NMR detection.
25
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Scheme 1.31 Preparation of Diisopropyl Methyl Silyl Ether 1.31.4 
 
Deprotection of the C-16 PMB group (DDQ) resulted in simultaneous 
oxidation of the TBS ether at C-5 to provide hydroxy aldehyde 1.32.1. This fortuitous 
result is likely due to oxidation of the electron-rich furan by a mechanism similar to 
that of DDQ oxidation of a PMB ether to provide a silyl oxocarbenium ion which 
upon attack by water would provide the aldehyde (Scheme 1.32).
26
 Acylation with 
crotonic anhydride provided cyclization precursor 1.32.2 ready for the key 
intramolecular C-C bond forming reaction. 
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 Piva, O.; Amougay, A.; Peter, J. P. Tetrahedron Lett. 1991, 32, 3993. 
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Scheme 1.32 Preparation of Cyclization Precursor 1.32.2 and Proposed Mechanism 
for the Oxidative Cleavage of the Furyl TBS Ether 
 
We were pleased to find that subjection of compound 1.32.2 to the standard 
intramolecular vinylogous aldol reaction conditions (lithium 2,2,6,6-tetramethyl-
piperidine (LTMP), 2.0 equiv; aluminum tris- (2,6-diphenylphenoxide) (ATPH), 2.2 
equiv; toluene/THF, -48 °C) provided the cyclized product in 86% yield as a 6:1 
diastereomeric mixture. In order to determine the stereochemistry at C-5 of this 
material, the alkene was reduced (H2, Pd/C, 1.33.2) and the alcohol oxidized to 
provide ketone 1.33.3. Reduction of the C-5-ketone with the (S)-CBS catalyst
27
 
provided the C-5 R-alcohol (1.33.4-R) in greater than 25:1 diastereoselectivity while 
reduction with the (R)-CBS catalyst provided the C-5 S-alcohol (1.33.4-S) in 4:1 
diastereoselectivity. The spectral data of 1.33.4-R were identical to that of 1.33.2, 
                                                 
27
 Corey, E. J.; Shibata, S.; Bakshi, R. K. J. Org. Chem. 1988, 53, 2861.  
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indicating that the product of the intramolecular vinylogous aldol reaction (1.33.1) 
bears the undesired configuration at C-5. While it is feasible that the stereochemistry 
at C-5 in compound 1.33.1 can be inverted, we instead studied a different cyclization 
precursor in order to directly obtain the desired stereochemical outcome as described 
below. 
 
 
Scheme 1.33 Intramolecular Vinylogous Aldol Reaction of 1.32.2 and Proof of 
Stereochemistry 
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We reasoned that the stereochemistry of the cyclization could be dictated by 
the conformation of the forming macrocycle, and that a different conformation could 
provide the desired stereochemical outcome. We therefore studied cyclization of 
silylene 1.34.1, which was prepared from silylene 1.31.3 by subjection to DDQ. 
Again, this resulted in the simultaneous deprotection of the PMB ether and oxidation 
at C-5 to provide the corresponding hydroxy aldehyde as observed on compound 
1.31.4. Acylation with crotonic anhydride then provided cyclization precursor 1.34.1. 
Subjection of compound 1.34.1 to our intramolecular vinylogous aldol reaction 
conditions provided macrolide 1.34.2 in 84% yield, again as a 6:1 diastereomeric 
mixture.   
 
Scheme 1.34 Preparation of Macrolide 1.34.2 
 
The stereochemistry of the C-5 alcohol in 1.34.2 was determined by chemical 
correlation as described for macrolide 1.33.1 in Scheme 1.33, and was found to have 
the desired S-configuration (Scheme 1.35). The alkene was reduced (H2, Pd/C, 
1.35.1) and the alcohol oxidized to provide ketone 1.35.2. Reduction of the C-5-
ketone with the (S)-CBS catalyst provided the C-5 R-alcohol (1.35.3-R) in greater 
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than 25:1 diastereoselectivity while reduction with the (R)-CBS catalyst provided the 
C-5 S-alcohol (1.35.3-S) in 4:1 diastereoselectivity. The spectral data of 1.35.3-S 
were identical to that of 1.35.1, indicating that the product of the intramolecular 
vinylogous aldol reaction (1.34.2) bears the desired configuration at C-5. 
 
 
Scheme 1.35 Stereochemical Determination of Macrocycle 1.34.2 
 
With the desired macrocycle 1.34.2 in hand, the dihydroxylation of the C2-C3 
alkene was examined. Subjection of compound 1.34.2 to dihydroxylation using the 
Upjohn conditions (OsO4, NMO)
28
 provided a 3:1 mixture of diastereomers which 
showed an intrinsic preference for the β-diol as drawn, which is the required 
                                                 
28
 VanRheenen, V.; Kelly, R. C.; Cha, D. Y. Tetrahedron Lett. 1976, 23, 1973. 
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stereochemistry for the synthesis of the natural product. The stereochemistry of these 
triols was determined by reagent-controlled dihydroxylations using AD-mix.
29
  
Treatment of 1.34.2 with AD-mix- provided a >10:1 mixture of 1.36.1 and 1.36.2.   
In acyclic systems, AD-mix- is known to produce the -diol, as drawn in Scheme 
1.36.  On the other hand, AD-mix- should provide the -diol, and in the 
dihydroxylation of 1.34.2, a 1.4:1 mixture of 1.36.1 and 1.36.2 is produced.  These 
results strongly support the assigned stereochemistry depicted in Scheme 1.36, where 
AD-mix- provides matched diastereoselectivity (>10:1 dr) and AD-mix- provides 
mismatched diastereoselectivity (1.4:1 dr).   
 
Scheme 1.36 Dihydroxylation of the C2-C2 Alkene 
 
In order to differentiate the hydroxyls in the resulting triol 1.36.1, the 
hydroxyl group at C-5 of 1.34.2 was protected as a TES ether and the alkene 
subjected to dihydroxylation using AD-mix-β to provide the diol bearing the natural 
                                                 
29
 (a) VanNieuwenhze, M.; Sharpless, K. B. Tetrahedron Lett. 1994, 35, 843. (b) Ahmed, M. M.; 
O’Doherty, G. Carbohydr. Res. 2006, 341, 1505. 
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stereochemistry in a 12:1 diastereomeric ratio. The stereochemistry of the product 
was established by subjection of compound 1.37.1 to acidic deprotection conditions, 
the product of which had identical spectra to that of triol 1.36.1 with the desired 
stereochemistry. Interestingly, selective removal of the TES ether in the presence of 
the silylene could be accomplished with PPTS while cleavage of the silylene in 
preference to the TES ether could be accomplished using HF• pyridine in 75% yield 
(data not shown). 
 
 
Scheme 1.37 Preparation of Diol 1.37.1 and Proof of Stereochemistry 
 
The C-2 hydroxyl group was then selectively protected as the TBS ether 
(TBSCl, imidazole), and the C-3 alcohol was methylated (trimethyloxonium 
tetrafluoroborate, proton sponge) (1.38.2, Scheme 1.38). With the installation of the 
protected diol complete, we turned our attention to the Achmatowicz reaction. We 
found that subjection of compound 1.38.2 to mild acid (PPTS, MeOH / DMF) 
selectively removed the TES group in preference to the silylene and TBS ethers to 
provide the desired C-5 alcohol.  After careful optimization, we found that subjection 
of this alcohol 1.38.3 to Achmatowicz reaction conditions (m-CPBA in the presence 
of trichloroacetic acid) with careful monitoring by TLC induced the oxidative 
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rearrangement and provided the desired pyranone 1.38.4 in 64% yield which is in 
good postion for conversion to the natural product. 
 
 
 
Scheme 1.38 Preparation of Pyranone 1.38.4 
 
We next turned our attention to the diastereoselective dihydroxylation of the 
C7-C8 alkene of pyranone 1.38.4. In order to achieve the desired stereochemistry in 
the natural product, we required an oxidant to approach the molecule from the β-face. 
We were encouraged to discover that in similar systems, O’Doherty observed 
dihydroxylation under Upjohn conditions (OsO4 cat., NMO) from the opposite face of 
a protected, pseudo-axial allylic alcohol (Scheme 1.39).
30
  
                                                 
30
 Babu, R. S.; O'Doherty, G. A. J. Am. Chem. Soc. 2003, 125, 12406. 
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Scheme 1.39 Literature precedence for desired Stereochemistry in Dihydroxylation 
 To mimic the precedented system, the pyranone ketone 1.38.4 was 
quantitately reduced to the α- (equatorial) position by axial attack of a hydride under 
Luche conditions (NaBH4, CeCl3(H2O)7) (1.40.1, data not shown). Acylated (1.40.2) 
and TES (1.40.3) ether protected derivatives of the hydroxyl group were also 
prepared by straightforward means to provide the dihydroxylation precursors shown 
in Scheme 1.40 but, surprisingly, there was no conversion of any of these precursors 
to the dihydroxylated product using catalytic OsO4. This is likely due to the hindered 
environment around the alkene. Under more forcing, superstoichiometric conditions, 
we did observe conversion to the diol but, disappointingly, the undesired 
stereochemistry was the only product observed.  
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Scheme 1.40 Dihydroxylation of the C7-C8 Olefin in Macrolides 1.40.1-3 
 It was hypothesized that the conformation about the macrolide was a 
contributing factor to the steric hindrance and blocking the β-face of the pyranone and 
that by adjusting the constraints about the macrolide would affect its conformation 
and thereby make the desired face of the alkene more accessible to dihydroxylation. 
This strategy had worked previously in reversing the stereoselectivity of the 
intramolecular vinylogous aldol, and as such, silylene-free intermediates 1.41.1 and 
1.41.2 were prepared (data not shown) and subjected to the superstoichiometric 
conditions as described above (Scheme 1.41). Unfortunately, the undesired 
stereochemistry was again the only observed product of the reaction and a more in 
depth look at this dihydroxylation was merited.  
 
Scheme 1.41  Dihydroxylation of the C7-C8 Olefin in Macrolides 1.41.1-2 
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 A closer examination of the system revealed the reason for the observed 
undesired stereoselectivity of the reaction. In order for a reagent to approach the 
alkene from the β-face, it must overcome an energetically unfavorable, developing 
syn-pentane interaction with the C-10 gem-dimethyl substituent 1.42.2. The α-face of 
the alkene has a less disfavorable interaction with the anomeric hydroxyl and is, 
therefore, more accessible to attack.   
 
Scheme 1.42 Rationale for undesired stereochemical outcome of the 
dihydroxylation of 1.42.1 
We proposed a strategy in which a directed dihydroxylation by a C-6 axial 
alcohol to the top face could be utilized (Scheme 1.43). Previously, Donahoe 
developed a method to prepare all syn triols by taking advantage of the tendency for a 
TMEDA/OsO4 complex to hydrogen bond the free hydroxyl and therefore deliver the 
reagent to the same face as the alcohol. Interestingly, these osmate esters do not 
cleave under standard workup conditions but instead require a harsher hydrolysis 
mediated by acidic methanol, reductive cleavage with Na2SO3, or ligand swap with 
excess ethylenediamine. We hoped the same tactic could be applied to our system and 
therefore prepared the C-6 axial “up” alcohol 1.43.1 by asymmetric reduction of the 
ketone with CBS catalyst (Scheme 1.43). 
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Scheme 1.43 Donohoe Directed Dihydroxylation with OsO4 and TMEDA 
 As shown in Scheme 1.44 below, even under directing conditions, our 
intermediates (1.44.1-4) are prone to undergo dihydroxylation on the bottom face of 
the molecule.  All of our intermediates contain the C9 hemiketal alcohol, and it is 
possible that the stereochemical outcome observed in this process is due to hydrogen 
bonding of the OsO4-TMEDA complex with this alcohol, but it is likely due to its 
hindered environment.  However, we cannot dismiss our previous hypothesis; the 
unfavorable interaction of the incoming osmium reagent with the gem-dimethyl group 
(a developing syn-pentane-like interaction) prevents dihydroxylation on the top face 
of the molecule despite having a directing group on that face.  As such, studying 
intermediates containing the protected alcohol at C9 would be a worthwhile endeavor. 
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Scheme 1.44 Dihydroxylation of the C7-C8 Olefin in Macrolides 1.44.1-4 
 
Pyran Model System Studies 
 
In order to preserve these valuable advanced intermediates, a model system 
was developed to mimic the actual system and its synthesis is described below 
(Scheme 1.45, other systems were also studied and are discussed in the experimental). 
2-Furoic acid 1.45.1 was subjected to a Friedel-Crafts alkylation (AlCl3, t-BuCl) 
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installing what would become the gem-dimethyl substituent in the model system. A 
CuO mediated decarboxylation of acid 1.45.2 with heating provided 2-t-butylfuran 
(1.45.3) in 40% yield over 2 steps. Lithiation α- to the furan oxygen and subsequent 
trapping by propionaldehyde provided the desired furyl alcohol 1.45.4 in good yield. 
This was subjected to an Achmatowicz oxidative rearrangement, providing the 
desired pyranone 1.45.5 as the only detectable diastereomer. 
 
 
Scheme 1.45 Preparation of model system 1.45.5 
  
To study the applicability of the model system to the actual system, pyranone 
1.45.5 was dihydroxylated under identical conditions (OsO4/TMEDA) providing an 
osmate ester 1.46.1 of unknown stereochemistry. Reduction of the ketone with 
NaBH4 provided alcohol 1.46.2, the stereochemistry of which could be ascertained by 
an analysis of coupling constants. We were pleased to find that system performed 
analogously to the actual system, giving the all syn triol. In obtaining data that our 
model system mimics the reactivity of that in the actual system, we continued 
studying the dihydroxylation under several different conditions as described below.  
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Scheme 1.46 Dihydroxylation of pyranone 1.45.5 
 
We wished to further study the hydroxyl directed dihydroxylation on the 
model system. In the actual system the pyranone ketone was stereoselectively reduced 
to the β-position using the CBS catalyst. The model system we had prepared was 
racemic and would therefore not be amenable to an enantioselective reduction. While 
possible to prepare an enantioenriched model system, it was simpler to pursue a 
hydroxyl-directed reduction of the racemic ketone. Evans had previously developed a 
method using Me4N(OAc)3BH whereby reduction cannot occur unless the reagent is 
bound to a directing alcohol. This is a method of choice for preparing 1,2- and 1,3-
anti-diols and it is so selective that even acetone can be used as a solvent in the 
reaction without undergoing reduction to i-PrOH. We hoped that the C-9 hemiketal 
hydroxyl of 1.45.5 could act as the binding site, thereby delivering the hydride across 
the ring to the bottom side of the ketone, resulting in the desired up stereochemistry in 
1.47.1 (Scheme 1.47).  
 
Scheme 1.47  Proposed directed reduction of ketone 1.45.5 
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 When the model system was subjected to the proposed conditions, ketone 
1.48.1 was isolated in good yield (Scheme 1.48). While we did not achieve the 
desired directed reduction to the underside of the ketone, we did observe a product 
that is consistent with 1,4-congugate addition of the hydride into the alkene of the 
α,β-unsaturated ketone. We propose a mechanism that involves direction of the 
hydride into the alkene in a conjugate fashion followed by elimination of the 
hemiketal alcohol. To the best of our knowledge, this is a novel observation and 
although not applicable to our current system of interest, this reactivity could 
potentially have utility in the stereoselective, hydroxyl directed reduction of γ-
hydroxy-α,β-unsaturated enones. The development and optimization of this reaction, 
however, is beyond the scope of this thesis research.  
 
Scheme 1.48 Directed reduction of ketone 1.45.5 
 
As aforementioned, studying intermediates containing the protected alcohol at 
C9 would be a worthwhile endeavor. We, therefore, studied conditions (TMSCl, 
DMAP, imid., DMF) that would protect the very sterically hindered C-9 hydroxyl as 
a TMS ether 1.49.1. We hypothesized that the large silyl group would block the 
bottom face of the alkene and force the dihydroxylation to come from the top face 
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despite the developing syn pentane interaction it must overcome. Gratifyingly, 
stoichiometric dihydroxylation of the TMS ether 1.49.1 (OsO4/TMEDA) provided a 
new product of unknown stereochemistry 1.49.2.  
In order to prove the stereochemistry by coupling constant analysis, we 
reduced the ketone 1.49.2 with NaBH4 (1.49.3, Scheme 1.49). The corresponding 
reduction in the actual system under these conditions provides the α-alcohol, and we 
expected the same outcome in the model system. However, with compound 1.49.2, 
NaBH4 attacked from the α-face to provide alcohol 1.49.3 of β-stereochemistry. This 
was initial evidence of obtaining the desired stereochemistry in the dihydroxylation 
step because a bulky osmate ester on the α-face would hinder hydride attack from the 
α-face of the carbonyl and favor β-attack. A closer examination of the coupling 
constants of triol 1.49.4 indicated that we had indeed obtained the desired 
stereochemistry in the dihydroxylation.  
 
Scheme 1.49  Synthesis of triol 1.49.4 
 With conditions identified that gave the desired stereochemistry of the 
dihydroxylation in the model system, we focused on their application to the actual 
system. Regrettably, none of the attempted protections of the hemiketal were 
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achieved (Scheme 1.50). It became clear that the hydroxyl of the actual system was 
more sterically hindered and could not be functionalized even under forcing 
conditions.  
  
Scheme 1.50 Attempted protection of 1.38.4 
The significant challenges associated with conversion of the substrates that 
were studied to the natural product led us to investigate alternative strategies to 
complete the synthesis of (+)-peloruside A. Although we had devised a novel solution 
to the limitations of the intramolecular Yamamoto vinylogous aldol reaction, the 
current non-enolizable aldehyde strategy presented us with obstacles that would not 
have to be faced if a method existed for the use of enolizable aldehyde coupling 
partners (Scheme 1.51). Most notably, the diastereoselective dihydroxylation of the 
C7-C8 alkene and deoxygenation at C6 would be avoided. While we have not 
completely exhausted the set of conditions to prepare the target molecule by this 
route, we felt it necessary to step back and more closely examine the fundamental 
aspects of the Yamamoto vinylogous aldol reaction.  
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Scheme 1.51 Proposed Yamamoto intramolecular vinylogous aldol reaction with 
enolizable aldehyde coupling partner 1.51.1. 
 
 
1.6 Experimental 
 
All reactions were performed in oven-dried or flame-dried glassware under a 
dry nitrogen atmosphere.  Toluene was washed with concentrated H2SO4, H2O, 1 M 
NaOH, H2O, dried over MgSO4, filtered and distilled from CaH2 under nitrogen prior 
to use.  MeOH, CH2Cl2, Et3N, 2,2,6,6-tetramethylpiperidine, 2,6-lutidine, and HMPA, 
were distilled from CaH2 under nitrogen prior to use. DMF was distilled at reduced 
pressure from CaH2.  DMSO was distilled from CaH2 and stored over 4 Å molecular 
sieves prior to use.  THF and Et2O were distilled from Na benzophenone ketyl under 
nitrogen prior to use.  Crotonic anhydride was fractionally distilled at reduced 
pressure.  85% MCPBA was purified by dissolving in CH2Cl2 and washing with pH 
7.5 phosphate buffer (1M).  All other chemicals were used as received from the 
supplier.  Cy2NLi was purchased as a solid from Aldrich chemical company and 
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suspended in dry, distilled toluene (weighed and transferred in a glove bag under 
nitrogen) prior to use.  Flash chromatography was performed using 60 Å silica gel 
(37-75 μ).  1H NMR spectra were recorded at either 400 MHz or 500 MHz in CDCl3 
using residual CHCl3 (7.24 ppm) as the internal reference.  
13
C NMR spectra were 
recorded at 75 MHz or 100 MHz in CDCl3 using residual CHCl3 (77.26 ppm) as the 
internal reference.  Infrared (IR) spectra were obtained as thin films on NaCl plates.  
Exact mass was determined using electrospray ionization. 
((5-bromofuran-2-yl)methoxy)(tert-butyl)dimethylsilane (1.29.2):  
 
 
 
 This reaction was performed according to the procedure of Joe Abramite.
31
 
Borane (500 mL of 1 M solution in THF, 0.5 mol, 2.0 equiv) was slowly added (over 
~ 4 hours) to a solution of 5-bromo-2-furoic acid (49.6 g, 0.26 mol, 1.0 equiv) in THF 
(0.3 L) at 0 
o
C.  The reaction was warmed to room temperature and stirred for 2 days.  
(Note: This reaction was also performed with BH3•SMe2 and provided similar 
results.)  The reaction was quenched by adding MeOH slowly at 0 
o
C until the 
evolution of H2 gas subsided.  The solution was warmed to room temperature; more 
MeOH (~200 mL) was added and the solution was stirred for 1 hr.  The majority of 
                                                 
31
 Abramite, J. The Intramolecular Yamamoto Vinylogous Aldol Reaction and Its Application in the 
Total Synthesis of (+)-Peloruside A. Dissertation, University of Colorado, Boulder.  
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the solvent was removed under reduced pressure to provide a solution of the crude 
product in approximately 50 mL of solvent.  A MeOH (200 mL) solvent exchange 
wherein MeOH was added then distilled at reduced pressure was performed twice to 
remove residual boron species as trimethylborate.  A pentane (200 mL) solvent 
exchange was then performed twice to remove the residual MeOH.  The crude 
bromo-furyl alcohol was carried on to the next step without purification.  Note that 
warming this material or exposure to silica gel results in a mildly exothermic 
decomposition to provide a blue/black tarry substance. 
 TBSCl (43.1 g, 0.29 mol, 1.1 equiv), imidazole (21.3 g, 0.31 mol, 1.2 equiv), 
and DMAP (0.5 g, 4 mmol, 1 mol %) were added sequentially to a solution of the 
crude alcohol (assumed to be 0.26 mol, 1 equiv) in CH2Cl2 (1 L) at 0 
o
C.  The 
reaction was warmed to room temperature and stir for approximately 1 hr, after which 
time TLC indicated complete conversion to the TBS ether.  The reaction mixture was 
filtered through Celite, and the filtrate was washed with dilute HCl and brine, dried 
over MgSO4, and concentrated under reduced pressure.  The crude product was 
purified by flash chromatography (30:1 hexanes:EtOAc) to provide 5
1
 (70 g, 0.24 
mol, 94% over two steps). 
1
H NMR (500 MHz; CDCl3):  δ 6.21 (d, J = 3.2, 1H), 6.19 (d, J = 3.2, 1H), 
4.57 (s, 2H), 1.03 – 0.72 (m, 9H), 0.20 – -0.03 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 
156.62, 121.33, 112.06, 110.12, 58.27, 26.10, 18.64, -4.99; HRMS (ESI) m/z calc’d 
for C5H4OBr [M - HOTBS]
+
: 158.9446; found: 158.9451. 
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Methyl 2-(5-((tert-butyldimethylsilyloxy)methyl)furan-2-yl)-2-methylpropanoate 
(1.29.2a)
31
 
 
  
A suspension of Cy2NLi (66.7 mL of a 0.8 M suspension in toluene, 53.3 
mmol, 1.6 equiv) was cannulated into a flask containing methyl isobutyrate (3.75 g, 
36.7 mmol, 1.1 equiv) at 0
 
ºC .  This mixture was stirred for 10 minutes and the 
resulting solution was cannulated into another flask containing bromofuran 1.29.2 
(9.70 g, 33.3 mmol, 1.0 equiv) and Pd(dba)2 (0.46 g, 0.5 mmol, 1.5 mol %).  A 
solution of PtBu3 (3.0 mL of 0.17 M in toluene, 0.5 mmol, 1.5 mol %) was added, and 
the reaction was then stirred at room temperature overnight (15 hours).  The solvent 
was removed under reduced pressure, and a solution of 5:1 hexanes to EtOAc (~150 
mL) was added to the crude mixture.  This mixture was washed with 1 M HCl (3 x 
100 mL), filtered through filter paper, and washed with water (100 mL), and brine (50 
mL), dried over MgSO4, and concentrated under reduced pressure.  The crude 
material was purified by flash chromatography (gradient, hexanes to 10:1 
hexanes:EtOAc) to provide 1.29.2a (7.7 g, 24.6 mmol, 90%). 
1
H NMR (400 MHz; CDCl3):  δ 6.15 (d, J = 3.2, 1H), 6.07 (d, J = 3.2, 1H), 
4.60 (s, 2H), 3.66 (s, 3H), 1.54 (s, 6H), 0.92 – 0.86 (m, 9H), 0.08 – 0.05 (m, 6H).  13C 
NMR (100 MHz; CDCl3):  δ 157.28, 153.59, 108.13, 105.63, 77.56, 77.44, 77.24, 
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76.92, 58.42, 52.59, 43.65, 26.05, 24.76, 18.57, -5.00; HRMS (ESI) m/z calc’d for 
C10H13O3 [M - HOTBS]
+
: 181.0865; found: 181.0862. 
 
2-(5-((tert-butyldimethylsilyloxy)methyl)furan-2-yl)-2-methylpropanal (1.29.3)
31
: 
 
 
 
 DIBAL-H (14.4 mL 1.0 M solution in hexanes, 14.4 mmol, 1.1 equiv) was 
added dropwise via cannula to a solution of ester 1.29.2a (4.1 g, 13.1 mmol, 1.0 
equiv) in Et2O (50 mL) at -78 
o
C.  The reaction was stirred for 1 hr at -78 
o
C, and then 
excess DIBAL-H was quenched with EtOAc (~20 mL).  The reaction was then 
cannulated into a vigorously stirred solution of saturated Rochelle’s salt (50 mL).  
This biphasic mixture was stirred at room temperature for 2 hours, after which time 
the organic phase was separated, washed with brine, dried over MgSO4, and 
concentrated under reduced pressure.  The crude material was purified by flash 
chromatography (30:1 hexanes:EtOAc) to provide aldehyde 1.29.3 (3.2 g, 11.5 mmol, 
88%). 
1
H NMR (500 MHz; CDCl3):  δ 9.48 (s, 1H), 6.17 (d, J = 3.2, 1H), 6.11 (d, J 
= 3.2, 1H), 4.58 (s, 2H), 1.39 (s, 6H), 0.98 – 0.76 (m, 9H), 0.14 – -0.10 (m, 6H).  13C 
NMR (100 MHz; CDCl3):  δ 200.41, 154.98, 154.79, 108.42, 107.39, 58.38, 48.21, 
26.05, 20.67, 18.60, -5.00. 
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(2S,3S)-2-(benzyloxy)-5-methylhex-5-en-3-ol (8)
31
: 
 
 
 
 Aldehyde 1.30.1 was prepared from (-)-ethyl lactate following known 
literature procedures (88% over two steps).
32
  Aldehyde 1.30.1 was then converted to 
alcohol 1.30.2 via a known literature procedure (89%, > 30:1 dr).
21
  
(S)-ethyl 2-(benzyloxy)propanoate:
  1
H NMR (500 MHz; CDCl3):  δ 7.42 – 
7.25 (m, 5H), 4.68 (d, J = 11.6, 1H), 4.43 (d, J = 11.6, 1H), 4.26 – 4.13 (m, 2H), 4.03 
(q, J = 6.9, 1H), 1.42 (d, J = 6.9, 3H), 1.28 (t, J = 7.1, 3H).   
1.30.1:
  1
H NMR (500 MHz; CDCl3):  δ 9.65 (d, J = 1.8, 1H), 7.41 – 7.27 (m, 
5H), 4.61 (q, J = 11.7, 2H), 3.88 (qd, J = 1.8, 7.0, 1H), 1.32 (d, J = 7.0, 3H).   
1.30.2: 
 1
H NMR (500 MHz; CDCl3):  δ 7.37 – 7.26 (m, 5H), 4.88 – 4.73 (m, 
2H), 4.66 (d, J = 11.5, 1H), 4.45 (d, J = 11.5, 1H), 3.69 – 3.60 (m, 1H), 3.44 (p, J = 
6.2, 1H), 2.42 (d, J = 3.8, 1H), 2.26 – 2.13 (m, 2H), 1.76 (s, 3H), 1.23 – 1.18 (m, 3H); 
13
C NMR (75 MHz, CDCl3) δ 142.95, 138.62, 128.69, 128.04, 127.97, 113.20, 77.92, 
72.76, 71.37, 41.76, 22.70, 15.86; HRMS (ESI) m/z calc’d for C14H20O2Na [M+Na]
+
: 
243.1361; found: 243.1360. 
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 Enders, D.; von Berg, S.; Jandeleit, B. Org. Synth. 2002, 78, 177. 
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1-(((2S,3S)-2-(benzyloxy)-5-methylhex-5-en-3-yloxy)methyl)-4-methoxybenzene 
(1.30.2a)
31
: 
 
A solution of alcohol 1.30.2 (0.86 g, 3.9 mmol, 1.0 equiv) in DMF (5 mL) was 
slowly added via cannula to stirred mixture of p-methoxybenzyl chloride (0.79 mL, 
5.9 mmol, 1.5 equiv) and sodium hydride (0.24 g 60% in mineral oil, 5.9 mmol, 1.5 
equiv) in DMF (5 mL) at 0 ºC.  The reaction was warmed to room temperature.  After 
4 hours, saturated NaHCO3 (10 mL), water (20 mL), hexanes (20 mL), and EtOAc (5 
mL) were added sequentially.  The organic phase was separated, washed with water, 
1 M CuSO4 and brine, dried over MgSO4, and concentrated under reduced pressure.  
The crude product was purified by flash chromatography (gradient, hexanes to 10:1 
hexanes:EtOAc) to provide olefin 1.30.2a (1.3 g, 3.8 mmol, 97%). 
1
H NMR (500 MHz; CDCl3):  δ 7.39 – 7.30 (m, 5H), 7.28 – 7.24 (m, 2H), 
6.91 – 6.85 (m, 2H), 4.81 (d, J = 14.8, 2H), 4.64 (d, J = 11.9, 1H), 4.57 – 4.50 (m, 
3H), 3.83 (s, 3H), 3.72 – 3.64 (m, 1H), 3.63 - 3.58 (m, 1H), 2.36 (dd, J = 3.8, 14.1, 
1H), 2.25 (dd, J = 8.6, 14.2, 1H), 1.75 (s, 3H), 1.20 (d, J = 6.3, 3H). 
 13
C NMR (100 
MHz; CDCl3):  δ 159.37, 143.46, 139.18, 131.17, 129.83, 128.59, 127.95, 127.74, 
127.69, 113.91, 112.84, 79.43, 77.54, 75.79, 72.46, 71.55, 55.54, 38.49, 23.19, 15.44.   
[α]D = +20.7 (c 2.65, CHCl3).  IR (cm
-1
):  3068, 3032, 2935, 2864, 1612, 1513, 1454, 
1174, 1092, 1037, 888, 821, 738, 698;  
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(4S,5S)-5-(benzyloxy)-4-(4-methoxybenzyloxy)hexan-2-one (1.30.3)
31
: 
 
 
 
2,6-Lutidine (0.77 mL, 6.6 mmol, 2.0 equiv), OsO4 (0.66 mL 0.1 M in water, 
0.07 mmol, 2 mol %), and sodium periodate (2.82 g, 13.2 mmol, 4.0 equiv) were 
added sequentially to a solution of olefin 1.30.2a (1.12 g, 3.3 mmol, 1.0 equiv) in 3:1 
dioxane:H2O (32 mL) at room temperature.  After stirring overnight (20 h), the 
reaction mixture was diluted with water (50 mL) and CH2Cl2 (100 mL).  The organic 
phase was separated, and the aqueous phases was extracted with CH2Cl2 (2 x 50 mL).  
The combined organic phases were washed with brine, dried over MgSO4, filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (gradient, hexanes to 2:1 hexanes:EtOAc) to provide ketone 1.30.3 
(1.1 g, 3.1 mmol, 95%). 
1
H NMR (500 MHz; CDCl3):  δ 7.35 – 7.25 (m, 5H), 7.21 – 7.16 (m, 2H), 
6.86 – 6.79 (m, 2H), 4.54 (d, J = 11.9, 1H), 4.47 (s, 2H), 4.46 – 4.41 (m, 1H), 4.10 – 
4.03 (m, 1H), 3.77 (s, 3H), 3.64 (qd, J = 4.5, 6.4, 1H), 2.68 – 2.62 (m, 2H), 2.09 (s, 
3H), 1.14 (d, J = 6.4, 3H). 
 13
C NMR (100 MHz; CDCl3):  δ 207.93, 159.46, 138.78, 
130.80, 129.85, 128.63, 127.98, 127.86, 113.98, 94.66, 77.50, 76.48, 74.76, 72.76, 
D = +7.0 (c 0.690, CHCl3).  IR (cm
-1
):  2933, 
2857, 1716, 1612, 1513, 1248, 1091, 822, 740; HRMS (ESI) m/z calc’d for 
C21H26O4Na [M+Na]
+
: 365.1729; found: 365.1718. 
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(3S,7S,8S)-8-(benzyloxy)-2-(5-((tert-butyldimethylsilyloxy)methyl)furan-2-yl)-3-
hydroxy-7-(4-methoxybenzyloxy)-2-methylnonan-5-one (1.31.3)
31
: 
 
 
 Diisopropylethylamine (0.71 mL, 4.1 mmol, 1.55 equiv) was added to a 
solution of ketone 1.30.3 (0.90 g, 2.6 mmol, 1.0 equiv) in Et2O (26 mL) at room 
temperature.  This solution was cooled to approximately -100 ºC (using a refrigerated 
Et2O/dry ice/liquid N2 bath), and nBu2BOTf (3.7 mL 1 M in CH2Cl2, 3.7 mmol, 1.4 
equiv) was added dropwise over ~3 min.  Following the addition, the reaction was 
stirred for 30 min, after which time a solution of aldehyde 1.29.3 (0.89 g, 3.2 mmol, 
1.2 equiv) in Et2O (7 mL) was slowly added (~ 1 hr) via cannula.  The reaction was 
maintained between -100 
o
C and -90 
o
C for 5 hr, and then the addition of liquid 
nitrogen was ceased and the solution warmed to -78 
o
C and stirred for 1 hr.  TLC 
indicated that the reaction was complete, and a solution of 6:1 MeOH to pH 7 buffer 
(33 mL) was added.  The reaction mixture was warmed to 0 
o
C (ice bath), and the 
septum was removed and a solution of 2:1 MeOH to 30% H2O2 (27 mL) was added 
dropwise via pipet over ~15 minutes in order to avoid an exotherm.  The reaction was 
warmed to room temperature and stirred for 2 hours.  The mixture was diluted with a 
solution of 1:1 hexanes to EtOAc (200 mL), and cooled in an ice bath.  A dilute 
solution of aqueous K2CO3 was then added dropwise over 15 minutes (caution, gas 
evolution!).  This biphasic mixture was vigorously stirred for 2 hours, then the 
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organic phase was separated, washed with brine, dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (gradient, 10:1 to 2:1 hexanes:EtOAc) to provide alcohol 1.31.1 
(1.43 g, 2.3 mmol, 87%, obtained as a ~6:1 mixture of diastereomers from which the 
minor diastereomer was removed in subsequent steps.). 
1
H NMR (500 MHz; CDCl3):  δ 7.34 – 7.25 (m, 5H), 7.16 (d, J = 8.7, 2H), 
6.84 – 6.79 (m, 2H), 6.10 (d, J = 3.1, 1H), 5.96 (d, J = 3.1, 1H), 4.56 (s, 2H), 4.50 (d, 
J = 11.9, 1H), 4.44 (s, 2H), 4.42 (d, J = 11.9, 1H), 4.05 (dt, J = 4.6, 9.2, 1H), 3.78 - 
3.73 (m, 4H), 3.61 (dd, J = 4.6, 6.4, 1H), 2.67 – 2.55 (m, 2H), 2.45 – 2.36 (m, 2H), 
1.24 (s, 3H), 1.20 (s, 3H), 1.11 (d, J = 6.4, 3H), 0.88 – 0.85 (m, 9H), 0.06 – 0.03 (m, 
6H). 
13
C NMR (101 MHz, CDCl3) δ 210.68, 160.01, 159.42, 153.20, 138.74, 138.66, 
130.76, 130.67, 130.61, 129.85, 129.80, 128.59, 127.94, 127.92, 127.82, 113.95, 
108.08, 106.04, 76.56, 76.44, 76.20, 74.79, 74.72, 74.67, 73.32, 72.79, 72.71, 71.27, 
58.44, 55.49, 46.41, 46.18, 44.00, 43.94, 43.84, 40.26, 31.33, 26.08, 23.89, 23.78, 
21.76, 21.51, 18.60, 14.79, 14.73, -4.92. 
 
D = +2.7 (c 1.00, CHCl3).  IR (cm
-1
):  
3503, 2932, 2858, 1715, 1614, 1514, 1463, 1380, 1249, 1079, 837. HRMS (ESI) m/z 
calc’d for C36H52O7NaSi [M+Na]
+
: 647.3380; found: 647.3384. 
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(3S,5S,7S,8S)-8-(benzyloxy)-2-(5-((tert-butyldimethylsilyloxy)methyl)furan-2-yl)-
7-(4-methoxybenzyloxy)-2-methylnonane-3,5-diol (1.31.2)
31
: 
 
 Me4NBH(OAc)3 (0.26 g, 1.0 mmol, 5.0 equiv) was added to a solution of 
acetonitrile (0.5 mL) and acetic acid (1.0 mL) at room temperature.  After 10 min, the 
solution was cooled to -20 ºC, and a solution of alcohol 1.31.1 (0.12 g, 0.2 mmol, 1.0 
equiv) in acetonitrile (0.5 mL) was added via cannula.  The reaction was stirred 
overnight (20 h) at -20 ºC.  A solution of saturated Rochelle’s salt (5 mL) was then 
added and reaction was stirred at room temperature for 10 min.  The reaction mixture 
was extracted with CH2Cl2 (2 x 10 mL).  The combined organic extracts were washed 
with saturated NaHCO3 and brine, dried over MgSO4, filtered, and concentrated 
under reduced pressure.  The crude material was purified by flash chromatography 
(gradient, 5:1 to 2:1 hexanes:EtOAc) to provide diol 1.31.2 (0.12 g, 0.12 mmol, 
93%).   
1
H NMR (500 MHz; CDCl3):  δ 7.37 – 7.26 (m, 6H), 7.19 – 7.14 (m, 2H), 
6.86 – 6.80 (m, 2H), 6.10 (d, J = 3.1, 1H), 5.97 (d, J = 3.1, 1H), 4.60 (d, J = 5.2, 1H), 
4.58 (d, J = 4.2, 1H), 4.56 (s, 2H), 4.49 – 4.45 (m, 1H), 4.39 (d, J = 10.9, 1H), 4.01 (s, 
1H), 3.94 (dt, J = 4.2, 8.7, 1H), 3.79 – 3.77 (m, 4H), 3.76 – 3.69 (m, 2H), 2.62 (d, J = 
4.2, 1H), 1.74 – 1.61 (m, 2H), 1.47 – 1.39 (m, 2H), 1.24 (s, 3H), 1.23 (s, 3H), 1.15 (d, 
J = 6.1, 4H), 0.90 – 0.83 (m, 9H), 0.08 – 0.03 (m, 6H). 13C NMR (75 MHz, CDCl3) δ 
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165.36, 159.11, 155.41, 143.96, 138.89, 128.50, 128.08, 127.68, 124.49, 106.58, 
106.23, 75.52, 75.37, 73.00, 71.39, 67.86, 67.08, 42.48, 41.73, 36.63, 35.58, 25.77, 
D = -13.1 (c 
0.890, CHCl3).  IR (cm
-1
):  3449, 2930, 2858, 1612, 1513, 1250, 1076, 837; HRMS 
(ESI) m/z calc’d for C36H55O7Si [M+H]
+
: 627.3717; found: 627.3731. 
 
(4R,6S)-4-((2S,3S)-3-(benzyloxy)-2-(4-methoxybenzyloxy)butyl)-6-(2-(5-((tert-
butyldimethylsilyloxy)methyl)furan-2-yl)propan-2-yl)-2,2-diisopropyl-1,3,2-
dioxasilinane (1.31.3)
31
: 
 
 
 DMAP (0.205 g, 1.68 mmol, 0.2 equiv), triethylamine (2.9 mL, 21 mmol, 2.5 
equiv), and dichlorodiisopropyl silane (2.27 mL, 12.6 mmol, 1.5 equiv) were added 
sequentially to a solution of diol 1.31.2 (5.26 g, 8.39 mmol, 1.0 equiv) in DMF (84 
mL) at room temperature. The reaction was stirred at room temperature for 12 hours 
then quenched with saturated NaHCO3. The mixture was diluted with 1:1 
Hexanes/EtOAc and poured into water. The organic phase was separated, washed 
with brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The 
crude product was purified by flash chromatography (gradient, CH2Cl2 to 10:10:1 
CH2Cl2:hexanes:Et2O) to provide silylene 1.31.3 (5.89 g, 7.97 mmol, 95%).  
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1
H NMR (500 MHz, CDCl3) δ 7.32 – 7.25 (m, 5H), 7.21 – 7.15 (m, 2H), 6.85 
– 6.79 (m, 2H), 6.08 (d, J = 3.1 Hz, 1H), 5.91 (d, J = 3.1 Hz, 1H), 4.59 – 4.51 (m, 
3H), 4.48 – 4.42 (m, 2H), 4.39 (d, J = 11.4 Hz, 1H), 4.14 – 4.04 (m, 2H), 3.78 (s, 3H), 
3.67 – 3.59 (m, 1H), 3.40 (dd, J = 10.9, 6.4 Hz, 1H), 1.87 (dt, J = 14.4, 7.3 Hz, 1H), 
1.75 – 1.57 (m, 2H), 1.27 (dt, J = 14.5, 2.2 Hz, 1H), 1.23 (s, 3H), 1.19 (s, 3H), 1.14 
(d, J = 6.3 Hz, 3H), 0.98 (dd, J = 7.2, 4.1 Hz, 6H), 0.92 (ddd, J = 9.9, 6.6, 3.3 Hz, 
6H), 0.89 – 0.85 (m, 10H), 0.04 (d, J = 2.2 Hz, 6H). 13C NMR (100 MHz; CDCl3):  δ 
160.58, 152.71, 139.08, 131.19, 129.71, 128.53, 128.00, 127.71, 113.87, 107.97, 
105.71, 77.92, 77.48, 75.13, 73.89, 72.01, 71.11, 69.03, 58.54, 55.52, 41.27, 37.03, 
34.67, 26.14, 24.46, 20.68, 17.24, 17.14, 17.06, 15.42, 13.96, 13.26, - D = 
+12.6 (c 0.170, CHCl3).  IR (cm
-1
):  2931, 2860, 1513, 1464, 1249, 1079, 837. 
 
5-(2-((4S,6R)-6-((2S,3S)-3-(benzyloxy)-2-hydroxybutyl)-2,2-diisopropyl-1,3,2-
dioxasilinan-4-yl)propan-2-yl)furan-2-carbaldehyde (1.34.1a)
31
: 
 
DDQ (4.3 g, 18.8 mmol, 2.3 equiv) was added to a solution of furan 1.31.3 
(6.0 g, 8.1 mmol, 1.0 equiv) in 10:1 CH2Cl2 to H2O (165 mL, biphasic).  The solution 
was heated to reflux for 1 hour, then cooled to room temperature and quenched with 
saturated NaHCO3 (150 mL).  The organic phase was separated, washed with water 
and brine, dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
68 
 
crude product was purified by flash chromatography (gradient, hexanes to 5:1 
hexanes:EtOAc) to provide the desired hydroxy aldehyde 1.34.1a (2.9 g, 5.8 mmol, 
72%). 
1
H NMR (500 MHz, CDCl3) δ 9.52 (s, 1H), 7.36 – 7.25 (m, 5H), 7.15 (d, J = 
3.6 Hz, 1H), 6.29 (d, J = 3.6 Hz, 1H), 4.62 (d, J = 11.8 Hz, 1H), 4.45 (d, J = 11.8 Hz, 
1H), 4.34 – 4.26 (m, 1H), 4.18 (dd, J = 9.9, 2.4 Hz, 1H), 3.70 – 3.62 (m, 1H), 3.53 – 
3.44 (m, 1H), 3.36 (d, J = 2.4 Hz, 1H), 1.89 – 1.75 (m, 2H), 1.56 – 1.46 (m, 2H), 1.33 
(s, 3H), 1.31 (s, 3H), 1.17 (d, J = 6.3 Hz, 3H), 1.00 – 0.78 (m, 18H). 13C NMR (100 
MHz; CDCl3):  δ 177.39, 168.22, 138.80, 128.65, 128.05, 127.91, 109.21, 77.48, 
74.13, 73.77, 71.80, 71.29, 42.22, 38.30, 35.39, 23.29, 21.58, 17.04, 17.02, 16.95, 
16.80, 15.04, 13.67, 13.19.  [α]D = +16.5 (c 0.280, CHCl3).  IR (cm
-1
):  3489, 2943, 
2866, 1680, 1512, 1464, 1385, 1248, 1107, 920, 803, 697; HRMS (ESI) m/z calc’d 
for C28H42O6NaSi [M+Na]
+
: 525.2648; found: 525.2651. 
 
(E)-((2S,3S)-3-(benzyloxy)-1-((4R,6S)-6-(2-(5-formylfuran-2-yl)propan-2-yl)-2,2-
diisopropyl-1,3,2-dioxasilinan-4-yl)butan-2-yl) but-2-enoate (1.34.1)
31
: 
 
Triethylamine (1.1 mL, 7.9 mmol, 1.5 equiv) and DMAP (0.13 g, 1.0 mmol, 
0.2 equiv) were added to a solution of alcohol 1.34.1a (2.63 g, 5.2 mmol, 1.0 equiv) 
and crotonic anhydride (1.0 mL, 6.8 mmol, 1.3 equiv) in CH2Cl2 (50 mL) at 0 ºC.  
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After 4 hours at 0 ºC, the reaction was quenched with saturated NaHCO3 (50 mL).  
The organic phase was separated, washed with water and brine, dried over MgSO4, 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
flash chromatography (gradient, hexanes to 5:1 hexanes:EtOAc) to provide ester 
1.34.1 (2.89 g, 5.1 mmol, 97%).  
1
H NMR (500 MHz, CDCl3) δ 9.53 (s, 1H), 7.38 – 7.27 (m, 5H), 7.16 (d, J = 
3.6 Hz, 1H), 6.97 (dq, J = 13.7, 6.8 Hz, 1H), 6.28 (d, J = 3.6 Hz, 1H), 5.85 (dd, J = 
15.5, 1.7 Hz, 1H), 5.04 – 4.96 (m, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 
Hz, 1H), 4.15 (d, J = 9.0 Hz, 1H), 4.03 (dd, J = 13.9, 6.5 Hz, 1H), 3.71 – 3.62 (m, 
1H), 2.03 (dt, J = 15.7, 5.4 Hz, 1H), 1.88 – 1.78 (m, 4H), 1.76 – 1.66 (m, 1H), 1.46 
(d, J = 14.7 Hz, 1H), 1.28 (dd, J = 24.6, 7.7 Hz, 8H), 1.15 (d, J = 6.4 Hz, 3H), 0.97 
(dd, J = 7.1, 3.2 Hz, 6H), 0.94 – 0.78 (m, 11H). 13C NMR (100 MHz; CDCl3):  δ 
181.13, 177.43, 166.28, 145.31, 138.67, 128.60, 128.08, 127.89, 122.90, 109.19, 
77.79, 77.48, 74.20, 73.66, 72.59, 71.11, 68.90, 42.13, 36.50, 34.20, 23.18, 21.59, 
18.27, 17.00, 16.94, 16.82, 15.38, 13.81, 13.10.  [α]D = +19.1 (c 0.067, CHCl3).  IR 
(cm
-1
):  2938, 2865, 1717, 1681, 1511, 1467, 1251, 1107, 696; HRMS (ESI) m/z 
calc’d for C32H47O7Si [M+H]
+
: 571.3091; found: 571.3108. 
 
Macrolide 1.34.2: 
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A solution of cyclization precursor 1.34.1 (76 mg, 0.13 mmol, 1.0 equiv) in 
toluene (1.5 mL) was added to a stirred solution of freshly prepared ATPH* (0.29 
mmol, 2.2 equiv) in toluene (1.5 mL) at -78 ºC.  After 20 minutes, the 1.34.1-ATPH 
solution was added dropwise via cannula (1 hour) to a stirred solution of LTMP** 
(0.40 mmol, 3.0 equiv) in THF (1.2 mL) and toluene (9.0 mL) at -78 ºC.  After 30 
minutes at -78 ºC, the ice bath was removed and saturated NH4Cl (10 mL) was 
immediately added.  The biphasic mixture was stirred vigorously for 20 minutes 
while warming to ambient temperature, then filtered through a small pad of Celite and 
rinsed with Et2O (20 mL).  The organic phase of the filtrate was separated and 
washed with brine, dried over MgSO4, filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash chromatography (gradient, 5:1 to 
1:1 hexanes:EtOAc) to provide the desired macrocycle 1.34.2 (65 mg, 0.11 mmol, 
85%, 5:1 dr).   
*Preparation of ATPH:  Me3Al (0.15 mL 2.0 M solution in hexanes, 0.29 
mmol, 2.2 equiv) was added to a stirred solution of 2,6-diphenylphenol (0.22 g, 0.88 
mmol, 6.6 equiv) in toluene (1.5 mL) at room temperature.  After 30 minutes, the 
ATPH solution was cooled to -78 ºC and used as described in the cyclization 
procedure. 
**Preparation of LTMP:  nBuLi (0.25 mL 1.6 M solution in hexanes, 0.40 
mmol, 3.0 equiv) was added to a stirred solution of 2,2,6,6-tetramethylpiperidine 
(0.77 mL, 0.47 mmol, 3.5 equiv) in THF (1.2 mL) at -78 ºC.  After 30 minutes and 
immediately before the cannulation step in the above procedure, the solution was 
diluted with cooled (ice bath) toluene (9.0 mL). 
71 
 
 1
H NMR (500 MHz, CDCl3) δ 7.34 – 7.25 (m, 5H), 6.65 (ddd, J = 15.3, 9.4, 
5.5 Hz, 1H), 6.12 (d, J = 3.2 Hz, 1H), 5.99 (d, J = 3.2 Hz, 1H), 5.65 (d, J = 15.8 Hz, 
1H), 5.32 – 5.25 (m, 1H), 5.01 – 4.92 (m, 1H), 4.54 (dd, J = 26.0, 11.8 Hz, 2H), 4.22 
(tt, J = 6.8, 4.1 Hz, 1H), 3.93 (t, J = 6.8 Hz, 1H), 3.72 (p, J = 6.3 Hz, 1H), 2.75 (dtd, J 
= 10.3, 5.3, 1.7 Hz, 1H), 2.58 (dt, J = 14.3, 8.8 Hz, 1H), 2.27 (d, J = 4.9 Hz, 1H), 2.02 
(ddd, J = 15.1, 6.7, 2.4 Hz, 1H), 1.83 (ddd, J = 15.2, 7.1, 2.7 Hz, 1H), 1.76 (ddd, J = 
14.4, 6.9, 4.3 Hz, 1H), 1.55 – 1.45 (m, 1H), 1.27 (s, 3H), 1.22 – 1.17 (m, 4H), 1.17 – 
1.08 (m, 4H), 1.07 – 0.90 (m, 14H).  13C NMR (101 MHz, CDCl3) δ 171.41, 165.19, 
160.11, 154.43, 143.16, 142.91, 138.78, 128.53, 128.13, 127.76, 125.34, 125.09, 
106.67, 106.23, 75.16, 75.03, 73.98, 72.42, 71.33, 67.63, 67.16, 60.66, 41.85, 41.26, 
36.31, 35.30, 31.88, 30.00, 25.91, 25.54, 22.94, 21.28, 18.77, 17.48, 17.34, 17.22, 
17.18, 15.80, 14.44, 13.40, 13.23. IR (cm
-1
):  3436, 2929, 2866, 1718, 1464, 1268, 
793, 697; HRMS (ESI) m/z calc’d for C32H46O7NaSi [M+Na]
+
: 593.2911; found: 
593.2930. 
 
Macrolide 1.35.1 (Structure Proof):
31
 
 
A mixture of 1.34.2 (48 mg, 0.084 mmol, 1.0 equiv) and 5% palladium on 
carbon (20 mg) in absolute EtOH was vigorously stirred under a hydrogen 
atmosphere (balloon) overnight at room temperature.  The reaction mixture was 
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filtered through a pad of silica gel, which was washed with EtOAc, and then the 
resulting filtrate was concentrated under reduced pressure to provide macrolide 1.35.1 
(47 mg, 0.082 mmol, 98%). 
1
H NMR (400 MHz, CDCl3) δ 7.33 – 7.20 (m, 5H), 6.10 (d, J = 3.1, 1H), 5.99 
(d, J = 3.1, 1H), 5.20 – 5.12 (m, 1H), 4.58 – 4.43 (m, 3H), 4.09 (dd, J = 5.1, 7.3, 1H), 
3.99 – 3.91 (m, 1H), 3.82 (p, J = 6.3, 1H), 2.33 – 2.11 (m, 2H), 1.98 – 1.50 (m, 9H), 
1.27 (s, 3H), 1.23 (s, 3H), 1.16 (d, J = 6.3, 3H), 1.06 – 0.77 (m, 14H). 
 
Ketone 1.35.2:
31
 
 
Dess-Martin periodinane (70 mg, 0.16 mmol, 2.0 equiv) was added to a stirred 
solution of alcohol 1.35.1 (47 mg, 0.082 mmol, 1.0 equiv) and pyridine (79 uL, 0.98 
mmol, 12.0 equiv) in CH2Cl2 (3.0 mL).  The mixture was stirred overnight (14 h) at 
room temperature.  The reaction was diluted with Et2O (3.0 mL), then a 1:1 mixture 
of saturated NaHCO3 and saturated Na2S2O3 (5.0 mL) was added, and the reaction 
was stirred vigorously for 15 minutes.  After the mixture was diluted further with 
Et2O (15 mL), the organic phase was separated, washed with saturated NaHCO3, 
deionized water and brine, dried over MgSO4, filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash chromatography (10:1 
hexanes:EtOAc) to provide ketone 1.35.2 (26 mg, 0.046 mmol, 56%). 
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1
H NMR (500 MHz; CDCl3):  δ 7.33 – 7.21 (m, 5H), 7.19 (d, J = 3.6, 1H), 
6.30 (d, J = 3.6, 1H), 5.04 (dt, J = 4.9, 7.3, 1H), 4.55 (d, J = 12.0, 1H), 4.44 (d, J = 
12.0, 1H), 4.04 (dd, J = 3.9, 7.4, 1H), 3.75 (p, J = 6.3, 1H), 3.65 (s, 1H), 3.18 (ddd, J 
= 5.4, 10.1, 15.8, 1H), 2.46 (dt, J = 5.5, 15.9, 1H), 2.37 – 2.22 (m, 2H), 2.19 – 1.98 
(m, 3H), 1.86 – 1.68 (m, 2H), 1.60 (ddd, J = 7.5, 9.7, 14.6, 1H), 1.38 (s, 3H), 1.26 (s, 
3H), 1.16 (d, J = 6.3, 3H), 1.02 – 0.68 (m, 14H).   
 
Alcohol 1.35.3-S:
31
 
 
(R)-2-Me-CBS-oxazaborolidine (84 µL of a 0.05 M solution in THF, 0.0042 
mmol, 0.4 equiv) and BH3•SMe2 (105 µL of a 0.2 M solution in THF, 0.021 mmol, 
2.0 equiv) were added sequentially to a solution of ketone 1.35.2 (6 mg, 0.01 mmol, 
1.0 equiv) in THF (0.1 mL) at room temperature.  After 20 min, the reaction was 
diluted with Et2O (1.0 mL) and quenched with brine (1.0 mL).  The organic phase 
was separated, dried over MgSO4, filtered, and concentrated under reduced pressure 
to provide alcohol 1.35.3-S, which has identical spectral data to 1.35.1 produced from 
the hydrogenation of 1.34.2. 
1
H NMR (400 MHz, CDCl3) δ 7.33 – 7.20 (m, 5H), 6.10 (d, J = 3.1, 1H), 5.99 
(d, J = 3.1, 1H), 5.20 – 5.12 (m, 1H), 4.58 – 4.43 (m, 3H), 4.09 (dd, J = 5.1, 7.3, 1H), 
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3.99 – 3.91 (m, 1H), 3.82 (p, J = 6.3, 1H), 2.33 – 2.11 (m, 2H), 1.98 – 1.50 (m, 9H), 
1.27 (s, 3H), 1.23 (s, 3H), 1.16 (d, J = 6.3, 3H), 1.06 – 0.77 (m, 14H).   
 
Macrolide 1.35.3-R:
31
 
 
(S)-2-Me-CBS-oxazaborolidine (84 uL of a 0.05 M solution in THF, 0.0042 
mmol, 0.4 equiv) and BH3•SMe2 (105 uL of a 0.2 M solution in THF, 0.021 mmol, 
2.0 equiv) were added sequentially to a solution of ketone 1.35.2 (6 mg, 0.01 mmol, 
1.0 equiv) in THF (0.1 mL) at room temperature.  After 20 min, the reaction was 
diluted with Et2O (1.0 mL) and quenched with brine (1.0 mL).  The organic phase 
was separated, dried over MgSO4, filtered, and concentrated under reduced pressure 
to provide alcohol 1.35.3-R which had spectral properties that were different from 
1.35.1 produced from the hydrogenation of 1.34.2. 
1
H NMR (500 MHz, CDCl3) δ 7.33 – 7.10 (m, 5H), 6.14 (d, J = 2.4, 1H), 6.01 
(d, J = 3.2, 1H), 5.14 (s, 2H), 4.86 – 4.80 (m, 1H), 4.55 (d, J = 11.9, 2H), 4.46 (d, J = 
12.0, 2H), 4.04 – 3.98 (m, 2H), 3.92 – 3.86 (m, 2H), 3.82 (s, 2H), 2.32 – 2.10 (m, 
2H), 1.95 – 1.44 (m, 9H), 1.29 – 0.77 (m, 23H).   
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TES Ether 1.37.1a:
31
 
 
 2,6-Lutidine (0.08 mL, 0.72 mmol, 3.0 equiv) and TESOTf (0.77 mL, 0.34 
mmol, 1.5 equiv) were added sequentially to a solution of alcohol 1.34.2 (0.13 g, 0.23 
mmol, 1.0 equiv) in CH2Cl2 (3 mL) at 0 
o
C.  The ice bath was removed and the 
reaction allowed to warm to room temperature over a period of 20 min, then 
quenched with saturated NaHCO3.  The organic phase was separated, washed with 
water and brine, dried over MgSO4, filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash chromatography (gradient, hexanes 
to 10:1 hexanes:EtOAc) to provide TES ether 1.37.1a (0.11 g, 0.21 mmol, 90%). 
 
1
H NMR (500 MHz, CDCl3) δ 7.34 – 7.23 (m, 5H), 6.64 (ddd, J = 15.2, 9.6, 
5.2 Hz, 1H), 6.04 (t, J = 3.5 Hz, 1H), 5.94 (d, J = 3.2 Hz, 1H), 5.65 – 5.55 (m, 1H), 
5.20 (td, J = 6.1, 3.0 Hz, 1H), 4.88 (dd, J = 8.9, 4.9 Hz, 1H), 4.57 (d, J = 11.8 Hz, 
1H), 4.52 (d, J = 11.8 Hz, 1H), 4.14 (td, J = 9.6, 3.7 Hz, 1H), 3.89 (t, J = 6.5 Hz, 1H), 
3.77 (p, J = 6.3 Hz, 1H), 2.71 (dtd, J = 13.5, 5.0, 1.8 Hz, 1H), 2.56 (dt, J = 14.3, 9.6 
Hz, 1H), 1.95 (ddd, J = 15.2, 6.2, 3.1 Hz, 1H), 1.78 (dddd, J = 20.7, 14.4, 6.2, 3.8 Hz, 
2H), 1.57 – 1.48 (m, 1H), 1.24 (s, 3H), 1.20 (s, 3H), 1.16 (d, J = 6.4 Hz, 3H), 1.06 – 
0.91 (m, 15H), 0.88 (t, J = 7.9 Hz, 10H), 0.57 – 0.48 (m, 6H).  13C NMR (75 MHz, 
CDCl3) δ 165.36, 159.11, 155.41, 143.96, 138.89, 128.50, 128.08, 127.68, 124.49, 
106.58, 106.23, 75.52, 75.37, 73.00, 71.39, 67.86, 67.08, 42.48, 41.73, 36.63, 35.58, 
76 
 
25.77, 19.47, 17.45, 17.30, 17.23, 17.15, 16.02, 13.42, 13.24, 6.89, 4.82; HRMS 
(ESI) m/z calc’d for C38H61O7Si2 [M+H]
+
: 685.3956; found: 685.3972. 
Diol 1.37.1:
31
 
 
(DHQD)2PHAL (23 mg, 0.12 mmol, 0.66 equiv), AD-mix-β (0.35 g), 
MeSO2NH2 (45 mg, 0.45 mmol, 2.5 equiv), and OsO4 (45 μL 0.1 M solution in H2O) 
were added sequentially to a solution of the TES ether 1.37.1a (0.10 g, 0.18 mmol, 
1.0 equiv) in 1:1 tBuOH/H2O (10 mL) at 0 ºC.  After 2 days at 0 ºC, Na2SO3 (250 
mg) was added and the reaction was stirred vigorously at room temperature for 1 hr.  
EtOAc was then added, the layers were separated, and the aqueous layer was 
extracted with EtOAc.  The combined organic extracts were washed with NaOH 
(2M), brine, and dried over MgSO4.  The solvent was removed under reduced 
pressure and the crude material was purified by flash chromatography (2:1 
hexanes:EtOAc) to provide diol 1.37.1 (0.10 mg, 0.17 mmol, 96 %, 12:1 dr). 
 1
H NMR (500 MHz; CDCl3):  δ 7.32 – 7.23 (m, 5H), 6.07 (d, J = 3.1, 1H), 
5.94 (d, J = 3.1, 1H), 5.25 – 5.16 (m, 1H), 4.88 (dd, J = 6.2, 8.1, 1H), 4.56 (d, J = 
11.8, 1H), 4.42 (d, J = 11.8, 1H), 4.11 (t, J = 6.5, 1H), 4.04 (t, J = 6.3, 1H), 4.02 – 
3.93 (m, 1H), 3.86 – 3.79 (m, 1H), 3.44 – 3.33 (m, 1H), 2.97 (d, J = 2.9, 1H), 2.36 (d, 
J = 6.5, 1H), 2.04 – 1.95 (m, 1H), 1.95 – 1.86 (m, 2H), 1.83 – 1.72 (m, 2H), 1.55 – 
1.46 (m, 1H), 1.23 (s, 4H), 1.22 (s, 4H), 1.19 (d, J = 6.3, 4H), 1.05 – 0.80 (m, 23H), 
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0.53 – 0.43 (m, 6H).  13C NMR (100 MHz; CDCl3):  δ 169.75, 160.56, 153.31, 
138.63, 128.67, 128.07, 127.96, 108.34, 106.37, 77.78, 77.48, 75.87, 75.50, 74.78, 
74.63, 71.33, 70.99, 66.85, 66.52, 41.77, 39.43, 37.32, 35.87, 29.98, 25.40, 21.65, 
17.37, 17.14, 17.07, 15.96, 13.38, 13.23, 6.90, 4.75.  [α]D = -29.3 (c 0.067, CHCl3).  
IR (cm
-1
):  3436, 2953, 2868, 1733, 1462, 1246, 1087, 744; HRMS (ESI) m/z calc’d 
for C38H63O9Si2 [M+H]
+
: 719.4011; found: 719.3995. 
 
TBS Ether 1.38.1:
31
 
 
TBSCl (0.46 g, 3.1 mmol, 8.5 equiv) and imidazole (0.42 g, 6.2 mmol, 17.0 
equiv) were added sequentially to a stirred solution of diol 1.37.1 (0.21 g, 0.36 mmol, 
1.0 equiv) in DMF (8 mL) at 0 ºC.  After 5 hr, the reaction was quenched with 
saturated NaHCO3 (10 mL) and diluted with 5:1 hexanes / EtOAc (20 mL).  The 
organic phase was separated, washed with water, CuSO4 (1M) and brine, dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified by flash chromatography (gradient, hexanes to 5:1 hexanes:EtOAc) to 
provide 1.38.1 (0.28 g, 0.34 mmol, 94%, ~10:1 regioisomeric ratio). 
 1
H NMR (500 MHz; CDCl3):  δ 7.32 – 7.19 (m, 5H), 6.08 (d, J = 3.1, 1H), 
5.94 (d, J = 3.1, 1H), 5.34 – 5.28 (m, 1H), 4.88 (dd, J = 5.7, 9.1, 1H), 4.58 (d, J = 
11.8, 1H), 4.50 (d, J = 11.8, 1H), 4.18 – 4.13 (m, 1H), 3.99 (t, J = 7.5, 2H), 3.85 – 
78 
 
3.80 (m, 1H), 3.33 – 3.26 (m, 1H), 2.90 (s, 1H), 2.10 – 2.02 (m, 1H), 1.88 (ddd, J = 
5.0, 10.8, 15.3, 2H), 1.69 (dd, J = 7.7, 13.4, 2H), 1.49 – 1.40 (m, 1H), 1.25 – 1.22 (m, 
6H), 1.14 (d, J = 6.3, 3H), 1.06 – 0.80 (m, 32H), 0.47 (ddd, J = 4.8, 7.9, 13.2, 6H), 
0.04 (s, 3H), -0.01 (s, 3H).  
13
C NMR (100 MHz; CDCl3):  δ 170.74, 160.80, 153.04, 
138.99, 128.43, 127.92, 127.59, 108.64, 106.09, 77.48, 74.69, 74.20, 73.71, 71.01, 
70.82, 66.72, 66.66, 41.80, 39.17, 36.51, 36.05, 26.00, 25.36, 21.54, 18.48, 17.39, 
17.23, 17.10, 15.85, 13.30, 13.15, 6.94, 4.77, -4.57, -5.23.  [α]D = -40.5 (c 0.360, 
CHCl3).  IR (cm
-1
):  3583, 2953, 2867, 1729, 1464, 1257, 1107, 1013, 839, 781, 743; 
HRMS (ESI) m/z calc’d for C44H76O9NaSi3 [M+Na]
+
: 855.4695; found: 855.4656. 
 
Methyl Ether 1.38.2:
31
 
 
 
1,8-Bis(dimethylamino)naphthalene (proton sponge, 408 mg, 1.90 mmol, 20.0 
equiv) and trimethyloxonium tetrafluoroborate (184 mg, 1.43 mmol, 15.0 equiv) were 
added sequentially to a stirred solution of alcohol 1.38.1 (67 mg, 0.095 mmol, 1.0 
equiv) in CH2Cl2 (5 mL) at room temperature.  After 1 hour the reaction was 
quenched by adding saturated NaHCO3 (5 mL).  The mixture was diluted with 
CH2Cl2 (10 mL), and the organic phase was separated, washed with brine, dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude material was 
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purified by flash chromatography (hexanes then 5:1 hexanes:EtOAc) to provide 
macrolide 1.38.2 (56 mg, 0.080 mmol, 84%). 
 1
H NMR (500 MHz; CDCl3):  δ 7.35 – 7.20 (m, 5H), 6.06 (d, J = 3.1, 1H), 
5.97 (d, J = 3.1, 1H), 5.22 – 5.16 (m, 1H), 4.83 (dd, J = 4.1, 10.7, 1H), 4.58 (d, J = 
12.1, 1H), 4.52 (d, J = 12.0, 1H), 4.08 – 4.02 (m, 2H), 3.98 – 3.87 (m, 2H), 3.44 (s, 
3H), 2.86 – 2.78 (m, 1H), 2.01 – 1.92 (m, 1H), 1.93 – 1.80 (m, 3H), 1.78 – 1.70 (m, 
1H), 1.60 – 1.51 (m, 1H), 1.27 (s, 3H), 1.21 (s, 3H), 1.12 (d, J = 6.3, 3H), 1.03 – 0.78 
(m, 32H), 0.45 (qd, J = 3.2, 7.9, 6H), 0.06 – 0.04 (m, 3H), -0.02 – -0.05 (m, 3H).  13C 
NMR (100 MHz; CDCl3):  δ 171.08, 160.38, 153.46, 139.11, 128.42, 127.84, 127.50, 
109.06, 106.59, 94.66, 79.74, 79.69, 77.48, 75.25, 74.27, 73.84, 70.69, 66.39, 65.82, 
61.54, 41.81, 39.67, 36.32, 35.89, 26.13, 26.00, 25.09, 23.12, 18.43, 17.33, 17.18, 
17.10, 15.77, 13.22, 13.12, 6.97, 4.81, -4.75, -4.93.  [α]D = -51.6 (c 0.212, CHCl3).  
IR (cm
-1
):  2953, 2925, 2860, 1730, 1464, 1254, 1104, 838, 733; HRMS (ESI) m/z 
calc’d for C45H78O9NaSi3 [M+Na]
+
: 869.4851; found: 869.4836. 
 
Alcohol 1.38.3:
31
 
 
 
PPTS (1.2 mg, 0.005 mmol) was added to a solution of 1.38.2 (34 mg, 0.040 
mmol) in 50:1 DMF / MeOH (3 mL) at 0 ºC.  The reaction was stirred for 20 h at 0 
o
C 
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and then quenched with saturated NaHCO3.  The reaction was extracted with 5:1 
hexanes/EtOAc (2 x 10 mL), and the combined organic phases washed with water, 1 
M CuSO4 and brine, and the aqueous layer back extracted with 5:1 hexanes/EtOAc.  
The organic phase was dried over MgSO4, filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash chromatography (gradient, hexanes 
to 5:1 hexanes:EtOAc) to provide alcohol 1.38.3 (26 mg, 0.035 mmol, 87%).  
 1
H NMR (500 MHz; CDCl3):  δ 7.31 – 7.19 (m, 5H), 6.13 (d, J = 3.1, 1H), 
5.97 (d, J = 3.1, 1H), 5.20 (q, J = 5.1, 1H), 4.80 (td, J = 3.9, 7.0, 1H), 4.56 – 4.49 (m, 
2H), 4.28 (d, J = 6.2, 1H), 4.07 – 3.99 (m, 2H), 3.96 (t, J = 6.3, 1H), 3.51 (s, 3H), 
3.19 (ddd, J = 3.3, 6.2, 9.7, 1H), 2.72 (d, J = 3.8, 1H), 2.03 – 1.94 (m, 3H), 1.83 – 
1.77 (m, 2H), 1.56 – 1.48 (m, 1H), 1.28 (s, 3H), 1.20 (s, 3H), 1.17 (d, J = 6.3, 3H), 
1.03 – 0.79 (m, 23H), 0.03 (s, 3H), -0.03 (s, 3H).  13C NMR (100 MHz; CDCl3):  δ 
170.89, 160.62, 153.39, 139.15, 128.42, 127.71, 127.50, 108.32, 106.70, 82.33, 77.48, 
75.76, 75.45, 75.25, 74.54, 70.75, 66.78, 66.46, 59.82, 41.70, 37.58, 37.32, 36.39, 
26.00, 24.73, 23.30, 18.40, 17.29, 17.21, 17.07, 17.05, 16.03, 13.26, 13.10, -4.75, -
5.08.  [α]D = +6.7 (c 0.193, CHCl3).  IR (cm
-1
):  3412, 2929, 2864, 1728, 1464, 1255, 
1127, 862, 786; HRMS (ESI) m/z calc’d for C39H65O9Si2 [M+H]
+
: 733.4167; found: 
733.4158. 
Pyranone 1.38.4: 
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m-CPBA (15 mg, 0.088 mmol, 1.3 equiv) was added to a solution of alcohol 
1.38.3 (50 mg, 0.068 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at room temperature.  
After stirring for 1 hr, trichloroacetic acid (0.7 mL 0.1 M solution in CH2Cl2, 0.005 
mmol, 10 mol %) was added, and the reaction was stirred overnight (16 h).  The 
reaction was quenched by adding saturated NaHCO3 (5.0 mL). The organic phase was 
separated, washed with water and brine, dried over MgSO4, filtered, and concentrated 
under reduced pressure.  The crude product was purified by flash chromatography 
(5:1 hexanes:EtOAc) to provide pyranone 1.38.4 (33 mg, 0.044 mmol, 64%). 
 1
H NMR (500 MHz; CDCl3):  δ 7.36 - 7.24 (m, 5H), 6.96 (d, J = 10.4, 1H), 
6.33 (s, 1H), 6.05 (d, J = 10.4, 1H), 5.30 (dd, J = 4.0, 9.6, 1H), 5.17 (d, J = 11.3, 1H), 
4.77 (dd, J = 6.8, 9.9, 1H), 4.69 – 4.58 (m, 3H), 4.47 (d, J = 1.4, 1H), 4.28 – 4.21 (m, 
1H), 4.16 (dd, J = 6.0, 9.6, 1H), 3.30 (s, 3H), 2.60 (dd, J = 10.2, 14.7, 1H), 2.31 – 
2.12 (m, 3H), 1.62 (dd, J = 12.1, 15.6, 1H), 1.51 (d, J = 14.6, 1H), 1.16 (s, 3H), 1.09 – 
0.95 (m, 15H), 0.91 (s, 9H), 0.86 (t, J = 7.3, 2H), 0.82 (s, 3H), 0.16 (s, 3H), 0.08 (s, 
3H).  
13
C NMR (100 MHz; CDCl3):  δ 197.59, 171.74, 146.15, 138.88, 128.58, 
128.00, 127.79, 99.13, 78.68, 77.48, 73.24, 72.73, 72.02, 71.63, 70.07, 67.49, 57.09, 
43.61, 36.75, 33.75, 31.87, 29.98, 27.03, 26.29, 25.93, 22.22, 18.87, 17.83, 17.58, 
17.21, 17.08, 16.15, 15.01, 14.69, 14.41, 14.27, -3.36, -4.62.  [α]D = +15.2 (c 0.334, 
CHCl3).  IR (cm
-1
):  3358, 2928, 2856, 1757, 1699, 1464, 1103, 838, 697; HRMS 
(ESI) m/z calc’d for C39H62O9NaSi2 [M-H2O+Na]
+
: 753.3830; found: 753.3813. 
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Model System 1.45.1e: 
 
Alcohol 1.45.1a 
To a solution of aldehyde 1.45.1e (11.53 g, 40.8 mmol) in MeOH (200 mL) at 
0 ºC was added NaBH4 (2.317 g, 61.2 mmol). The reaction was monitored by TLC 
and after consumption of the starting material the reaction was carefully quenched 
with 1 M HCl. After diluting with Et2O (30 mL), the organic phase was separated, 
washed with deionized water and brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  MeOH was added and then removed under 
reduced pressure.  After repeating the MeOH exchange once more, the crude product 
was purified by flash chromatography (gradient 15:1 to 2:1 hexanes:EtOAc) to 
provide alcohol 1.45.1a (9.63 g, 33.9 mmol, 83%). 
Rf = 0.65 (2:1 hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3) δ 6.12 (d, J = 
3.1 Hz, 1H), 6.00 (d, J = 3.1 Hz, 1H), 4.58 (s, 2H), 3.56 (d, J = 6.7 Hz, 2H), 1.41 (t, J 
= 6.7 Hz, 1H), 1.25 (s, 6H), 0.87 (s, 9H), 0.05 (s, 6H). 
 
Bis-TBS ether 1.45.1b 
To a stirring solution of 1.45.1a (15 g, 52.7 mmol) in 260 mL CH2Cl2 was 
added imidazole (4.67 g, 68.5 mmol, 1.3 equiv), DMAP (1.288 g, 10.55 mmol, 0.2 
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equiv) and TBSCl (9.54 g, 63.3 mmol, 1.2 equiv).  The mixture was stirred at room 
temperature for 2 h, then 100 mL of water was added.  The mixture was transferred to 
a separatory funnel.  The aqueous layer was separated and extracted with ether (2x).  
The combined organic layers were then washed with water (2x), dried with MgSO4 
and filtered.  The solvent was removed in vacuo and the residue was purified by 
column chromatography (60:1 hexanes:EtOAc with 0.5% Et3N) to give 1.45.1b 
(19.48 g, 48.9 mmol, 93%) as a clear colorless liquid. 
1
H NMR (500 MHz, CDCl3) δ 6.10 (d, J = 3.1 Hz, 1H), 5.94 (d, J = 3.1 Hz, 
1H), 4.60 (s, 2H), 3.56 (s, 2H), 1.23 (s, 6H), 0.91 (s, 9H), 0.86 (s, 9H), 0.08 (s, 6H), -
0.03 (s, 6H). 
 
Aldehyde 1.45.1c 
DDQ (5.54 g, 24.4 mmol, 1.0 equiv) was added to a solution of furan 1.45.1b 
(9.73 g, 24.4 mmol, 1.0 equiv) in 10:1 CH2Cl2 to H2O (122 mL, biphasic).  The 
solution was heated to reflux for 1 hour, then cooled to room temperature and 
quenched with saturated NaHCO3 (150 mL).  The organic phase was separated, 
washed with water and brine, dried over MgSO4, filtered, and concentrated under 
reduced pressure.  The crude product (2:1 ratio of desired product versus open diketo 
form) was purified by flash chromatography (2:1 hexanes:CHCl3) to provide the 
desired aldehyde 1.45.1c (4.7 g, 16.64 mmol, 68%). 
Rf = 0.5 (CHCl3); 
1
H NMR (500 MHz, CDCl3) δ 9.51 (s, 1H), 7.14 (d, J = 3.6 
Hz, 1H), 6.27 (d, J = 3.6 Hz, 1H), 3.60 (s, 2H), 1.28 (s, 6H), 0.79 (s, 9H), -0.08 (s, 
6H). 
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Alcohol 1.45.1d 
MeLi (18.24 mL, 29.2 mmol, 1.6 M solution in THF) was added to a stirred 
solution of aldehyde 1.45.1c (6.34 g, 22.45 mmol) in THF (112 mL) at -78 
o
C.  After 
1 hour, the reaction was quenched with saturated NH4Cl (50 mL) and diluted with 
Et2O (100 mL).  The organic phase was separated, washed with deionized water and 
brine, dried over anhydrous MgSO4, and concentrated under reduced pressure.  The 
crude product was purified by flash chromatography (15:1 hexanes:EtOAc) to 
provide alcohol 1.45.1d (6.04 g, 20.23 mmol, 90%). 
Rf = 0.2 (15:1 hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3) δ 6.08 (dd, J = 
3.2, 0.6 Hz, 1H), 5.93 (d, J = 3.2 Hz, 1H), 4.84 – 4.77 (m, 1H), 3.53 (s, 2H), 1.80 (dd, 
J = 4.9, 1.7 Hz, 1H), 1.50 (d, J = 6.6 Hz, 3H), 1.21 (s, 6H), 0.82 (s, 9H), -0.07 (s, 6H). 
 
Pyranone 1.45.1e 
m-CPBA (4.19 g, 24.28 mmol, 1.2 equiv) was added to a solution of alcohol 
1.45.1d (6.04 g, 20.23 mmol, 1.0 equiv) in CH2Cl2 (100 mL) at room temperature and 
the reaction was stirred overnight (16 h).  The reaction was quenched by adding 
saturated NaHCO3 (50 mL). The organic phase was separated, washed with water and 
brine, dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
crude product was purified by flash chromatography (20:1 hexanes:EtOAc) to 
provide pyranone 1.45.1e (4.88 g, 15.52 mmol, 77%). 
Rf = 0.30 (10:1 hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3) δ 6.87 (d, J = 10.4 Hz, 
1H), 6.01 (d, J = 10.4 Hz, 1H), 5.69 (s, 1H), 4.72 (q, J = 6.8 Hz, 1H), 4.21 (d, J = 9.3 
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Hz, 1H), 3.22 (d, J = 9.3 Hz, 1H), 1.33 (d, J = 6.8 Hz, 3H), 1.20 (s, 3H), 0.90 (s, 9H), 
0.77 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H).  
 
Alcohol 1.45.1f 
 
NaBH4 (0.433 g, 11.45 mmol, 5.0 equiv) was added to a solution of 1.45.1e 
(0.72 g, 2.29 mmol, 1.0 equiv) and CeCl3•7H2O (5.12 g, 13.74 mmol, 6.0 equiv) in 
1:1 MeOH to CH2Cl2 (50 mL) at -78 
o
C.  After 20 min, the reaction was quenched by 
adding saturated NaHCO3 (40 mL).  Et2O (100 mL) was added, the organic phase was 
separated, washed with deionized water and brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (8:1 CH2Cl2:Et2O) to provide alcohol 1.45.1f quantitatively. 
1
H NMR (500 MHz, CDCl3) δ 5.86 (dd, J = 10.3, 1.5 Hz, 1H), 5.76 (dd, J = 
10.3, 2.2 Hz, 1H), 5.47 (s, 1H), 4.14 (d, J = 9.2 Hz, 1H), 3.82 (dq, J = 8.9, 6.2 Hz, 
1H), 3.67 (tt, J = 8.9, 1.8 Hz, 1H), 3.15 (d, J = 9.2 Hz, 1H), 1.34 (dd, J = 8.9, 0.8 Hz, 
1H), 1.27 (d, J = 6.2 Hz, 3H), 1.11 (s, 3H), 0.89 (s, 9H), 0.69 (s, 3H), 0.08 (s, 3H), 
0.07 (s, 3H). 
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Thiocarbonate 1.45.1e: 
 
 To a stirred solution of thiocarbonate 1.45.1f (4 mg, 0.013 mmol), pyridine (4 
uL, 0.051 mmol, 4 equiv), and DMAP (1.5 mg, 0.013 mmol, 1 equiv) in CH2Cl2 
(1mL) at rt was added acid chloride (5 uL, 0.038 mmol, 3 equiv). The reaction was 
quenched by adding saturated NaHCO3 (2 mL).  The organic phase was separated, 
washed with deionized water and brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (7:1 hexanes:EtOAc) to provide carbonate 1.45.1g (5 mg, 0.011 
mmol, 87%). 
 Rf = 0.15 (5:1 hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 
(m, 5H), 6.07 (dd, J = 10.4, 1.5 Hz, 1H), 5.95 (dd, J = 10.4, 2.1 Hz, 1H), 5.63 (s, 1H), 
5.47 (d, J = 9.3 Hz, 1H), 4.35 (dq, J = 9.6, 6.4 Hz, 1H), 4.22 (d, J = 9.3 Hz, 1H), 3.23 
(d, J = 9.3 Hz, 1H), 1.34 (d, J = 6.2 Hz, 3H), 1.19 (s, 3H), 0.95 (s, 9H), 0.79 (s, 3H), 
0.15 (s, 3H), 0.13 (s, 3H). 
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Pyran 1.45.1h: 
 
 To a stirred solution of pyran 1.45.1f (0.01 g, 0.032 mmol), Et3N (9 uL, 0.064 
mmol), and DMAP (1 mg, 6 umol) in CH2Cl2 at rt was added Ac2O (0.015 mL, 0.158 
mmol). The reaction was quenched by adding saturated NaHCO3 (3 mL).  The 
organic phase was separated, washed with deionized water and brine, dried over 
anhydrous MgSO4, and concentrated under reduced pressure.  The crude product was 
purified by flash chromatography (5:1 hexanes:EtOAc) to 279 (9 mg, 0.025 mmol, 
79%). 
 
1
H NMR (500 MHz, CDCl3) δ 5.81 (dd, J = 10.4, 2.0 Hz, 1H), 5.76 (dd, J = 
10.4, 1.5 Hz, 1H), 5.51 (s, 1H), 4.98 (dt, J = 9.4, 1.7 Hz, 1H), 4.18 (d, J = 9.2 Hz, 
1H), 3.91 (td, J = 9.0, 3.0 Hz, 1H), 3.15 (d, J = 9.2 Hz, 1H), 2.05 (s, 3H), 1.64 (dqd, J 
= 15.0, 7.5, 3.0 Hz, 1H), 1.45 – 1.34 (m, 1H), 1.12 (s, 3H), 0.95 (t, J = 7.4 Hz, 3H), 
0.88 (s, 9H), 0.70 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H).  
 
Diene 1.45.1i: 
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 To a solution of 1.45.1h (0.010 g, 0.027 mmol) in toluene (3 mL) was added 
Pd(PPh3)4 (6 mg, 5 umol), and ammonium formate (3.5 mg, 0.054 mmol). The 
reaction was refluxed for 3 hours, allowed to cool to room temperature, and quenched 
by adding saturated NaHCO3 (3 mL).  The organic phase was separated, washed with 
deionized water and brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure.  The crude product was purified by flash chromatography (20:1 
hexanes:EtOAc) to 1.45.1i (5 mg, 0.014 mmol, 53%). 
1
H NMR (400 MHz, CDCl3) δ 6.21 – 6.17 (m, 1H), 5.95 (d, J = 3.2 Hz, 1H), 
5.71 (t, J = 7.2 Hz, 1H), 3.54 (q, J = 9.4 Hz, 2H), 1.94 (pd, J = 7.4, 1.4 Hz, 3H), 1.22 
(d, J = 3.3 Hz, 6H), 0.91 – 0.86 (m, 6H), 0.83 (s, 9H), -0.07 (d, J = 4.5 Hz, 6H). 
 
Compounds 1.45.1j-l  
 
  
To a solution of alcohol 1.45.1f (0.311 g, 0.983 mmol) in CH2Cl2/MeOH (1:1, 
5 mL) at rt was added PPTS (0.025 g, 0.098 mmol). After 1 hour, the reaction was 
quenched by adding saturated NaHCO3 (5 mL).  The organic phase was separated, 
washed with deionized water and brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (10:1 hexanes:EtOAc) to the desired product 1.45.1k.  
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1
H NMR (500 MHz, CDCl3) δ 4.83 (d, J = 5.2 Hz, 1H), 3.76 (dq, J = 9.9, 6.3 
Hz, 1H), 3.67 (t, J = 4.8 Hz, 1H), 3.46 – 3.34 (m, 6H), 2.67 (d, J = 9.3 Hz, 1H), 1.33 
(d, J = 6.3 Hz, 3H), 1.03 (d, J = 3.6 Hz, 6H), 0.87 (s, 9H), 0.01 (s, 6H). 
 
Thiocarbonate 1.45.1m: 
 
 To a stirred solution of thiocarbonate 1.45.1k (0.024 g, 0.073 mmol), pyridine 
(0.023 mL, 0.290 mmol, 4 equiv), and DMAP (0.2 mg, 1.5 umol, .02 equiv) in 
CH2Cl2 (1 mL) at rt was added acid chloride (0.029 mL, 0.218 mmol, 3 equiv). The 
reaction was quenched by adding saturated NaHCO3 (2 mL).  The organic phase was 
separated, washed with deionized water and brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (7:1 hexanes:EtOAc) to provide carbonate 1.45.1m (8 mg, 0.016 
mmol, 22%). 
 
1
H NMR (500 MHz, CDCl3) δ 7.47 – 7.41 (m, 2H), 7.34 – 7.29 (m, 1H), 7.16 
– 7.10 (m, 2H), 5.23 (dd, J = 9.9, 3.9 Hz, 1H), 4.86 (d, J = 5.5 Hz, 1H), 4.35 (dq, J = 
9.9, 6.3 Hz, 1H), 4.15 (dd, J = 5.5, 3.9 Hz, 1H), 3.49 – 3.45 (m, 4H), 3.41 (d, J = 9.1 
Hz, 1H), 1.38 (d, J = 6.4 Hz, 3H), 1.05 (d, J = 7.5 Hz, 6H), 0.88 (s, 9H), 0.02 (d, J = 
1.8 Hz, 6H). 
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Model System 1.45.5 
 
 
Carboxylic Acid 1.45.2: 
To a stirred solution of 2-furoic acid 1.45.1 (1g, 8.92 mmol) in CH2Cl2 at 0 ºC 
was added aluminum chloride (2.379 g, 17.84 mmol, 2 equiv) portionwise to keep the 
temperature below 10 ºC. t-Butyl chloride (0.970 mL, 8.92 mmol, 1 equiv) was added 
gradually over 40 minutes. The mixture was allowed to warm to rt and stir for 1 hour. 
The reaction was quenched by pouring over ice, separating the organic layer, washed 
with water and brine, dried over MgSO4, filtered, and concentrated under reduced 
pressure.  The crude product 1.45.2 was used without purification in the next step. 
1
H NMR (500 MHz, CDCl3) δ 11.02 (bs, 1H), 7.23 (d, J = 3.5 Hz, 1H), 6.16 
(d, J = 3.5 Hz, 1H), 1.35 (s, 9H). 
 
2-t-Butylfuran 1.45.3 
 To a stirred solution of carboxylic acid 1.45.2 (37.5 g, 223 mmol) in quinoline 
(68 mL) was added CuO (7.57 g, 95 mmol). The reaction flask was fitted with a 
distillation head and heated to 220 
o
C. The distillate was washed several times with 
1M HCl to remove excess quinoline. CH2Cl2 was added and the organic phase was 
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separated, washed with water and brine, dried over MgSO4, filtered, and concentrated 
under reduced pressure to give 1.45.3 (17.9 g, 144 mmol, 65%).  
 
1
H NMR (500 MHz, CDCl3) δ 7.31 (dd, J = 1.8, 0.9 Hz, 1H), 6.27 (dd, J = 
3.2, 1.8 Hz, 1H), 5.96 (dd, J = 3.2, 0.9 Hz, 1H), 1.29 (s, 9H). 
 
Alcohol 1.45.4 
To a stirred solution of furan 1.46.3 (17.93 g, 144 mmol) in THF (255 mL) at 
0 ºC was added n-BuLi (1.55 in hexanes, 93 mL, 144 mmol). The mixture was stirred 
for 30 minutes and which time a solution of propionaldehyde (7.99 g, 138 mmol) in 
THF (20 mL) was added dropwise. After 15 minutes, the reaction was quenched by 
adding saturated NaHCO3 (100 mL) and diluted with Et2O (200 mL). The organic 
phase was separated, washed with water and brine, dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (9:1 hexanes:EtOAc) to provide alcohol 1.46.4 (19.61 g, 108 mmol, 
78%). 
Rf = 0.33 (7:1 hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3) δ 6.10 (dd, J = 
3.1, 0.6 Hz, 1H), 5.89 (d, J = 3.1 Hz, 1H), 4.56 (dd, J = 11.9, 6.7 Hz, 1H), 1.95 – 1.77 
(m, 3H), 1.27 (s, 9H), 0.96 (t, J = 7.5 Hz, 3H). 
 
Pyranone 1.46.5 
m-CPBA (26.5 g, 118 mmol, 1.1 equiv) was added to a solution of alcohol 
1.46.4 (19.61 g, 108 mmol, 1.0 equiv) in CH2Cl2 (540 mL) at room temperature and 
the reaction was stirred overnight (16 h).  The reaction was quenched by adding 
92 
 
saturated NaHCO3 (250 mL). The organic phase was separated, washed with water 
and brine, dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
crude product was purified by flash chromatography (gradient 10:1 to 5:1 
hexanes:EtOAc) to provide pyranone 1.46.5 (96:1 dr, 16.53 g, 83 mmol, 77%). 
Rf = 0.50 (2:1 hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3) δ 7.03 (d, J = 
10.4 Hz, 1H), 6.12 (d, J = 10.4 Hz, 1H), 4.45 (dd, J = 7.2, 3.9 Hz, 1H), 2.38 (s, 1H), 
1.96 (dqd, J = 14.9, 7.5, 3.9 Hz, 1H), 1.78 (dp, J = 14.5, 7.3 Hz, 1H), 1.07 (s, 9H), 
0.97 (t, J = 7.4 Hz, 3H). 
 
Alcohol ## 
 
 To a solution of ketone 1.45.5 (0.388 g, 1.959 mmol) in THF (10 mL) at -78 
ºC was cannulated a cooled solution of 1 M DIBAL-H in hexanes (2.55 mL, 2.55 
mmol). The solution was stirred for 1.5 hours at which time EtOAc was added and 
stirred for an additional hour. The solution was cannulated into a vigorously stirred 
solution of saturated Rochelle’s salt and stirred for 2 hours. The organic layer was 
separated, dried over MgSO4, and concentrated in vacuo. The crude product was then 
purified by recrystallization (CH2Cl2) to give the desired alcohol 1.45.5a a white solid 
(0.131 g, 1.76 mmol, 90%). 
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1
H NMR (500 MHz, CDCl3) δ 5.95 (dd, J = 10.3, 1.5 Hz, 1H), 5.89 (dd, J = 
10.3, 2.1 Hz, 1H), 3.88 – 3.83 (m, 1H), 3.55 (td, J = 8.7, 3.0 Hz, 1H), 2.24 (s, 1H), 
1.89 (dqd, J = 15.0, 7.5, 3.0 Hz, 1H), 1.56 – 1.47 (m, 1H), 1.38 (d, J = 8.0 Hz, 1H), 
1.04 – 0.95 (m, 12H). 
 
Ketone 1.48.1: 
 
 Me4NBH(OAc)3 (0.37 g, 1.4 mmol, 5.0 equiv) was added to a solution of 
acetonitrile (0.5 mL) and acetic acid (1.0 mL) at room temperature.  After 10 min, the 
solution was cooled to -20 
o
C, and a solution of ketone 1.45.5 (0.056 g, 0.280 mmol, 
1.0 equiv) in acetonitrile (0.5 mL) was added via cannula.  The reaction was allowed 
to stir overnight (20 h) at -20 
oC.  A solution of saturated Rochelle’s salt (5 mL) was 
added and reaction was allowed to stir at room temperature for 10 min.  The reaction 
mixture was extracted with CH2Cl2 (2 x 10 mL).  The combined organic extracts were 
washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  The crude material was purified by column 
chromatography (gradient 20:1 to 10:1 hexanes:EtOAc) to provide keton 1.48.1 (0.18 
g, 0.10 mmol, 36%). 
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1
H NMR (500 MHz, CDCl3) δ 4.80 (dd, J = 4.0, 3.5 Hz, 1H), 3.95 – 3.87 (m, 
1H), 2.85 (td, J = 3.7, 1.2 Hz, 2H), 1.94 – 1.82 (m, 1H), 1.82 – 1.67 (m, 1H), 1.12 (s, 
9H), 1.04 (t, J = 7.4 Hz, 3H). 
 
TMS Ether 1.49.1: 
 
To a solution of ketone 1.45.5 (0.99 g, 4.99 mmol) and imidazole (0.459 g, 
6.74 mmol) in dry CH2Cl2 (16 mL) at 0 °C with stirring was added TMSCl (0.83 mL, 
6.49 mmol) and DMAP (0.031 g, 0.25 mmol). The reaction mixture was allowed to 
warm to room temperature and was stirred for 18 h. Then, distilled water was added 
and the reaction mixture was extracted with CH2Cl2, dried, filtered, and concentrated 
under reduced pressure. Purification by flash chromatography (hexanes:EtOAc 40:1) 
afforded the desired TMS ether 1.49.1 quantitatively as a colorless oil. 
1
H NMR (500 MHz, CDCl3) δ 7.04 (d, J = 10.5 Hz, 1H), 6.08 (d, J = 10.5 Hz, 
1H), 4.28 (dd, J = 6.3, 4.2 Hz, 1H), 1.93 (dqd, J = 14.9, 7.5, 4.2 Hz, 1H), 1.88 – 1.79 
(m, 1H), 1.00 (s, 9H), 0.96 (t, J = 7.4 Hz, 3H), 0.14 (s, 9H). 
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Alcohol 1.49.1a 
 
 To a solution of ketone 1.49.1 (0.05 g, 0.185 mmol) in THF (5 mL) at -78 ºC 
was cannulated a cooled solution of 1 M DIBAL-H in hexanes (0.24 mL, 0.24 mmol). 
The solution was stirred for 15 minutes at which time EtOAc was added and stirred 
for an additional 10 minutes. The solution was cannulated into a vigorously stirred 
solution of saturated Rochelle’s salt and stirred for 10 minutes. Et2O was added, the 
organic layer was separated, dried over MgSO4, and concentrated in vacuo. The crude 
product 1.49.1a was then purified by flash chromatography (10:1 hexanes:EtOAc) to 
give the desired alcohol (0.040 g, 0.147 mmol, 79%). 
 
1
H NMR (500 MHz, CDCl3) δ 5.89 – 5.82 (m, 2H), 3.89 – 3.84 (m, 1H), 3.45 
(ddd, J = 9.1, 7.1, 3.4 Hz, 1H), 1.85 (dqd, J = 15.1, 7.5, 3.4 Hz, 1H), 1.61 – 1.52 (m, 
1H), 1.34 (d, J = 7.1 Hz, 1H), 1.00 (t, J = 7.4 Hz, 3H), 0.91 (s, 9H), 0.14 (s, 9H). 
 
Osmate Ester 1.49.2: 
 
 OsO4 (0.67 mL 0.5 M solution in CH2Cl2, 0.334 mmol, 2.0 equiv) was added 
to a solution of ketone 1.49.1 (0.045 g, 0.167 mmol, 1.0 equiv) and TMEDA (0.076 
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mL, 0.501 mmol, 3 equiv) in CH2Cl2 (1.0 mL) at -78 
o
C.  After stirring at this 
temperature for 1.5 hr, the CH2Cl2 was removed under reduced pressure, and then 
THF (1 mL), H2O (1 mL), and Na2SO3 (0.1 g) were added.  This mixture was allowed 
to stir vigorously for 30 min.  The mixture was extracted with CHCl3 (3 x 2 mL), the 
combined organic extracts were washed with brine, dried over anhydrous CaCl2, and 
concentrated under reduced pressure to provide osmate ester 1.49.2 (0.062 g, 0.097 
mmol, 58%). 
 
1
H NMR (500 MHz, CDCl3) δ 4.96 (d, J = 4.6 Hz, 1H), 4.49 (dd, J = 4.6, 1.1 
Hz, 1H), 4.08 (dd, J = 6.1, 4.9 Hz, 1H), 3.15 – 3.03 (m, 6H), 2.97 (s, 1H), 2.92 (s, 
1H), 2.86 (s, 1H), 2.83 (s, 1H), 1.94 – 1.75 (m, 2H), 1.27 (dd, J = 13.2, 6.0 Hz, 3H), 
1.16 (s, 9H), 0.22 (s, 9H). 
 
Osmate Ester 1.49.3 
 
NaBH4 (4 mg, 0.113 mmol, 5.0 equiv) was added to a solution of 1.49.2 
(0.015 g, 0.023 mmol, 1.0 equiv) in 1:2 MeOH to CH2Cl2 (1 mL) at 0 
o
C.  After 20 
min, the reaction was quenched by adding saturated NaHCO3 (40 mL).  Et2O (100 
mL) was added, the organic phase was separated, washed with deionized water and 
brine, dried over anhydrous MgSO4, and concentrated under reduced pressure to give 
the crude product 1.49.3 (yield not determined). 
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1
H NMR (500 MHz, CDCl3) δ 4.45 (d, J = 4.7 Hz, 1H), 4.09 – 4.00 (m, 2H), 
3.62 (d, J = 4.8 Hz, 1H), 3.52 (t, J = 7.0 Hz, 1H), 3.18 – 3.05 (m, 4H), 2.97 (s, 3H), 
2.90 (s, 3H), 2.89 (s, 3H), 2.84 (s, 3H), 1.88 – 1.69 (m, 3H), 1.13 (s, 9H), 0.99 (t, J = 
7.5 Hz, 3H), 0.18 (s, 9H). 
 
Triol 1.49.4: 
 
Ethylenediamine (0.053 mL, 0.778 mmol, 50 equiv) was added to a solution 
of osmate ester 1.49.3 (.010 g, 0.016 mmol) in CH2Cl2 (1.5 mL) at room temperature.  
The reaction was allow to stir for 1 hr, after which time dilute HCl (1.5 mL) and 
CH2Cl2 (2.0 mL) were added.  The organic phase was separated, washed with 
saturated NaHCO3 and brine, dried over anhydrous CaCl2, and concentrated under 
reduced pressure.  The crude product was purified by flash chromatography (gradient 
hexanes to 2:1 hexanes:EtOAc) to provide triol 1.49.4 (yield not determined). 
1
H NMR (500 MHz, CDCl3) δ 3.85 – 3.80 (m, 2H), 3.80 – 3.76 (m, 1H), 3.52 (td, J = 
7.2, 1.4 Hz, 1H), 2.93 (d, J = 8.5 Hz, 1H), 2.76 (d, J = 8.8 Hz, 1H), 2.47 (d, J = 6.2 
Hz, 1H), 1.95 – 1.87 (m, 1H), 1.80 – 1.59 (m, 5H), 1.50 (dt, J = 13.8, 5.3 Hz, 1H), 
1.08 (s, 9H), 0.99 (t, J = 7.5 Hz, 3H), 0.20 (s, 9H).  
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Osmate Ester 1.46.1: 
 
 OsO4 (1.82 mL 0.5 M solution in CH2Cl2, 0.908 mmol, 2.0 equiv) was added 
to a solution of ketone 1.45.5 (0.090 g, 0.454 mmol, 1.0 equiv) and TMEDA (0.206 
mL, 1.362 mmol, 3 equiv) in CH2Cl2 (4.5 mL) at -78 
o
C.  After stirring at this 
temperature for 1.5 hr, the CH2Cl2 was removed under reduced pressure, and then 
THF (2 mL), H2O (2 mL), and Na2SO3 (0.5 g) were added.  This mixture was allowed 
to stir vigorously for 30 min.  The mixture was extracted with CHCl3 (3 x 5 mL), the 
combined organic extracts were washed with brine, dried over anhydrous CaCl2, and 
concentrated under reduced pressure to provide osmate ester 1.46.1 (0.17 g, 0.299 
mmol, 66%). 
 
1
H NMR (500 MHz, CDCl3) δ 5.51 – 5.44 (m, 1H), 3.21 (dd, J = 6.8, 3.2 Hz, 
2H), 3.15 (dd, J = 6.9, 3.3 Hz, 2H), 3.02 – 2.87 (m, 15H), 2.00 – 1.90 (m, 1H), 1.91 – 
1.80 (m, 1H), 1.24 (s, 9H), 0.98 (t, J = 7.4 Hz, 3H).  
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Chapter 2 
Development of a Novel Lewis Acid for Intramolecular Vinylogous Aldol 
Reactions 
2.1 The Development of ATNP 
The Intermolecular Vinylogous Aldol Reaction 
The aldol reaction is a versatile carbon-carbon bond forming transformation 
that is widely used and of great importance in organic synthesis.
33
 The extension of 
this reaction to its vinylog (i.e., the vinylogous aldol reaction) is well known, and in 
its simplest form, proceeds via a dienolate and an aldehyde.
34
 The product, a -
hydroxy-,-unsaturated carbonyl compound, is rich in functionality, and as this 
bond construction occurs in an uncommon position (between the - and -carbons of 
the product), it offers novel strategic disconnections in synthetic planning. In recent 
years, the reaction has gained significant attention from the organic community, and 
an important advance was described by Hisashi Yamamoto with the use of the very 
bulky Lewis acid, aluminum tris(2,6-diphenylphenoxide) (ATPH 2.1.1, Scheme 1).
35
 
                                                 
33
 For recent reviews on the aldol reaction, see: (a) Modern Aldol Reactions; Mahrwald, R., Ed.; 
Wiley-VCH: Weinheim, 2004; (b) Paterson, I. Total Synthesis of Polyketides using Asymmetric Aldol 
Reactions. In Asymmetric Synthesis, 2nd ed.; Christmann, M., Brase, S., Eds.; Wiley-VCH Verlag 
GmbH & Co.: Weinheim, Germany, 2008; pp 293 - 298. 
34
 For recent reviews on the vinylogous aldol reaction, see: (a) Casiraghi, G.; Battistini, L.; Curti, C.; 
Rassu, G.; Zanardi, F. Chem. Rev. 2011, 111, 3076; (b) Denmark, S. E.; Heemstra, J. R.; Beutner, G. 
L. Angew. Chem. Int. Ed. Engl. 2005, 44, 4682. 
35
 (a) Saito, S.; Shiozawa, M.; Ito, M.; Yamamoto, H. J. Am. Chem. Soc. 1998, 120, 813; (b) Saito, 
S.; Shiozawa, M.; Yamamoto, H. Angew. Chem. Int. Ed. Engl. 1999, 38, 1769; (c) Saito, S.; Shiozawa, 
M.; Nagahara, T.; Nakadai, M.; Yamamoto, H. J. Am. Chem. Soc. 2000, 122, 7847.; (d) Saito, S.; 
Nagahara, T.; Shiozawa, M.; Nakadai, M.; Yamamoto, H. J. Am. Chem. Soc. 2003, 125, 6200; (e) 
Takikawa, H.; Ishihara, K.; Saito, S.; Yamamoto, H. Synlett. 2004, 732  
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ATPH is used in reactions of lithium enolates and aldehydes, and it is thought to bind 
to both the dienolate and the aldehyde components of the reaction. Due to its bulk, it 
prevents reaction at the -carbon of the dienolate, thereby forcing the reaction to 
occur at the distal -carbon (Scheme 2.1).  
 
Scheme 2.1 Yamamoto Vinylogous Aldol Reaction with ATPH 
An important feature of the Yamamoto protocol is that the components must 
all be combined prior to the addition of the base; attempts to conduct the reaction in a 
stepwise fashion wherein the enolate is first formed then the aldehyde added provide 
significantly diminished yields.  Because this reaction is not amenable to a two-step 
enolization/aldehyde addition protocol, if the aldehyde component is enolizable, there 
must be selectivity in the initial deprotonation step, otherwise a mixture of enolates 
will result, providing a mixture of products. While Yamamoto has described notable 
selectivity with many substrate combinations, in the case of crotonate esters, the 
reaction provides low yields when the aldehyde is enolizable and unhindered at the α-
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carbon. For example, attempted vinylogous aldol reaction between methyl crotonate 
and valeraldehyde provides the desired product in a yield of only 22% (Table 1, entry 
1). This significantly limits the scope of this reaction, and we recently had a need to 
apply this method to an unbranched enolizable aldehyde. We, therefore, studied 
different Lewis acids to overcome this limitation.  
 
Scheme 2.2 Unsuccessful vinylogous aldol reaction with enolizable aldehyde 
 
Utilizing Enolizable Aldehydes 
In order to use enolizable aldehydes in this reaction, we required a Lewis acid 
that upon binding to an aldehyde renders it immune to enolization by bulky kinetic 
bases such as LDA or LTMP. We, therefore, studied a number of Lewis acids as 
surrogates for ATPH in a model vinylogous aldol reaction between methyl crotonate 
(2.2.2) and valeraldehyde (2.2.1) in search of one possessing the right combination of 
tight binding and bulk (Table 1). Under standard reaction conditions (addition of a 
cooled solution of LTMP (2.3 equivs) in THF to a toluene solution of the Lewis acid 
(3.3 equivs), ester (2 equivs) and aldehyde at -78 ºC), none of the known Lewis acids 
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that we studied, including those devised by Yamamoto (MAD,
36
 MABR,
37
 MAT,
38
 
ATD,
39
 Me-ATPH
40
), were successful (Table 2.1). 
 
 
Table 2.1 Vinylogous Aldol Reaction of an Enolizable Aldehyde with Various 
Known Lewis Acids 
We considered the design features of ATPH and sought a Lewis acid with 
comparable bulk in the vicinity of the aluminum, but with extended “reach” such that, 
upon binding to an aldehyde, there is greater hindrance of the protons on the α-carbon 
and limited accessibility to base. We, therefore, considered replacing the phenyl 
                                                 
36
 Starowieyski, K. B.; Pasynkiewicz, S.; Skowrońska-Ptasińska, M. J. Organomet. Chem. 1975, 90, 
C43. 
37
 Maruoka, K.; Nonoshita, K.; Banno, H.; Yamamoto, H. J. Am. Chem. Soc. 1988, 110, 7922. 
38
 Maruoka, K.; Itoh, T.; Sakurai, M.; Nonoshita, K.; Yamamoto, H. J. Am. Chem. Soc. 1988, 110, 
3588.  
39
 Healy, M. D.; Barron, A. R. Angew. Chem. Int. Ed. Engl. 1992, 31, 921. 
40
 Takikawa, H.; Ishihara, K.; Saito, S.; Yamamoto, H. Synlett 2004, 732. 
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groups of ATPH with 2-naphthyl groups and devised aluminum tris(2,6-di-2-
naphthylphenoxide) (ATNP) wherein the naphthyl groups should extend further 
forward toward the α-carbon of the aldehyde (Figure 2.1).  
 
Figure 2.1 Extending the Reach of ATPH with Napthyl Groups 
To model this hypothesis, we began with the crystal structure of Yamamoto’s 
ATPH/methyl crotonate complex available from the Cambridge Crystallographic 
Data Centre CIF Depository. We added the corresponding 2-naphthyl groups and 
exchanged the ester for valeraldehyde and adjusted the complexation bond lengths 
and bond angles to the known values for ATPH-aldehyde complexes. We then 
minimized the energy of the structure (MM2 force field, see Experimental), to obtain 
a model of ATNP bound to valeraldehyde (Figure 2.2). In this model, the aluminum 
atom (light blue) of ATNP is shown coordinated to the oxygen (red) of valeraldehyde 
(carbons shown in yellow). The distal phenyl rings of the 2-naphthyl groups are 
shown in green and the enolizable protons are highlighted in blue. The aldehydic 
proton is also shown in blue; all other hydrogens have been omitted for clarity. This 
structure revealed that the additional reach of the 2-naphthyl groups indeed blocks the 
enolizable protons of the aldehyde.  
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Figure 2.2 A Model of ATNP Bound to Valeraldehyde 
 
The next task was to develop a synthesis of this hypothetical Lewis acid, 
ATNP. It was imagined that a Suzuki reaction would be employed to prepare the 
coupling product. Hence, we synthesized the corresponding naphthylboronic acid 
2.3.2 in a straightforward manner by metalation of β-bromonaphthalene 2.3.1 with n-
BuLi and trapping with trimethylborate (Scheme 2.3). We then examined an array of 
Suzuki coupling conditions as described in below for the coupling of boronic acid 
2.3.2 with 2,6-dibromophenol 2.3.3. However, under the conditions initially 
examined, we were unable to obtain a yield higher than 29%.  
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entry catalyst ligand base solvent temp  yield 
       
1 Pd2(dba)3 P(tBu)3 KF THF 25 5 
2 Pd2(dba)3 P(tBu)3 KF THF 70 5 
3 Pd(OAc)2 -- Na2CO3 DMF/H2O 60 29 
 
Scheme 2.3  Synthesis of ATNP 
 
It is known that electron rich aryl bromides, such as the phenol in this case, 
are less reactive than their electron deficient counterparts. We hypothesized that 
acylating the phenol, thereby reducing its electron density, would improve the yield 
and we therefore utilized 2.4.1 in the Suzuki reaction. Unfortunately, this reaction 
was low yielding under the conditions we examined and this substrate was abandoned 
(Scheme 2.4). 
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Scheme 2.4 Suzuki Coupling of Acylated Phenol 2.4.1 
 Boronic acids are often difficult to work with because of their tendency to 
dimerize and trimerize.  The pinacol derivative 2.5.1 was consequently prepared and 
its use was investigated in the coupling reaction (Scheme 2.5).  
 
entry catalyst ligand base solvent temp  yield 
       
1 Pd2(dba)3 P(tBu)3 KF THF 25 57 
2 Pd2(dba)3 P(tBu)3 KF THF 75 50 
3 Pd(OAc)2 RuPhos K3PO4 Tol/H2O 100 77 
Scheme 2.5 Suzuki reaction of pinacol borate 2.5.1 
It appeared that exchanging the phosphorous ligand to RuPhos significantly 
increased the yield of the reaction and it was assumed that the boronic acid might be 
as suitable of a coupling partner in this reaction as the pinacol ester 2.5.1.  This turned 
out to be the case and conditions were ultimately developed (Pd(OAc)2, RuPhos, 
K3PO4, toluene/H2O, 100 ºC) that provide the desired product in 98% yield. As in the 
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case of ATPH, ATNP (2.6.1) is prepared in situ immediately prior to use by stirring 
the corresponding phenol with trimethylaluminum (Scheme 2.6).  
 
Scheme 2.6  Optimized preparation of ATNP 
 
Gratifyingly, with ATNP using the conditions described in Scheme 1, the 
vinylogous aldol reaction of methyl crotonate (2.2.2) and valeraldehyde (2.2.1) 
proceeds cleanly to provide the desired γ-adduct (2.2.3) in 82% yield (Scheme 2.7). 
This is a substantial improvement over the 22% yield observed by Yamamoto using 
ATPH. 
 
Scheme 2.7 The Use of ATNP in a Vinylogous Aldol Reaction with an Enolizable 
Aldehyde 
With ATNP identified, we wished to optimize the reaction conditions and 
minimize the loading of methyl crotonate. Typically, two equivs of the crotonate are 
used by Yamamoto with approximately equal amounts of LTMP, and we wished to 
optimize this reaction using lower loadings of crotonate, which would require a 
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corresponding decrease in LTMP. We find that a modest decrease in yield is observed 
with the use of 1.5 equivs of crotonate (76%, Table 2.2, entry 2) and a more 
significant decrease with 1.1 equivs (60%, Table 2, entry 3). Neither slow addition of 
the base nor changing the order of addition such that the ATNP complexed substrates 
are added to the LTMP were beneficial (Table 2.2, entries 4 and 5). The reaction 
requires lower temperature to proceed cleanly; at -20 ºC, the reaction produces greater 
amounts of byproducts and proceeds in 54% yield (Table 2.2, entry 6). Finally, 
inverse addition wherein ATNP complexed substrates are added to the LTMP was not 
advantageous and provided the product in 61% yield (Table 2.2, entry 7). 
 
 
 
entry 
ester 
(equiv) 
ATNP 
(equiv) 
LTMP 
(equiv) 
mode of 
addition
a
 
temp 
(ºC) 
yield 
(%) 
 
1 
2 
3 
4 
5 
6 
7 
 
2 
1.5 
1.1 
1.1 
1.1 
2 
2 
 
 
3.3 
2.7 
2.3 
2.3 
2.3 
3.3 
3.3 
 
2.3 
1.7 
1.3 
1.3 
1.3 
2.3 
2.3 
 
 
std 
std 
std 
slow std  
std  
inverse 
inverse 
 
 
-78 
-78 
-78 
-78 
-78 
-20 
-78 
 
82 
76 
60 
55 
44 
54 
61 
 
Table 2.2  Optimization of Reaction Conditions – The mode of addition refers to 
the manner in which the complex and base were combined. std = cooled solution of 
LTMP added rapidly by cannula to ATNP-complex; slow std = cooled solution of 
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LTMP added dropwise by cannula to ATNP-complex; inverse = cooled solution of 
ATNP-complex added rapidly by cannula to LTMP. 
Our optimized conditions are very similar to those of Yamamoto and consist 
of running the reaction at -78 ºC using 2 equivs of the ester, 2.3 equivs of LTMP and 
3.3 equivs of ATNP for every equiv of aldehyde. With these conditions identified, we 
studied the scope of the reaction with a variety of aldehydes. Our results are shown in 
the following tables. 
entry aldehyde product yield (%) dr 
1 
 
 
2.2.1 
 
 
2.2.3 
82 
2  
2.3.5 
 
2.3.6 
76 
3 
 
2.3.7 
 
 
2.3.8 
82 
 
4 
 
 
2.3.9 
 
 
2.3.10 
96 
 
5 
 
 
2.3.11 
 
 
2.3.12 
97 
 
6 
 
 
2.3.13 
 
 
2.3.14 
97 
 
7 
 
 
2.3.15 
 
 
2.3.16 
77 
 
 
8 
 
 
2.3.17 
 
 
 
2.3.18 
 
 
77 
2.4:1 dr 
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9 
 
2.3.19 
 
2.3.20 
87 
10:1 dr 
 
 
10 
 
 
2.3.21 
 
 
2.3.22 
 
65 
1.3:1 dr 
 
 
11 
 
 
2.3.23 
 
 
2.3.24 
 
78 
3.4:1 dr 
 
12 
 
 
2.3.25 
 
 
2.3.26 
 
43 
 
Table 2.3  Scope of the Vinylogous Aldol Reaction with ATNP 
Other unbranched, enolizable aliphatic aldehydes, such as heptanal (2.3.5) and 
hydrocinnamaldehyde (2.3.7), provided comparable results (76% and 82% yields, 
respectively, Table 2.3 entries 2 and 3). The α-branched aldehyde, 
cyclohexylcarboxaldehyde (2.3.9), was also an excellent partner and provided the 
product (2.3.10) in 96% yield (Table 2.3, entry 4). The reaction proceeded cleanly 
using pivaldehyde (2.3.11), a highly congested non-enolizable aldehyde (97%, Table 
3 entry 5), and as expected, benzaldehyde (2.3.13) was an efficient reaction partner 
and provided the product in excellent yield (97%, Table 2.3 entry 6). We also studied 
oxygenation at the α- and β-position of the aldehyde and found that the reaction is 
tolerant of oxygenation in both positions with silyl as well as benzyl protecting 
groups. For example, the α-oxygenated substrate, triethylsiloxy acetaldehyde (2.3.15), 
provided the product in good yield (77%, Table 2.3, entry 7) while the -benzylated 
substrates 2.3.17 and 2.3.19 also provided the products in yields of 77% and 87% 
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(Table 3, entries 8 and 9, respectively). Compounds 2.3.17 and 2.3.19 also provided 
the opportunity to study asymmetric induction with stereogenicity at the -position. 
We found that branching is required for high levels of selectivity; unbranched 
aldehyde 2.3.17 provided the product with a modest 2.4:1 dr while branched aldehyde 
2.3.19 provided the product with a 10:1 dr (Table 3, entry 9 and 10, respectively). In 
both cases, the major isomer was the anti-diastereomer. In addition, we find that -
oxygenated substrates 2.3.21 and 2.3.23 provide the product in good chemical yield 
with no evidence of -elimination, but with low to moderate levels of asymmetric 
induction (Table 3, entry 10, 65% yield, 1.3:1 dr; entry 11, 78% yield, 3.4:1 dr). 
Finally, cinnamaldehyde 2.3.25 provided the desired product in modest yield due to 
competitive conjugate addition (Table 3, entry 12).
41
 
We also wished to expand the scope of the nucleophiles in this reaction. First 
we examined the diastereoselectivity of the reaction when using an ester that would 
create a new stereocenter in the product. The homolog of methyl crotonate 2.8.3 was 
prepared via a Horner-Wadsworth-Emmons reaction (Scheme 2.8). The vinylogous 
aldol reaction of this substrate with benzaldehyde was studied and gratifyingly gave a 
96% yield of the desired product 2.8.4 favoring the anti-stereochemistry. 
Scheme 2.8 Vinylogous Aldol reaction of Ester 2.8.3 
                                                 
41
 Saito, S.; Yamamoto, H. Chem. Comm. 1997, 1585. 
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 We propose an open transition state for this reaction of the ATNP-aldehyde 
complex wherein the ATNP is on the side of the hydrogen of the aldehyde. Our 
model assumes that ATNP is larger than the phenyl group of the aldehyde and that 
antiperiplanar attack will occur. In the transition state leading to the major anti- 
product, there is a steric interaction between the methyl group of the enolate and the 
phenyl group of the aldehyde. In the transition state leading to the minor product, the 
corresponding interaction is between the methyl group and ATNP (Figure 2.3). 
 
Figure 2.3  Transition State of the Vinylogous Aldol Reaction of Ester 2.8.3 
 The chemistry of the undesired side products derived from enolization through 
the furan in the original peloruside A model studies was also developed. Ester 2.9.2 
was prepared
42
 and utilized in a vinylogous aldol reaction with ATNP and LTMP 
wherein enolization through the furan occurs. Reaction with benzaldehyde provides 
the doubly vinylogous aldol product 2.9.3 in 84% yield (Scheme 2.9). This reaction is 
also amenable to the enolizable aldehydes and proceeds in 70% yield with 
valeraldehyde.  
                                                 
42
 Reddy, K. R.; Venkateshwar, M.; Maheswari, C. U.; Prashanthi, S. Synth.Comm. 2009, 40, 186. 
113 
 
 
Scheme 2.9 Preparation of Furyl Ester 2.9.2 and its use in the Vinylogous Aldol 
Reaction 
 
2.2 Application of ATNP to the Synthesis of Macrolides  
Synthesis of Substrates 
With the use of ATNP as a Lewis acid with enolizable aldehydes developed in 
an intermolecular fashion, we wished to make this a feasible method for forming 
medium-membered rings with enolizable aldehyde partners. Before application of this 
method to a natural product synthesis, we conceived a series of model systems shown 
below (Scheme 2.10). These intramolecular vinylogous aldol precursors could be 
synthesized in similar fashions and give us the opportunity to study the formation of 
rings of various sizes, and the diastereoselectivities in their reactions.  
 
Scheme 2.10  Proposed intramolecular vinylogous aldol 
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A representative synthesis of an intramolecular precursor is shown below 
(Scheme 2.11) Beginning with 2-iodobenzylalcohol 2.11.1, 2-iodobenaldehyde 2.11.2 
was prepared in a straightforward manner by oxidation with PCC. Nucleophilic attack 
by methyl Grignard gave the corresponding secondary alcohol 2.11.3 without any 
detectable metal-halide exchange. The alcohol was then protected as a TBS ether 
2.11.4 under standard conditions. The next step of the synthesis involved a tandem 
palladium catalyzed Heck arylation and alkene isomerization with hexenol. Once the 
Heck coupling is complete, the resulting alkene can equilibrate and migrate to the 
terminus to provide the enol. This enol then irreversibly tautomerizes to the aldehyde. 
The TBS ether is then cleaved under acidic conditions at 50 ºC to provide the free 
alcohol 2.11.6. The hydroxyl group was then acylated with crotonic anhydride to 
provide the corresponding precursor 2.11.7 for an intramolecular vinylogous aldol 
reaction with an enolizable aldehyde coupling partner.   
Scheme 2.11 Synthesis of intramolecular vinylogous aldol precursor 2.11.7 
The Intramolecular Vinylogous Aldol Reaction 
After preparing the necessary substrates, we wished to apply the 
intramolecular vinylogous aldol reaction using ATNP to make medium-membered 
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lactones of 12- and 14-members. The results are shown below in Table 2.4. A control, 
non-enolizable substrate 2.4.12, which is known to undergo successful cyclizations 
with ATPH was carried out with ATNP demonstrating the utility of the new Lewis 
acid to promote these macroaldolizations. Both 12- and 14-membered ring systems 
were formed in good yields (79-94%) and in moderate levels of diastereoselectivity.  
 
Table 2.4  The intramolecular vinylogous reaction of enolizable aldehydes 
2.3 Future Directions 
ATNP mediated additions to chiral aldehydes will also be studied in order to 
assess the diastereotopic face selectivity of the substrates in this reaction (Scheme 
2.12). We have studied a single example of a chiral aldehyde bearing a stereocenter at 
the α-carbon, and found that the reaction provides a diastereomeric ratio of 10:1 
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favoring the anti-product (Table 2.3, entry 9; duplicated in Scheme 2.12). This is 
consistent with the polar Felkin-Anh model, as expected using an aluminum Lewis 
acid not capable of chelation. We suspect that this reaction will benefit from the 
sterics of the ATNP as Heathcock has shown that increasing the substituents size of 
Lewis acid bound carbonyls will increase the stereoselectivity in nucleophilic 
additions to chiral substrates. We will study the substrates shown in Scheme 2.12 
bearing alkyl and alkoxy groups at the α- and β-carbons using methyl crotonate as 
well as the homolog, 2.8.3. 
 
 
 
 
Scheme 2.12  Additions to Chiral Aldehydes 
 
 
As described above, we had initially studied the synthesis of peloruside A via 
a non-enolizable furfural derivative that was subjected to an intramolecular 
vinylogous aldol reaction to form the macrolide. This synthesis was problematic as 
the product must be subjected to an Achmatowicz rearrangement which produces a 
pyranone, and we experienced difficulty installing the requisite hydroxy and methoxy 
substituents with the correct stereochemistry on the pyranone. Proceeding through the 
furfural was required because our previous methods were not amenable to the use of 
enolizable aldehydes; however, the use of ATNP avoids these limitations and we 
have redesigned this synthesis to proceed in a more direct fashion. Our plan is heavily 
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influenced by our lessons from our work with the furfural system and is shown in 
Scheme 2.13 below.  
We will begin with D-lyxose which is commercially available (current price is 
about $2.50/gram from Carbosynth) and which will be converted by a known 
procedure to TBS acetonide 2.13.1. This compound will then be subjected to Wittig 
olefination, deprotection and oxidative cleavage with periodate to provide enal 2.13.3. 
The aldehyde will then undergo an aldol reaction with methyl isobutyrate by a known 
procedure, reduced to the diol with lithium aluminum hydride, then oxidized (Dess-
Martin periodinane) to keto aldehyde 2.13.4.  
 
 
Scheme 2.13 Preparation of Aldehyde 2.13.4 
 
As described above, ketone 1.30.3 will then undergo a 1,5-anti-aldol reaction 
with aldehyde 2.13.4 to merge the two fragments together. The product of the aldol 
reaction will then be subjected to a hydroxyl-directed anti reduction 
(Me4N(OAc)3BH), and protected as the isopropyl silylene 2.14.1 (Scheme 2.14). 
Deprotection of the PMB ether (DDQ) will be followed by acylation of the resulting 
alcohol with crotonic anhydride to give the crotonate ester (not shown). This 
compound will then undergo selective hydroboration/oxidation of the less hindered 
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and more reactive terminal alkene with a bulky hydroborating agent (9-BBN) to 
provide the primary alcohol which will be oxidized (Swern) to provide aldehyde 
2.14.2 ready for the key intramolecular vinylogous aldol reaction. This will be 
conducted using our standard conditions, which are 2.3 equivalents of ATNP and 1.2 
equivalents of LTMP at -78 °C. Of course, these conditions are amenable to 
optimization with respect to the number of equivalents of the reagents use, the 
temperature and time of the reaction and the solvent, and we will study the 
optimization of this reaction should our initial attempts prove unsuccessful or 
moderately successful. We anticipate obtaining the desired stereochemistry at the C-5 
alcohol in the vinylogous aldol reaction based on our previous work using furfural 
substrate 1.34.1 and derivatives (data not shown) wherein we found that when the 
hydroxyl groups at C-11 and C-13 are engaged as a silylene, we obtain the desired 
stereochemical outcome at C-5. The stereochemistry was, however, reversed when 
these two alcohols were not protected in a cyclic array. In any event, if we obtain the 
undesired stereochemistry, we will perform the vinylogous aldol reaction on a 
substrate wherein the hydroxyl groups at C-11 and C-13 are not tied up as a silylene. 
Should this also fail we will then resort to an inversion (Mitsunobu or an oxidation / 
reduction sequence) to provide the desired stereochemistry. We do not anticipate the 
ketone at C9 to be problematic in the vinylogous aldol reaction as it is very hindered 
and significantly less electrophilic than the aldehyde.  
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Scheme 2.14 Preparation of macrolide 2.14.3 
 
Completion of the synthesis will then proceed by dihydroxylation of the 
enoate using the matched AD-mix-β reagent: again this transformation has 
precedence in our prior work using the furfural approach wherein these conditions 
provided the desired stereochemistry on compound 2.14.3 (Scheme 2.15). Silylation 
of the hydroxyl group at C-2 was found to be selective on our previous furfural-
derived system, and will be followed by methylation using methyl Meerwein’s 
reagent and the mild base 2,6-di-t-Butyl-pyridine so as to avoid any potential silyl 
migration. Removal of the benzyl ether and subsequent oxidation of the free hydroxyl 
would provide 2.15.1. Removal of the labile silylene in the presence of the TBS ether 
with HF in pyridine is well precedented, and we have observed this transformation on 
our furfural system. This will be followed by selective methylation of the hydroxyl 
group at C-13 with methyl Meerwein’s reagent and 2,6-di-t-butylpyridine, a 
transformation which has precedent in the work of Debrabander. Protection of the 
alcohol as a TBS ether provides ketone 2.15.2.  Installation of the alkene will be 
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accomplished using the known phosphonium salt 2.15.3 and will take advantage of 
Clark Still’s observation that Wittig reactions on α-alkoxy ketones selectively provide 
the Z- alkene geometry. Deprotection of the remaining acetonide will be followed by 
methylation of the more accessible hydroxyl group on C-7, a transformation that has 
precedence in the work of Taylor. 
 
 
Scheme 2.15 Completion of Peloruside A 
 
2.4   Experimental 
All reactions were performed in oven-dried or flame-dried glassware under a 
dry nitrogen atmosphere.  Toluene was washed with cold concentrated H2SO4, H2O, 1 
M NaOH, H2O, dried over anhydrous MgSO4, filtered and distilled from CaH2 under 
nitrogen prior to use.  CH2Cl2, Et3N, and 2,2,6,6-tetramethylpiperidine were distilled 
from CaH2 under nitrogen prior to use.  THF and Et2O were distilled from Na 
benzophenone ketyl under nitrogen prior to use.  DMF was distilled from CaH2 at 
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reduced pressure prior to use. Commercially available aldehyde substrates 2.2.1, 
2.3.5, 2.3.7, 2.3.9, 2.3.11, 2.3.13, and 2.3.24 were distilled immediately before use. 
Non-commercially available aldehydes 2.3.15,
43
 2.3.17,
44
 2.3.19,
45
 2.3.21,
46
 and 
2.3.23
47
 were prepared according to standard literature procedures. All other 
chemicals were used as received from the supplier.  Flash chromatography was 
performed using 60 Å silica gel (37-75 m).  1H NMR spectra were recorded at 500 
MHz in CDCl3 using residual CHCl3 (7.24 ppm) as the internal reference.  
13
C NMR 
spectra were recorded at 75 MHz in CDCl3 using residual CHCl3 (77.26 ppm) as the 
internal reference. Exact mass was determined using electrospray ionization on the 
sodiated ([M+Na]
+
) molecular ion. 
 
 
 
3-(benzyloxy)propan-1-ol 2.3.1c: 
 
To a stirring solution of propane-1,3-diol 2.3.1a (2.89 g, 2.75 mL, 38.0 mmol) 
in THF (60 mL) at rt, was added NaH (60% dispersion in mineral oil, 1.745 g, 43.9 
mmol) in portions. Upon completion of the addition, the suspension was stirred for 30 
minutes at which time benzyl bromide (5g, 3.48 mL, 29.2 mmol) and TBAI 
                                                 
43
 Angle, S. R.; Choi, I.; Tham, F. S. J. Org. Chem. 2008, 73, 6268. 
44
 Enders, D.; Berg, S. von Org. Synth. 2002, 10, 18. 
45
 Li, W.; Ewing, W.; Harris, B. J. Am. Chem. Soc. 1990, 112, 7659. 
46
 Ishiyama, H.; Ishibashi, M.; Ogawa, A.; Yoshida, S.; Kobayashi, J. J. Org. Chem. 1997, 62, 3831. 
47
 Keck, G. E.; Murry, J. A. J. Org. Chem. 1991, 56, 6606. 
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(tetrabutylammonium iodide, 1.080 g, 2.92 mmol) were added, the flask fitted with a 
condenser, and brought to reflux for 12 hours. The reaction mixture was cooled to 
room temperature, diluted with ether (50 mL), washed with saturated NaHCO3, (25 m 
L) and brine (25 mL).  The organic layer was dried (MgSO4) and concentrated in 
vacuo.  The crude oil was then purified by flash chromatography (2% MeOH in 
CH2Cl2) to provide the desired alcohol (2.3.1b, 4.81 g, 29.1 mmol, 95%) as a 
colorless oil. 
1
H NMR (500 MHz, CDCl3) δ 7.37 – 7.25 (m, 5H), 4.51 (s, 2H), 3.77 (t, J = 5.6 Hz, 
2H), 3.65 (t, J = 5.8 Hz, 2H), 1.89 – 1.81 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 
138.30, 128.71, 127.97, 127.90, 73.55, 69.74, 62.28, 32.35. 
 
3-(benzyloxy)propanal 2.3.1c: 
 
To a solution of oxalyl chloride (3.44 g, 2.34 mL, 27.1 mmol) in CH2Cl2 (80 
mL) at -78 ºC was added DMSO (5.64 g, 5.12 mL, 72.2 mmol) in CH2Cl2 (10 mL) 
over 10 minutes.  The reaction was allowed to stir an additional 15 minutes after 
which alcohol 2.3.1b (3.0 g, 18.05 mmol) in CH2Cl2 (5mL) was added.  The reaction 
was allowed to stir for 1 hour at which time Et3N (7.31 g, 10.15 mL, 72.2 mmol) was 
added and the cold bath removed, and reaction stirred overnight. The reaction mixture 
was poured into water (50 mL) and extracted with EtOAc (3 x 50 mL). The organic 
layers were combined then washed saturated NaHCO3 (30 mL) and brine (25 mL).  
The organic layer was dried (MgSO4) and concentrated in vacuo.  The crude oil was 
123 
 
then purified by flash chromatography (10:1 hexanes:EtOAc) to give the desired 
product 2.3.1c (2.74 g, 16.69 mmol, 92%) as a colorless oil. 
 
1
H NMR (500 MHz, CDCl3) δ 9.80 (t, J = 1.8 Hz, 1H), 7.41 – 7.27 (m, 5H), 
4.54 (s, 2H), 3.82 (t, J = 6.1 Hz, 2H), 2.71 (td, J = 6.1, 1.8 Hz, 2H); 
13
C NMR (75 
MHz, CDCl3) δ 201.38, 138.08, 128.70, 128.03, 127.95, 73.52, 64.08, 44.13. 
 
 
 
  
Alcohol 2.3.1d: 
TBSCl (1.0 g mmol, 6.63 mmol) in CH2Cl2 (10 mL) was added to a stirred 
solution of 1,3-propanediol 2.3.1a (2.02 g, 1.92 mL, 26.5 mmol) and imidazole 
(13.27 mmol, 0.903 g) in DMF (1.5 ml) at 0 ºC over 1 hour. The solution was allowed 
to warm to rt and stir for 16 hours. The reaction mixture was extracted with petroleum 
ether (3x 10 mL), the organic layers combined, washed with saturated NaHCO3 (20 
mL) and brine (20 mL), dried over anhydrous MgSO4, and concentrated under 
reduced pressure on the rotary evaporator.  The crude product was purified by flash 
chromatography (gradient20:1 hexanes:EtOAc to EtOAc) to provide the desired 
alcohol 2.3.1d (.356 g, 1.872 mmol, 28%) as a colorless oil. 
1
H NMR (500 MHz, CDCl3) δ 3.84 – 3.80 (m, 2H), 3.80 – 3.76 (m, 2H), 2.55 
(bs, 1H), 1.81 – 1.70 (m, 2H), 0.88 (s, 9H), 0.06 (s, 6H); 13C NMR (75 MHz, CDCl3) 
δ 63.26, 62.80, 34.40, 26.13, 18.43, -5.24. 
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Aldehyde 2.3.1e: 
To a solution of oxalyl chloride (.336 g, 0.232 mL, 2.65 mmol) in CH2Cl2 (8 
mL) at -78 ºC was added DMSO (.552 g, 0.502 mL, 7.07 mmol) in CH2Cl2 (1 mL) 
over 10 minutes and let stir an additional 15 minutes. Alcohol 2.3.1d (.336 g, 1.77 
mmol) in CH2Cl2 (1 mL) was added and let stir for 1 hour at which time Et3N (.715 g, 
0.993 mL, 7.07 mmol) was added and the stirring solution was let warm to rt and stir 
overnight. The reaction mixture was poured into water (20 mL) and extracted with 
EtOAc (3 x 15 mL). The combined organic layers were combined and washed 
saturated NaHCO3 (15 mL) and brine (15 mL).  The organic layer was dried (MgSO4) 
and concentrated in vacuo.  The crude oil was then purified by flash chromatography 
(10:1 hexanes:EtOAc) to give the desired product 2.3.1e (.184 g, 0.977 mmol, 55%) 
as a colorless oil. 
1
H NMR (500 MHz, CDCl3) δ 9.78 (t, J = 2.1 Hz, 1H), 3.97 (t, J = 6.0 Hz, 
2H), 2.58 (td, J = 6.0, 2.1 Hz, 2H), 0.86 (s, 9H), 0.04 (s, 6H); 
13
C NMR (75 MHz, 
CDCl3) δ 202.30, 57.65, 46.82, 26.06, 18.47, -5.19. 
 
 
 
Ester 2.3.15b 
To a solution of α-hydroxy ester 2.3.15a (1 g, 0.926 mL, 9.61 mmol) in 
CH2Cl2 (19 mL), was added Et3N (1.26 g, 1.76 mL, 12.49 mmol) at rt and then the 
reaction mixture was stirred for 30 min. The reaction mixture was cooled to 0 ºC and 
TESCl (1.59 g, 1.79 mL, 10.57 mmol) was added dropwise. The mixture was allowed 
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to warm to rt followed by stirring for 3 h. Saturated aqueous NaHCO3 was poured 
into the mixture, the aqueous layer was extracted with CH2Cl2. The combined organic 
layers were dried over (MgSO4) and concentrated to afford the crude product. Flash 
chromatography (20:1 hexanes/ ethyl acetate) gave the desired product 2.3.15b.
 
1
H NMR (500 MHz, CDCl3) δ 4.21 (s, 1H), 4.18 (q, J = 7.2 Hz, 1H), 1.26 (t, J 
= 7.1 Hz, 1H), 0.95 (t, J = 7.9 Hz, 3H), 0.63 (q, J = 8.0 Hz, 2H); 
13
C NMR (75 MHz, 
CDCl3) δ 171.94, 61.74, 61.01, 14.45, 6.87, 4.57. 
 
Aldehyde 2.3.15  
To a solution of ester 2.3.15a (1.5 g, 6.87 mmol) in hexanes/ether (10:1, 35 
mL) at -78 ºC was added a -78 ºC solution of DIBAL-H (1 M solution in hexanes) 
(8.24 mL, 8.24 mmol) dropwise by cannula. The reaction mixture was stirred for 1.5 
hr at -78 ºC at which time MeOH (10 mL) was added and let stir for 1 hour at -78 ºC. 
The reaction mixture was cannulated into a vigorously stirred saturated aqueous 
solution of Rochelle’s Salt (50 mL) and let warm to RT and stirred overnight. The 
organic layer was separated, washed with saturated NaHCO3, (25 mL) and brine(25 
mL).  The organic layer was dried (MgSO4) and concentrated in vacuo.  The crude oil 
was then purified by flash chromatography (20:1 hexanes:EtOAc) to give the desired 
aldehyde 2.3.15 (.465 g, 2.67 mmol, 39%) as a yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 9.69 (t, J = 0.8 Hz, 1H), 4.19 (d, J = 0.8 Hz, 
2H), 0.95 (t, J = 7.9 Hz, 9H), 0.63 (q, J = 8.0 Hz, 6H); 
13
C NMR (75 MHz, CDCl3) δ 
202.62, 69.49, 6.85, 4.54. 
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(−)-(S)-Ethyl 2-(benzyloxy)propanoate 2.3.17b: 
 To a stirring solution of (R)-ethyl-2-hydroxybutyrate 2.3.17a (1 g, 8.47 mmol) 
and benzyl trichloroacetimidate (3.21 g, 12.7 mmol) in 19 mL of 
cyc1ohexane:CH2Cl2 (2:1) was added 0.075 mL of triflic acid.  This solution was 
allowed to stir at room temperature for 36 h and then quenched with aqueous 
NaHCO3. The organic layer was separated and the aqueous layer was washed three 
times with 20-mL portions of CH2Cl2. The organic layers were combined, dried over 
MgSO4, and concentrated in vacuo.  The resulting solid was filtered and washed with 
hexanes.  The crude product was then purified by flash chromatography (12:1 
hexanes:EtOAc) to give the desired ester 2.3.17b as a white solid (1.29 g, 79%). 
1
H NMR (500 MHz, CDCl3) δ 7.45 – 7.28 (m, 5H), 4.71 (d, J = 11.6 Hz, 1H), 
4.46 (d, J = 11.6 Hz, 1H), 4.30 – 4.16 (m, 2H), 4.06 (q, J = 6.9 Hz, 1H), 1.45 (d, J = 
6.9 Hz, 3H), 1.31 (t, J = 7.1 Hz, 3H). 
 
(−)-(S)-2-(Benzyloxy)propanal 2.3.17: 
 To a solution of ester 2.3.17b (1.29 g, 6.21 mmol) in hexanes:ether (6:1, 35 
mL) at -78 ºC was cannulated a cooled solution of 1 M DIBAL-H in hexanes (6.83 
mL, .683 mmol). The solution was stirred for 1.5 hours at which time MeOH (10 mL) 
was added and stirred for an additional hour. The solution was cannulated into a 
vigorously stirred solution of saturated Rochelle’s salt and stirred for 2 hours. The 
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organic layer was separated, dried over MgSO4, and concentrated in vacuo. The crude 
product was then purified by flash chromatography (10:1 hexanes:EtOAc) to give the 
desired aldehyde 2.3.17 as a yellow oil (0.855 g, 5.21 mmol, 79%). 
1
H NMR (500 MHz, CDCl3) δ 9.68 (d, J = 1.8 Hz, 1H), 7.47 – 7.29 (m, 5H), 
4.64 (q, J = 11.7 Hz, 2H), 1.35 (d, J = 6.9 Hz, 3H). 
 
 
3-(tert-butyldimethylsiloxy)-butyrate 2.3.21b: 
To a stirred solution of tert-butyldimethylsilyl chloride (TBSCl, 1.37 g, 9.08 
mmol), DMAP (0.092 g, 0.757 mmol) and imidazole (0.67 g, 9.84 mmol) dissolved in 
dry DMF (15 mL) was added the ethyl ester 2.3.21a (1.0 g, 7.57 mmol). The solution 
was stirred for 14 hours and after addition of saturated NaHCO3 aqueous solution (25 
mL), the mixture was extracted with Et2O (30 mL x 3), washed with H2O, brine, dried 
over MgSO4, and concentrated in vacuo. Crude material 2.3.21b was attained in 
quantitative yield and deemed pure enough for the next step. 
1
H NMR (500 MHz, CDCl3) δ 4.36 – 4.21 (m, 1H), 4.20 – 4.04 (m, 2H), 2.48 
(dd, J = 14.5, 7.7 Hz, 1H), 2.37 (dd, J = 14.5, 5.3 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H), 
1.20 (d, J = 6.1 Hz, 3H), 0.87 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H). 
 
3-(tert-Butyldimethylsiloxy)butanal 2.3.21: 
 To a solution of ester 2.3.21b (1.87 g, 7.57 mmol) in hexanes:ether (6:1, 38 
mL) at -78 ºC was cannulated a cooled solution of 1 M DIBAL-H in hexanes (8.33 
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mL, 8.33 mmol). The solution was stirred for 1.5 hours at which time MeOH (10 mL) 
was added and stirred for an additional hour. The solution was cannulated into a 
vigorously stirred solution of saturated Rochelle’s salt and stirred for 2 hours. The 
organic layer was separated, dried over MgSO4, and concentrated in vacuo. The crude 
product was then purified by flash chromatography (40:1 petroleum ether:EtOAc) to 
give the desired aldehyde 2.3.21 as a yellow oil (1.50 g, 7.43 mmol, 98%). 
 
1
H NMR (400 MHz, CDCl3) δ 9.81 (dd, J = 2.8, 2.1 Hz, 1H), 4.36 (dqd, J = 
12.3, 6.2, 5.0 Hz, 1H), 2.56 (ddd, J = 15.7, 7.0, 2.8 Hz, 1H), 2.47 (ddd, J = 15.7, 5.0, 
2.1 Hz, 1H), 1.24 (d, J = 6.2 Hz, 3H), 0.88 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 
 
Ethyl-3-(Benzyloxy)butyrate 2.3.23b:  
To a stirring solution of ethyl-3-hydroxybutyrate 2.3.23a (1 g, 7.57 mmol) and 
benzyl trichloroacetimidate (9.08 mmol) in 21 mL of cyc1ohexane:CH2Cl2 was added 
0.067 mL of triflic acid.  This solution was allowed to stir at room temperature for 36 
h and then quenched with aqueous NaHCO3. The organic layer was separated and the 
aqueous layer was washed three times with 20-mL portions of CH2Cl2. The organic 
layers were combined, dried over MgSO4, and concentrated in vacuo.  The resulting 
solid was filtered and washed with hexanes.  The crude product was then purified by 
flash chromatography (20:1 hexanes:EtOAc) to give the desired ester 2.3.23b (0.473 
g, 93% BRSM). 
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1
H NMR (500 MHz, CDCl3) δ 7.41 – 7.28 (m, 5H), 4.58 (d, J = 11.6 Hz, 1H), 
4.51 (d, J = 11.6 Hz, 1H), 4.22 – 4.08 (m, 2H), 4.03 (dp, J = 7.3, 6.1 Hz, 1H), 2.66 
(dd, J = 15.0, 7.3 Hz, 1H), 2.44 (dd, J = 15.0, 5.7 Hz, 1H), 1.30 – 1.23 (m, 6H). 
 
3-(Benzyloxy)butanal 2.3.23: 
To a solution of ester 2.3.23b (0.386 g, 1.734 mmol) in hexanes:ether (4:1, 10 
mL) at -78 ºC was cannulated a cooled solution of 1 M DIBAL-H in hexanes (1.91 
mL, 1.908 mmol). The solution was stirred for 1.5 hours at which time MeOH (10 
mL) was added and stirred for an additional hour. The solution was cannulated into a 
vigorously stirred solution of saturated Rochelle’s salt and stirred for 2 hours. The 
organic layer was separated, dried over MgSO4, and concentrated in vacuo. The crude 
product was then purified by flash chromatography (10:1 hexanes:EtOAc) to give the 
desired aldehyde 2.3.21 as a yellow oil (0.164 g, 0.920 mmol, 53%). 
 
1
H NMR (400 MHz, CDCl3) δ 9.79 (dd, J = 2.5, 1.9 Hz, 1H), 7.43 – 7.26 (m, 
5H), 4.61 (d, J = 11.6 Hz, 1H), 4.48 (d, J = 11.6 Hz, 1H), 4.09 (dqd, J = 7.4, 6.2, 5.0 
Hz, 1H), 2.71 (ddd, J = 16.4, 7.4, 2.5 Hz, 1H), 2.53 (ddd, J = 16.4, 5.0, 1.9 Hz, 1H), 
1.30 (d, J = 6.2 Hz, 3H). 
 
 
 
 
 
130 
 
1.4-bis-(tert-butyldimethylsilyloxy)but-2-ene 2.3.1g: 
According to a literature procedure,
48
 a solution of 2-butene-1,4-diol 2.3.1f 
(1.5 g, 17.03 mmol) and imidazole (4.46 g, 3.41 mmol) in dry CH2Cl2 (45 mL) was 
cooled to 0 °C with stirring under argon atmosphere and a solution of tert-
butyldimethylsilyl chloride (6.15 g, 40.9 mmol) and DMAP (0.416 g, 3.41 mmol) in 
dry CH2Cl2 (40 mL) at 0 °C was added via cannula. The reaction mixture was 
allowed to warm to room temperature and was stirred for 18 h. Then, distilled water 
(125 mL) was added and the reaction mixture was extracted with CH2Cl2, dried, 
filtered, and concentrated under reduced pressure. Purification by flash 
chromatography using EtOAc/hexanes (1:50) afforded the desired bi-protected alkene 
2.3.1g (5.2 g, 96 %) as a colorless oil. 
1
H NMR (500 MHz, CDCl3) δ 5.56 (td, J = 3.3, 1.6 Hz, 2H), 4.24 (dd, J = 3.4, 
0.8 Hz, 4H), 0.91 (s, 18H), 0.08 (s, 12H). 
 
Aldehyde 2.3.1h: 
According to a literature procedure,
48
 a solution of 2.3.1g (3.10 g, 9.78 mmol) 
in dry CH2Cl2 (49 mL) was cooled to -78 °C, and ozone was bubbled through until 
the solution turned blue. Nitrogen was then bubbled through the solution until the 
reaction mixture turned colorless. Triphenylphosphine (3.08 g, 11.74 mmol) was 
added, and the mixture was warmed to room temperature and stirred under nitrogen 
for 1.5 h. The solvent was removed in vacuo, and the residue was purified by flash 
                                                 
48
 J. A. Lafontaine; D. P. Provencal; C. Gardelli; J. W. Leahy J. Org. Chem. 2003, 68 (11), 4215. 
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chromatography (20:1 hexanes:EtOAc) to yield 2.3.1h (1.63 g, 9.35 mmol, 96%) as a 
colorless oil. 
1
H NMR (500 MHz, CDCl3) δ 9.71 (t, J = 0.8 Hz, 1H), 4.23 (d, J = 0.8 Hz, 
2H), 0.94 (s, 9H), 0.11 (s, 6H). 
 
 
Ester 2.3.1j: 
 To a flask containing TBSCl (3.83 g, 25.4 mmol) and DMAP (3.10 g, 25.4 
mmol) in DMF (51 mL) at 0 °C alcohol 2.3.1i (3.0 g, 25.4 mmol) was added slowly 
and let stir 2 hours. The reaction was quenched with saturated ammonium chloride, 
extracted with hexanes (3x), washed with water, brine, dried over MgSO4 
concentrated in vacuo. The crude reaction was purified by flash chromatography 
(20:1) to give the product 2.3.1j as a yellow oil (5.2 g, 22.38 mmol, 88%).  
 
1
H NMR (500 MHz, CDCl3) δ 4.32 (q, J = 6.7 Hz, 1H), 4.19 (qq, J = 10.8, 7.1 
Hz, 2H), 1.41 (d, J = 6.8 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H), 0.91 (s, 9H), 0.11 (s, 3H), 
0.08 (s, 3H). 
 
Aldehyde 2.3.1k: 
 To a solution of ester 2.3.1j (1.0 g, 4.30 mmol) in hexanes (22 mL) at -78 ºC 
was cannulated a cooled solution of 1 M DIBAL-H in hexanes (4.73 mL, 4.73 mmol). 
The solution was stirred for 1.5 hours at which time MeOH (10 mL) was added and 
stirred for an additional hour. The solution was cannulated into a vigorously stirred 
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solution of saturated Rochelle’s salt and stirred for 2 hours. The organic layer was 
separated, dried over MgSO4, and concentrated in vacuo. The crude product was then 
purified by flash chromatography (40:1 hexanes:EtOAc) to give the desired aldehyde 
2.3.1k as a yellow oil (0.044 g, 0.169 mmol, 79%). 
 
1
H NMR (500 MHz, CDCl3) δ 9.59 (d, J = 1.3 Hz, 1H), 4.07 (qd, J = 6.9, 1.3 
Hz, 1H), 1.26 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 0.08 (d, J = 6.2 Hz, 6H). 
 
 
 
 
(R)-2-hydroxy-3-methylbutanoic acid 2.3.19b 
Acid 2.3.19b was prepared according to a literature procedure.
45
 L-Valine 
2.3.19a (1.60 g, 13.66 mmol) was placed into 3-necked flask, and water (10 mL) was 
added.  The flask was fitted with two addition funnels and a stirrer-bar.  In one 
addition funnel, was placed 2 N H2SO4 (7.50 mL).  To the other addition funnel was 
added 2 N NaNO3 (7.50 mL).  The reaction vessel was cooled to 0 ºC, and the acid 
was added dropwise with stirring. After the  L-valine  dissolved,  the  sodium  nitrite  
solution  was  added dropwise,  and the rate of  addition of  the  acid  was  adjusted 
similarly. After the addition was complete, the reaction was stirred at 0 ºC for 3 h and 
then allowed to stir at room temperature for 12 h. After this time, the reaction mixture 
was extracted with EtOAc (5 x 10 mL).  The combined organic extracts were dried 
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(Na2SO3), filtered, and concentrated.  The resulting  crude solid was recrystallized 
twice from  ether/ petroleum  ether  to  afford  compound  2.3.19b (0.92 g,  57%  
yield)  as a  white, crystalline solid. 
1
H NMR (300 MHz, CDCl3) δ 7.30 (br s, 2H), 4.16 (d, J = 3.6, 1H), 2.09-2.19 
(m, 1H), 1.05 (d, J = 6.9, 3H), 0.92 (d, J = 6.9, 3H).   
 
(R)-methyl 2-hydroxy-3-methylbutanoate 2.3.19c: 
Ester 2.3.19c was prepared in a similar manner to a procedure in the 
literature.
45
 Refluxing a solution of (R)-2-hydroxy- 3-methylbutanoic acid (5.0 g, 42.3 
mmol) in MeOH (85 mL) with a catalytic amount of concentrated H2SO4 (.45 mL, 
8.47 mmol) for 2 h. The reaction was concentrated in vacuo, diluted with ether (80 
mL), and washed with saturated NaHCO3, (80 mL) and brine (50 mL). The organic 
phase was dried (MgSO4), filtered, and concentrated, which gave 4.24 g (76%) 
Methyl (R)-2-(Benzyloxy)-3-methylbutanoate 2.3.19c as an oil with spectra that were 
consistent with the reported data.  
1
H NMR (500 MHz, CDCl3) δ 4.03 (dd, J = 5.4, 3.6 Hz, 1H), 3.78 (s, 3H), 
2.64 (d, J = 5.9 Hz, 1H), 2.05 (heptd, J = 6.9, 3.5 Hz, 1H), 1.00 (d, J = 6.9 Hz, 3H), 
0.84 (d, J = 6.9 Hz, 3H);  
13
C NMR (75 MHz, CDCl3) δ 175.63, 75.28, 52.63, 32.40, 
19.00, 16.24. 
 
(R)-methyl 2-(benzyloxy)-3-methylbutanoate 2.3.19d 
Methyl (R)-2-hydroxy-3-methylbutanoate 2.3.19c (1.0 g, 7.57 mmol) was 
dissolved in a solution of cyclohexane/CH2CI2, (2:l, 19 mL).  The reaction flask was 
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cooled to 0 ºC, and benzyl 2,2,2-trichloroacetimidate (1.69 mL, 9.08 mmol) was 
added with stirring. To the resulting solution was added a catalytic amount of 
trifluoro-methanesulfonic acid (0.67 mL, 0.757 mmol).  After 24 hours, the reaction 
was filtered, and the collected solid was rinsed with cyclohexane.  The filtrate was 
washed with saturated NaHCO3, (3 x 25 mL) and brine (25 mL).  The organic layer 
was dried (MgSO4) and concentrated in vacuo.  The crude oil was then purified by 
flash chromatography (20:1 hexanes:EtOAc).  Pure methyl (R)-2-(ben-zyloxy)-3-
methylbutanoate 2.3.19d (.858 g, 51% yield) was obtained as a colorless oil with 
spectra consistent with reported data. 
1
H NMR (500 MHz, CDCl3) δ 7.41 – 7.25 (m, 5H), 4.68 (d, J = 11.8 Hz, 1H), 
4.36 (d, J = 11.8 Hz, 1H), 3.73 (s, 3H), 3.68 (d, J = 5.7 Hz, 1H), 2.13 – 2.00 (m, 1H), 
0.94 (dd, J = 12.1, 6.8 Hz, 6H). 
 
(R)-2-(benzyloxy)-3-methylbutanal 2.3.19: 
To a solution of ester 2.3.19d (.858 g, 3.86 mmol) in hexanes/ether (10:1, 40 
mL) at -78 ºC was added a -78 ºC solution of DIBAL-H (1 M solution in hexanes) 
(4.25 mL, 4.25 mmol) dropwise by cannula. The reaction mixture was stirred for 1.5 
hr at -78 ºC at which time MeOH (10 mL) was added and let stir for 1 hour at -78 ºC. 
The reaction mixture was cannulated into a vigorously stirred saturated aqueous 
solution of Rochelle’s Salt (50 mL) and let warm to RT and stirred overnight. The 
organic layer was separated, washed with saturated NaHCO3, (25 mL) and brine(25 
mL).  The organic layer was dried (MgSO4) and concentrated in vacuo.  The crude oil 
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was then purified by flash chromatography (30:1 hexanes:EtOAc) to give the desired 
aldehyde 2.3.19 (0.531 g, 2.76 mmol, 72%) as a yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 9.64 (d, J = 2.7 Hz, 1H), 7.42 – 7.26 (m, 5H), 
4.67 (d, J = 11.8 Hz, 1H), 4.48 (d, J = 11.8 Hz, 1H), 3.46 (dd, J = 5.8, 2.7 Hz, 1H), 
2.08 (qd, J = 12.7, 6.9 Hz, 1H), 0.98 (dd, J = 9.3, 6.9 Hz, 6H).  
 
Methyl 2-(diethoxyphosphoryl)acetate 2.4.2 
A stirred mixture of methyl bromoacetate 2.4.1 (2.85, 30.1 mmol) and 
triethylphosphite (5.0 g, 30.1 mmol) was heated at 60 °C for 2 h. After this time 
volatiles were removed in vacuo to give 2.4.2 as a colorless liquid (6.1 g, 29.0 mmol, 
96%). 
1
H NMR (400 MHz, CDCl3), δ  4.17  (qd, J = 8.3, 0.9 Hz, 4H), 3.75  (s,  3H), 
2.96  (d, J  =  21.5  Hz,  2H), 1.33 (td, J =  7.0,  0.5  Hz,  6H); 
13
C NMR (100 MHz, 
CDCl3), δ 166.2 (d, J = 5.4 Hz), 62.5 (d, J  = 6.2  Hz), 52.4, 34.0 (d, J  = 135.3 Hz), 
16.2 (d, J = 6.2 Hz). 
 
Methyl 2-Butenoate 2.4.3 
To a solution of NaH (60% in mineral oil, 0.571 g, 14.27 mmol) in THF (30 
mL) was added dropwise the phosphonate 2.4.2 (3.0 g, 2.63 mL, 14.27 mL) at 0 ºC. 
After 30 minutes, the aldehyde (0.638 g, 0.792 mL, 10.98 mmol) in THF (7 mL) was 
added dropwise The resultant mixture was stirred for 1.5 h and then quenched with 
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water and ether. The organic phase was washed with saturated brine, dried over 
anhydrous MgSO4, filtered, and the solvent was removed by evaporation under 
reduced pressure. Purification by flash chromatography (50:1 petroleum ether:EtOAc 
provided the desired ester (0.994 g, 8.71 mmol, 79%). 
1
H NMR (500 MHz, CDCl3) δ 7.04 (dt, J = 15.7, 6.4 Hz, 1H), 5.83 (dt, J = 
15.7, 1.7 Hz, 1H), 3.74 (s, 3H), 2.38 – 2.13 (m, 2H), 1.08 (t, J = 7.4 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 9.8, 25.1, 53.8, 122.2, 135.5, 174.2. 
 
 
Furan-2-carboxylic acid methyl ester 2.5.2 
A solution of 70% aqueous TBHP (1.5 mmol) was added dropwise to a 
solution of aldehyde 2.5.1 (1.0 mmol) and potassium iodide (0.05 mmol) in 5 mL of 
methanol over a period of 30 min and stirred at 65 °C. Progress of the reaction was 
monitored by TLC, and after completion of the reaction, the mixture was quenched 
with saturated aqueous Na2S2O3, washed with brine, extracted with ethyl acetate, and 
dried over anhydrous Na2SO4. Removal of the solvent under vacuum afforded the 
crude product 2.5.2, which was purified by column chromatography using a 
hexane/ethyl acetate mixture.  
1
H NMR (300 MHz, CDCl3) δ 7.03 – 6.88 (m, 1H), 6.10 – 5.85 (m, 1H), 3.79 
– 3.62 (m, 3H), 2.25 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 157.02, 142.80, 119.29, 
109.36, 108.32, 51.49, 13.73.  
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Naphthalen-1-yl-1-boronic acid 2.3.2 
 Following a modification of a literature procedure,
49
 a three-necked 1 L flask 
fitted with two dropping funnels, magnetic stirring bar, and low-temperature 
thermometer was charged with 1-bromonaphthalene (8.3 g, 40.0 mmol) under Argon. 
Dry THF (100 mL) was added, and the solution was cooled to -78 ºC. To this solution 
was added n-butyllithium (25.0 mL of a 1.6 M solution, 40.0 mmol) dropwise 
through the first dropping funnel. The solution was stirred at -78 °C for  2 h 
whereupon trimethyl borate (6.3 g, 60.0 mmol) dissolved in 10 mL of dry THF was 
added dropwise through the second dropping funnel. The solution was allowed to 
warm to room temperature overnight. The reaction was quenched with dilute HCl 
(20%, 70 mL), and the reaction mixture was concentrated at 30 °C to 50% of its 
original volume by rotary evaporation and poured into H2O. The resulted biphasic 
solution was extracted with Et2O (2 X 50 mL). The ethereal solution was washed 
twice with H2O and concentrated by rotary evaporation. The crude product was 
dissolved in 10% aqueous NaOH (80 mL) and extracted with Et2O to remove liquid 
byproducts. The clear basic aqueous phase was collected and acidified by 10% HCl at 
0 °C. Naphthalen-1-yl-1-boronic acid was collected as a white solid powder by 
filtration and washed with H2O several times to remove HCl. It was dried at 20 °C 
under vacuum and used without further purification (92% isolated yield). 
                                                 
49
 Percec, V.; Bera, T. K.; De, B. B.; Sanai, Y.; Smith, J.; Holerca, M. N.; Barboiu, B.; Grubbs, R. 
B.; Fréchet, J. M. J. Org. Chem. 2001, 66, 2104. 
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1
H NMR (400 MHz, CDCl3) δ= 8.91 (s,1H), 8.35 (d, 1H, J=8.2 Hz), 8.11 
(d,1H, J=7.3 Hz), 8.01 (d, 1H, J=8.2 Hz), 7.96 (d,1H, J=7.3Hz), 7.64 (m, 2H); 
13
C 
NMR (100 MHz, CDCl3) δ = 137.89, 135.88, 132.91, 130.68, 129.12, 127.89, 127.67, 
127.37, 126.05  
 
4,4,5,5-Tetramethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborolane 2.5.1: 
Boronic Acid 2.3.2 (5.0 g, 10.82 mmol) and pinacol (4.09 g, 34.6 mmol) were 
dissolved in anhydrous cyclohexane (100 mL). The mixture was refluxed for 12 h at 
rt and concentrated under reduced pressure. The crude product was puriﬁed by 
recrystallization (hexanes), yielding the ester 2.5.1 in the form of white crystalline 
solid. 
1
H NMR (400 MHz, CDCl3) δ = 8.37 (s, 1H), 7.88-7.81 (m, 4H), 7.52-7.44 
(m, 2H), 1.38 (s, 12H); 
13
C NMR (100 MHz, CDCl3) δ = 136.2, 135.0, 132.8, 130.4, 
128.6, 127.7, 127.0, 126.9, 125.8, 83.9, 24.9; mp = 62–65 °C. 
 
1-acetoxy-2,6-dibromobenzene 2.4.1: 
Following a modification on a literature procedure,
50
 a mixture of 2,6-
dibromobenzene 2.3.3 (1.0 g, 3.97 mmol) and pyridine (3.21 mL, 39.7 mmol) was 
                                                 
50
 Suzuki, K.; Kawano, M.; Sato, S.; Fujita, M. J. Am. Chem. Soc. 2007, 129, 10652. 
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stirred in acetic anhydride (14.2 mL) at 80 ºC for 4 hours under nitrogen atmosphere. 
The reaction mixture was evaporated under reduced pressure, and the residue was 
purified by recrystallization (CHCl3, hexanes) to give the title compound 2.4.1 as a 
white solid (.243 g, .827 mmol) in 21% yield.  
1
H NMR (500 MHz, CDCl3) 7.55 (d, J = 8.1 Hz, 2H), 7.01 (t, J = 8.1 Hz, 1H), 
2.40 (s, 3H); 
13
C NMR (75 MHz, CDCl3) 167.24, 146.3, 132.4, 128.2, 117.8, 20.5; IR 
(KBr, cm.1) 1773, 1567, 1437, 1367, 1182, 1069, 1010, 900, 775, 729.  mp = 46-47 
ºC. 
 
1-acetoxy-2,6-di-2-napthylbenzene 2.4.2: 
Open to the atmosphere, 1-acetoxy-2,6-dibromobenzene 2.4.1 (0.131 g, 0.447 
mmol), 2-naphthalenylboronic acid 2.3.2 (0.169g, 0.983 mmol), KF (0.174 g, 2.99 
mmol), Pd2(dba)3 (0.041 g, 0.045 mmol), and THF (5 mL) are added to a 10 mL RBF 
equipped with a stir bar. The vial is then capped with a septum, an argon inlet is 
attached, and the reaction mixture is gently sparged for about one minute. Then, a 
solution of the P(t-Bu)3 in toluene is added by syringe, and the reaction mixture was 
stirred at room temperature for 2 days. At the conclusion of the reaction, the reaction 
mixture was diluted with Et2O, filtered through a pad of silica gel with copious 
washings, concentrated, and purified by column chromatography on silica gel (40:1 
hexanes:EtOAc) to give 2.4.2 as a white solid. 
1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 1.3 Hz, 2H), 7.93 – 7.85 (m, 7H), 
7.64 (dd, J = 8.5, 1.7 Hz, 2H), 7.57 – 7.44 (m, 8H), 1.73 (s, 3H). 
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2-(naphthalen-2-yl)-6-(naphthalen-7-yl)phenol 2.3.4: 
 To a solution of 2.4.2 in THF/MeOH (5 mL, 1:1) was added 4M aqueous 
NaOH (0.10 mL, 0.180 mmol). The solution was stirred for 1 hour at which time 4M 
aqueous HCl was carefully added until the solution was acidic. The mixture was 
diluted with water and extracted 3x with CH2Cl2. The organic layers were combined, 
dried (MgSO4) and concentrated in vacuo to give the title compound 2.3.4.  
1
H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 1.5 Hz, 2H), 7.97 (d, J = 8.5 Hz, 
2H), 7.93 – 7.87 (m, 4H), 7.72 (dd, J = 8.5, 1.8 Hz, 2H), 7.58 – 7.48 (m, 4H), 7.42 (d, 
J = 7.6 Hz, 2H), 7.15 
(t, J = 7.6 Hz, 1H), 5.61 (s, 1H). 
13
C NMR (75 MHz, CDCl3) δ 149.72, 135.05, 
133.54, 132.68, 130.29, 128.79, 128.51, 128.15, 128.10, 127.73, 127.51, 126.41, 
126.26, 120.92; Rf = 0.31 (hexanes/EtOAc 40:1); mp = 139-141ºC. 
 
 
 
2-(naphthalen-2-yl)-6-(naphthalen-7-yl)phenol 2.3.4: 
To a dry 500 ml resealable tube equipped with a stirbar was added 
naphthalene-2-boronic acid 2.3.2 (11.47 g, 66.7 mmol), 2,6-dibromophenol 2.3.3 (5.6 
g, 22.23 mmol), tripotassium phosphate (18.87 g, 89 mmol), RuPhos (2-
dicyclohexylphosphino-2',6'-diisopropoxybiphenyl; 0.415 g, 0.889 mmol), and 
Pd(OAc)
2
 (0.1g, 0.445 mmol). The vessel was evacuated and refilled with argon and 
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toluene (100 ml) and H2O (10 ml) were added, and the vessel was sealed. The 
reaction mixture was heated to 100 ºC for 16 hours with stirring. The reaction was 
then cooled to room temperature and concentrated in vacuo. The crude reaction 
mixture was diluted with Et2O, filtered through a pad of silica, washed with ether 
until the washings were clear, concentrated, and recrystallized from EtOAc/hexanes 
by dissolving in hot hexanes containing a minimal amount of EtOAc then allowing to 
cool. The mother liquor was concentrated and recrystallized as described above. The 
combined crystals provided 7.54g (98%) of a fluffy, white solid.
 
1
H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 1.5 Hz, 2H), 7.97 (d, J = 8.5 Hz, 
2H), 7.93 – 7.87 (m, 4H), 7.72 (dd, J = 8.5, 1.8 Hz, 2H), 7.58 – 7.48 (m, 4H), 7.42 (d, 
J = 7.6 Hz, 2H), 7.15 
(t, J = 7.6 Hz, 1H), 5.61 (s, 1H). 
13
C NMR (75 MHz, CDCl3) δ 149.72, 135.05, 
133.54, 132.68, 130.29, 128.79, 128.51, 128.15, 128.10, 127.73, 127.51, 126.41, 
126.26, 120.92; Rf = 0.31 (hexanes/EtOAc 40:1); mp = 139-141ºC. 
 
General Intermolecular Vinylogous Aldol Procedure: 
 
Preparation of ATNP (2.6.1):  Me3Al (0.457 mL, 0.914 mmol, 2.0 M solution 
in hexanes) was added to a stirred solution of 2,6-dinapthalphenol 2.3.4 (0.950 g, 2.74 
mmol) in toluene (15 mL) at room temperature.  After 20 minutes, the ATNP solution 
was cooled to -78 
o
C and used as described in the vinylogous aldol procedure. 
Preparation of LTMP:  n-BuLi (0.398 mL, 0.637 mmol, 1.6 M solution in 
hexanes) was added to a stirred solution of 2,2,6,6-tetramethylpiperdine (TMP, 0.108 
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mL, 0.637 mmol) in THF (1.5 mL) at -78 
o
C.  The cold bath was lowered and the 
solution allowed to stir for 10 minutes.  The solution was cooled back to -78 
o
C and 
used as described below in the vinylogous aldol procedure. 
The aldehyde (0.277 mmol) and ester (0.554 mmol) were added to a stirred 
solution of freshly prepared ATNP (0.914 mmol) in toluene (15 mL) at -78 
o
C 
(acetone/dry ice bath).  After 20 minutes, a stirred solution of LTMP (0.638 mmol) in 
THF (1.5 mL) at – 78oC was added via cannula to the ATPH-substrate solution. After 
3 hours following the addition, saturated NH4Cl (15 mL) was added, and the biphasic 
mixture was stirred vigorously for 30 minutes while warming to ambient temperature.  
The organic phase separated and the aqueous layer extracted with ether (3 times). The 
combined organic layers were washed with brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  The reaction mixture was recrystallized from 
hexanes/chloroform to remove the majority of 2,6-dinapthalphenol (2.3.4). 
Purification of the crude product was achieved with flash chromatography (10:1 
hexanes:EtOAc then 3:1 hexanes:EtOAc) to provide the desired product along with 
additional recovered 2,6-dinapthalphenol. The combined yield of recovered 2,6-
dinapthalphenol was typically above 90%. 
 
(E)-methyl 5-hydroxynon-2-enoate (2.2.3) 
Compound 2.2.3 was prepared from valeraldehyde 2.2.1 and methyl crotonate 
2.2.2 in 82% yield after purification according to the general procedure. 
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Rf = 0.34 (hexanes/EtOAc 3:1); 
1
H NMR (500 MHz, CDCl3) δ 7.03 – 6.91 
(m, 1H), 5.89 (dt, J = 15.7, 1.2 Hz, 1H), 3.74 (m, 1H), 3.72 – 3.68 (s, 3H), 2.39 
(dddd, J = 13.1, 6.9, 4.5, 1.4 Hz, 1H), 2.35 – 2.25 (m, 1H), 1.67 – 1.13 (m, 7H), 0.89 
(t, J = 7.1 Hz, 3H);  
13
C NMR (75 MHz, CDCl3) δ 166.74, 145.53, 123.45, 70.57, 
51.50, 40.17, 36.84, 27.74, 22.62, 14.03; HRMS (ESI) m/z calc’d for C10H18O3Na 
[M+Na]
+
: 209.1154; found: 209.1156. 
 
(E)-methyl 5-hydroxyundec-2-enoate (2.2.6) 
Compound 2.3.6 was prepared from heptaldehyde 2.3.5 and methyl crotonate 
2.2.2 in 76% yield after purification according to the general procedure. 
Rf = 0.62 (hexanes/EtOAc 2:1); 
1
H NMR (400 MHz, CDCl3) δ 7.03 – 6.91 
(m, 1H), 5.89 (dt, J = 15.7, 1.4 Hz, 1H), 3.79 – 3.72 (m, 1H), 3.71 (s, 3H), 2.50 – 2.24 
(m, 2H), 1.54 (s, 1H), 1.50 – 1.16 (m, 10H), 0.86 (t, J = 6.8 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 166.99, 145.80, 123.68, 70.82, 51.74, 40.42, 37.41, 32.02, 29.45, 
25.79, 22.83, 14.31; HRMS (ESI) m/z calc’d for C12H22O3Na [M+Na]
+
: 237.1467; 
found: 237.1462. 
 
 
 
(E)-methyl 5-hydroxy-7-phenylhept-2-enoate (2.3.8) 
Compound 2.3.8 was prepared from dihydrocinnamaldehyde 2.3.7 and methyl 
crotonate 2.2.2 in 82% yield after purification according to the general procedure. 
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Rf = 0.38 (hexanes/EtOAc 2:1); 
1
H NMR (500 MHz, CDCl3) δ 7.32 – 7.25 
(m, 2H), 7.18 (dt, J = 3.1, 2.6 Hz, 3H), 7.01 – 6.88 (m, 1H), 5.89 (dt, J = 15.6, 1.4 Hz, 
1H), 3.81 – 3.73 (m, 1H), 3.71 (s, 3H), 2.84 – 2.73 (m, 1H), 2.67 (dt, J = 13.8, 7.9 Hz, 
1H), 2.46 – 2.27 (m, 2H), 1.84 – 1.73 (m, 2H), 1.60 – 1.52 (m, 1H);   13C NMR (75 
MHz, CDCl3) δ 166.94, 145.44, 141.80, 128.72, 128.64, 126.22, 123.86, 70.04, 
51.77, 40.58, 38.92, 32.19. 
 
 
 
(E)-methyl 5-cyclohexyl-5-hydroxypent-2-enoate (2.3.10) 
Compound 2.3.10 was prepared from cyclohexanecarboxaldehyde 2.3.9 and 
methyl crotonate 2.2.2 in 96% yield after purification according to the general 
procedure. 
Rf = 0.42 (hexanes/EtOAc 3:1); 
1
H NMR (500 MHz, CDCl3) 
1
H NMR (500 
MHz, CDCl3) δ 7.05 – 6.93 (m, 1H), 5.90 (dt, J = 15.7, 1.4 Hz, 1H), 3.71 (s, 3H), 
3.53 – 3.45 (m, 1H), 2.42 (dddd, J = 14.5, 6.9, 3.8, 1.6 Hz, 1H), 2.36 – 2.25 (m, 1H), 
1.85 – 1.78 (m, 1H), 1.75 (tdd, J = 8.1, 5.9, 3.3 Hz, 2H), 1.65 (ddd, J = 12.6, 5.8, 3.3 
Hz, 2H), 1.47 (bs, 1H), 1.40 – 1.28 (m, 1H), 1.28 – 0.93 (m, 5H); 13C NMR (75 MHz, 
CDCl3) δ 167.02, 146.52, 123.50, 75.00, 51.73, 43.52, 37.38, 29.35, 28.08, 26.64, 
26.40, 26.25; HRMS (ESI) m/z calc’d for C12H20O3Na [M+Na]
+
: 235.1310; found: 
235.1299. 
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5-hydroxy-6,6-dimethyl-hept-2-enoic acid methyl ester (2.3.12) 
Compound 2.3.12 was prepared from pivaldehyde 2.3.11 and methyl 
crotonate 2.2.2 in 97% yield in purification according to the general procedure.  
Rf = 0.44 (hexanes/EtOAc 3:1); 
1
H NMR (500 MHz, CDCl3) ä 7.04 (ddd, J = 
15.6, 7.9, 6.7 Hz, 1H), 5.90 (dt, J = 15.6, 1.4 Hz, 1H), 3.71 (s, 3H), 3.35 (d, J = 10.3 
Hz, 1H), 2.42 (ddt, J = 14.6, 6.6, 1.9 Hz, 1H), 2.18 (dddd, J = 14.6, 10.3, 8.0, 1.3 Hz, 
1H), 1.76 (s, 1H), 0.91 (s, 9H); 
13
C NMR (75 MHz, CDCl3) ä 167.07, 147.84, 123.08, 
78.55, 51.67, 35.24, 35.08, 25.83. 
 
 
 
(E)-methyl 5-hydroxy-5-phenylpent-2-enoate (2.3.14) 
Compound 2.3.14 was prepared from benzaldehyde 2.3.13 and methyl 
crotonate 2.2.2 in 97% yield after purification according to the general procedure. 
Rf = 0.33 (hexanes/EtOAc 3:1); 
1
H NMR (500 MHz, CDCl3) δ 7.39 – 7.25 
(m, 5H), 6.95 (dt, J = 15.6, 7.3 Hz, 1H), 5.89 (dt, J = 15.7, 1.4 Hz, 1H), 4.82 (dd, J = 
7.8, 5.2 Hz, 1H), 3.70 (s, 3H), 2.74 – 2.53 (m, 2H), 2.21 – 1.51 (bs, 1H); 13C NMR 
(75 MHz, CDCl3) δ 166.91, 145.12, 143.61, 128.90, 128.23, 125.96, 123.91, 73.38, 
51.76, 42.08; HRMS (ESI) m/z calc’d for C12H14O3Na [M+Na]
+
: 229.0841; found: 
229.0848. 
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(E)-methyl 6-[(triethylsiloxy]-5-hydroxy-2-hexenoate (2.3.16) 
Compound 2.3.16 was prepared from aldehyde 2.3.15 and methyl crotonate 
2.2.2 in 77% yield after purification according to the general procedure. 
Rf = 0.22 (hexanes/EtOAc 5:1); 
1
H NMR (500 MHz, CDCl3) δ 6.98 (dt, J = 
15.6, 7.3 Hz, 1H), 5.90 (dt, J = 15.7, 1.5 Hz, 1H), 3.83 – 3.72 (m, 1H), 3.71 (s, 3H), 
3.61 (dd, J = 9.9, 3.6 Hz, 1H), 3.43 (dd, J = 9.9, 6.9 Hz, 1H), 2.48 (d, J = 4.1 Hz, 1H), 
2.40 – 2.30 (m, 2H), 0.94 (t, J = 8.0 Hz, 9H), 0.59 (q, J = 8.0 Hz, 6H); 13C NMR (75 
MHz, CDCl3) δ 163.96, 145.34, 123.45, 70.77, 66.40, 51.73, 36.19, 6.94, 4.55.  
 
(E,5S,6R)-methyl 6-(benzyloxy)-5-hydroxyhept-2-enoate (2.3.18) 
Compound 2.3.18 was prepared from 2.3.17 and methyl crotonate 2.2.2 in 
77% yield and in a 2.4:1 anti:syn mixture of diastereomers after purification 
according to the general procedure. 
Major isomer: Rf = 0.23 (hexanes/EtOAc 3:1); 
1H NMR (500 MHz, CDCl3) δ 
7.43 – 7.27 (m, 5H), 7.08 – 6.91 (m, 1H), 6.00 – 5.89 (m, 1H), 4.63 (d, J = 11.7 Hz, 
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1H), 4.49 (d, J = 11.7 Hz, 1H), 3.85 (m, 1H), 3.73 (s, 3H), 3.59 – 3.50 (m, 1H), 2.42 – 
2.34 (m, 2H), 2.11 (bs, 1H), 1.20 (d, J = 6.3 Hz, 3H). 
 
Structure Proof:  
 
 
Diol 2.3.18a 
Ester 2.3.18, which was produced as a 2.4:1 mixture of diastereomers was 
subjected to ozonolysis and reduction according to a literature procedure to provide 
diol 2.3.18a as a 2.4:1 mixture.
51
 The spectroscopic data for the minor diastereomer 
of this mixture was consistent with that of the known syn diastereomer
52
 indicating 
that the anti-isomer is the major diastereomer in the reaction. 
 
 
Ester 2.3.2h 
Compound 2.3.2h was prepared from aldehyde 12.3.1h and methyl crotonate 
2.2.2 in 54% yield after purification according to the general procedure. 
1
H NMR (500 MHz, CDCl3) ä 7.00 (dt, J = 15.6, 7.3 Hz, 1H), 5.92 (dt, J = 
15.7, 1.5 Hz, 1H), 3.84 – 3.77 (m, 1H), 3.74 (s, 3H), 3.64 (dd, J = 10.0, 3.7 Hz, 1H), 
                                                 
51
 Flippin, L.; Gallagher, D. J. Org. Chem. 1989, 54, 1430. 
52
 Terasaka, T.; Okumura, H.; Tsuji, K.; Kato, T.; Nakanishi, I.; Kinoshita, T.; Kato, Y.; Kuno, M.; 
Seki, N.; Naoe, Y.; Inoue, T.; Tanaka, K.; Nakamura, K. J. Med. Chem. 2004, 47, 2728. 
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3.46 (dd, J = 10.0, 6.7 Hz, 1H), 2.46 (d, J = 4.4 Hz, 1H), 2.41 – 2.35 (m, 2H), 1.02 – 
0.79 (m, 9H), 0.08 (s, 6H); 
13
C NMR (75 MHz, CDCl3) ä 166.96, 145.31, 123.47, 
70.74, 66.69, 51.73, 36.22, 26.09, 18.51, -5.13, -5.16. 
 
 
Ester 2.3.2k 
Compound 2.3.2k was prepared from 2.3.1k and methyl crotonate 2.2.2 in 
59% yield after purification in a 4:1 anti:syn mixture of diastereomers according to 
the general procedure. 
1
H NMR (500 MHz, CDCl3) δ 7.03 (dt, J = 15.6, 7.3 Hz, 1H), 5.94 (dt, J = 
15.7, 1.5 Hz, 1H), 3.81 (qd, J = 6.3, 3.7 Hz, 1H), 3.74 (s, 3H), 3.70 – 3.61 (m, 1H), 
2.37 – 2.29 (m, 2H), 2.18 (bs, 1H), 1.12 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.09 (s, 
3H), 0.08 (s, 3H). 
 
Ester 2.3.2e 
Compound 2.3.2e was prepared from aldehyde 2.3.1e and methyl crotonate 
2.2.2 in 59% yield after purification according to the general procedure. 
1
H NMR (500 MHz, CDCl3) ä 7.01 (dt, J = 15.6, 7.4 Hz, 1H), 5.92 (dt, J = 
15.7, 1.5 Hz, 1H), 4.07 – 3.97 (m, 1H), 3.96 – 3.88 (m, 1H), 3.83 (ddd, J = 10.2, 8.9, 
3.9 Hz, 1H), 3.73 (s, 3H), 3.65 (d, J = 1.1 Hz, 1H), 2.49 – 2.32 (m, 2H), 1.76 – 1.62 
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(m, 2H), 0.91 (s, 9H), 0.09 (s, 3H), 0.09 (s, 3H); 
13
C NMR (75 MHz, CDCl3) ä 
145.88, 137.98, 123.38, 71.37, 62.99, 51.70, 40.45, 37.91, 26.08, 18.35, -5.31, -5.35. 
 
 
 
 
(E,5S,6R)-methyl 6-(benzyloxy)-5-hydroxy-7-methyloct-2-enoate (2.3.20) 
Compound 2.3.20 was prepared from 2.3.19 and methyl crotonate 2.2.2 in 
87% yield after purification in a 10:1 anti:syn mixture of diastereomers according to 
the general procedure. 
Rf = 0.22 (hexanes/EtOAc 5:1); 
1
H NMR (500 MHz, CDCl3) δ 7.38 – 7.30 
(m, 4H), 7.28 (dd, J = 10.2, 4.2 Hz, 1H), 7.05 – 6.95 (m, 1H), 5.90 (d, J = 15.7 Hz, 
1H), 5.86 (d, J = 15.7 Hz, 1H), 4.67 (d, J = 11.4 Hz, 1H), 4.61 (d, J = 11.4 Hz, 1H, 
3.90 – 3.82 (m, 1H), 3.71 (s, 3H), 3.23 – 3.16 (m, 1H), 2.47 (ddd, J = 8.2, 5.3, 4.3 Hz, 
1H), 2.44 – 2.33 (m, 1H), 1.90 (dq, J = 13.5, 6.8 Hz, 1H), 1.02 (d, J = 6.7 Hz, 3H), 
0.96 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 166.95, 146.42, 138.75, 
128.74, 128.00, 127.88, 123.60, 87.61, 75.18, 71.32, 51.74, 35.57, 30.26, 20.19, 
18.61; HRMS (ESI) m/z calc’d for C17H24O4Na [M+Na]
+
: 315.1572; found: 
315.1567. 
Structure Proof:  
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Compound 2.3.20 was protected as a TBS ether, subjected to ozonolysis and 
reduction to provide 2.3.20b. Authentic syn isomer, 2.3.20e, was prepared according 
to a literature procedure
53
 and provided different spectral data than 2.3.20b. This 
indicates that the anti-isomer is the major diastereomer in the reaction. 
 
 (E,5S,6R)-methyl-6-(benzyloxy)-5-(yloxy)(tert-butyl)dimethylsilane-7-
methyloct-2-enoate (2.3.20a) 
TBSCl (0.384 mmol, 0.058 g), imidazole (0.508 mmol, 0.034 g), and DMAP 
(0.025 mmol, 3 mg) were added to a stirred solution of 2.3.20 (0.127 mmol, 0.037 g) 
in DMF (6 ml) at 0 ºC. The solution was allowed to warm to RT and stir for 6 days at 
which time TLC indicated consumption of the starting material. The reaction was 
diluted with Et2O (6 mL), washed with saturated NaHCO3 and brine, dried over 
anhydrous MgSO4, and concentrated under reduced pressure.  The crude product was 
purified by flash chromatography (25:1 hexanes:EtOAc) to provide the desired ester 
2.3.20a (0.038 g, 0.094 mmol, 74%)  
Rf = 0.75 (hexanes/EtOAc 5:1); [α]D
24
 -12.4º (c 0.034, CHCl3); 
1
H NMR (500 
MHz, CDCl3) δ 7.38 – 7.25 (m, 5H), 7.06 (dt, J = 15.4, 7.5 Hz, 1H), 5.85 (dt, J = 
15.6, 1.4 Hz, 1H), 4.84 (d, J = 11.2 Hz, 1H), 4.52 (d, J = 11.2 Hz, 1H), 3.93 (dt, J = 
7.4, 3.7 Hz, 1H), 3.71 (s, 4H), 3.13 (dd, J = 7.0, 3.6 Hz, 1H), 2.57 (dtd, J = 8.9, 7.7, 
1.3 Hz, 1H), 2.39 (dddd, J = 14.7, 7.1, 3.7, 1.5 Hz, 1H), 1.83 – 1.72 (m, 1H), 0.96 
(dd, J = 17.0, 6.7 Hz, 6H), 0.89 (s, 9H), 0.05 (d, J = 11.1 Hz, 6H); 
13
C NMR (75 
                                                 
53
 Heathcock, C.; Kiyooka, S.-ichi J. Org. Chem. 1984, 49, 4214. 
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MHz, CDCl3) δ 167.08, 147.71, 139.34, 128.52, 127.89, 127.65, 122.93, 88.83, 
75.28, 73.26, 51.62, 35.48, 30.45, 26.12, 20.55, 19.07, 18.28, -4.05, -4.23. 
 
Alcohol 2.3.20b 
A flask was charged with DCM (5 mL) and ester 2.2.20a (0.019g, 0.046 
mmol), and the solution was cooled to -78 ºC in a dry ice-acetone bath. A stream of 
ozone from a Welsbach ozone generator was bubbled into the DCM solution until a 
persistent blue color of unreacted ozone was noticeable.  The reaction mixture was 
allowed to warm to room temperature, and dry nitrogen was bubbled through for 1 
minute to remove excess ozone. Borane dimethyl sulfide complex (0.017 g, 0.022 
mL, 0.230 mmol) was added by syringe and the reaction mixture was allowed to stir 
at RT overnight. Aqueous HCl (5%, 5 mL) was added and the resulting mixture 
stirred vigorously for 30 minutes. Solid NaHCO3 was carefully added (caution, gas 
evolution) and the organic layer was separated, washed with brine and dried over 
anhydrous MgSO4. The reaction mixture was filtered and concentrated to provide the 
crude product.  Flash chromatography (10:1 hexanes:EtOAc) gave the desired alcohol 
(2.2.20b 8 mg, 0.024 mmol, 51%). 
Rf = 0.30 (hexanes/EtOAc 5:1); 
1
H NMR (500 MHz, CDCl3) δ 7.39 – 7.25 
(m, 5H), 4.98 (d, J = 10.8 Hz, 1H), 4.52 (d, J = 10.8 Hz, 1H), 4.10 (td, J = 4.9, 2.8 
Hz, 1H), 3.87 (ddd, J = 11.2, 7.8, 3.6 Hz, 1H), 3.63 (ddd, J = 10.9, 6.8, 3.8 Hz, 1H), 
3.14 (dd, J = 8.8, 2.7 Hz, 1H), 1.96 – 1.83 (m, 1H), 1.81 – 1.66 (m, 2H), 0.99 (d, J = 
6.6 Hz, 3H), 0.92 (s, 8H), 0.89 (d, J = 6.8 Hz, 3H), 0.10 (d, J = 7.5 Hz, 6H); 
13
C 
NMR (75 MHz, CDCl3) δ 128.61, 128.14, 127.85, 89.84, 76.07, 72.21, 58.63, 34.43, 
30.95, 26.18, 20.19, 20.06, -4.09, -4.53. 
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(4R,5R)-5-(benzyloxy)-6-methylhept-1-en-4-ol (2.3.20c) 
A solution of stannic chloride (0.061 mL, 36 mg, 0.138 mmol) in dry CH2C12 
(6 ml) was cooled to -78 ºC. To this solution was added dropwise a solution of (R)-2-
(benzyloxy)-3-methylbutanal 2.3.19 (26.5 mg, 0.138 mmol) in CH2C12 (0.5 ml) via 
syringe over a 2-min period.  The reaction was stirred for 3 min and 
allyltrimethylsilane (0.026 mL, 19 mg, 0.165 mmol) was added in one portion. After 
stirring at -78 ºC for 15 min, the reaction mixture was quenched with water, allowed 
to warm to room temperature and extracted with ether.  The ethereal layer was dried 
over MgSO4 concentrated at reduced pressure, and purified by flash chromatography 
(15:1 hexanes/EtOAc) to afford 32 mg (49%) of a clear, colorless liquid, which was 
desired compound 2.3.20c. 
 
Rf = 0.22 (hexanes/EtOAc 10:1); [α]D
24
 -5.5º (c 0.022, CHCl3);
 1
H NMR (500 
MHz, CDCl3) δ 7.39 – 7.25 (m, 5H), 5.92 – 5.77 (m, 1H), 5.08 (dt, J = 3.5, 1.5 Hz, 
2H), 4.64 (dd, J = 50.9, 11.1 Hz, 2H), 3.75 – 3.64 (m, 1H), 3.08 (dd, J = 5.6, 4.0 Hz, 
1H), 2.33 – 2.23 (m, 3H), 2.03 – 1.91 (m, 1H), 0.98 (dd, J = 9.1, 6.9 Hz, 6H); 13C 
NMR (75 MHz, CDCl3) δ 138.70, 135.30, 128.70, 128.01, 127.98, 117.53, 86.40, 
75.13, 71.20, 39.78, 30.29, 19.94, 18.28. 
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((4R,5R)-5-(benzyloxy)-6-methylhept-1-en-4-yloxy)(tert-butyl)dimethylsilane 
(2.3.20d) 
TBSCl (0.337 mmol, 0.051 g), imidazole (0.405 mmol, 0.028 g), and DMAP 
(0.013 mmol, 1.6 mg) were added to a stirred solution of 2.3.20c (0.067 mmol, 0.016 
g) in DMF (1.5 ml) at 0 ºC. The solution was allowed to warm to RT and stir for 16 
hours at which time TLC indicated consumption of the starting material. Et2O (6 mL) 
was added, and the solution was washed with saturated NaHCO3 and brine, dried over 
anhydrous MgSO4, and concentrated under reduced pressure.  The crude product was 
purified by flash chromatography (gradient 80:1 to 10:1 hexanes:EtOAc) to provide 
2.3.20d (0.010 g, 0.027 mmol, 41%). 
Rf = 0.20 (hexanes/EtOAc 80:1); [α]D
24
 -30.3º (c 0.034, CHCl3); 
1
H NMR 
(500 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 5.92 – 5.79 (m, 1H), 5.09 – 4.97 (m, 2H), 
4.69 (d, J = 11.7 Hz, 1H), 4.54 (d, J = 11.7 Hz, 1H), 3.83 (dd, J = 11.3, 5.0 Hz, 1H), 
3.03 (t, J = 5.6 Hz, 1H), 2.41 (ddd, J = 12.5, 6.2, 4.8 Hz, 1H), 2.19 (dt, J = 14.2, 7.2 
Hz, 1H), 1.91 (dq, J = 13.3, 6.7 Hz, 1H), 0.97 – 0.90 (m, 6H), 0.87 (s, 9H), 0.00 (d, J 
= 14.5 Hz, 6H); 
13
C NMR (75 MHz, CDCl3) δ 135.94, 128.43, 127.63, 127.44, 
127.11, 116.97, 86.59, 73.75, 73.66, 38.14, 29.08, 26.18, 20.91, 18.62, 18.32, -4.09, -
4.16. 
 
Primary Alcohol (20e) 
A flask was charged with DCM (2 mL) and ester 2.3.20d (6.7 mg, 0.019 
mmol), and the solution was cooled to -78 ºC in a dry ice-acetone bath. A stream of 
ozone from a Welsbach ozone generator was bubbled into the DCM solution until a 
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persistent blue color of unreacted ozone was noticeable.  The reaction mixture was 
allowed to warm to room temperature, and dry nitrogen was bubbled through for 1 
minute to remove excess ozone.  Borane dimethyl sulfide complex (7.3 mg, 0.009 
mL, .096 mmol) was added by syringe and the reaction mixture was allowed to stir at 
RT overnight. Aqueous HCl (5%, 2 mL) was added and the resulting mixture stirred 
vigorously for 30 minutes. Solid NaHCO3 was carefully added (caution, gas 
evolution) and the organic layer was separated, washed with brine and dried over 
anhydrous MgSO4. The reaction mixture was filtered and concentrated to provide the 
crude product.  Flash chromatography (10:1 hexanes:EtOAc) gave the desired alcohol 
(2.3.20b 4 mg, 0.011 mmol, 59%). 
Rf = 0.45 (hexanes/EtOAc 5:1); [α]D
25
 -35.8º (c 0.026, CHCl3); 
1
H NMR (500 
MHz, CDCl3) δ 7.32 (d, J = 4.4 Hz, 4H), 7.27 (dd, J = 8.1, 4.1 Hz, 1H), 4.66 (d, J = 
11.5 Hz, 1H), 4.56 (d, J = 11.5 Hz, 1H), 3.99 (dd, J = 11.3, 5.2 Hz, 1H), 3.72 (bs, 
2H), 3.10 (dd, J = 6.7, 4.8 Hz, 1H), 2.45 (bs, 1H), 2.01 – 1.85 (m, 2H), 1.70 (ddd, J = 
14.5, 11.1, 4.9 Hz, 1H), 0.99 – 0.93 (m, 6H), 0.87 (s, 9H), 0.03 (d, J = 16.8 Hz, 6H); 
13
C NMR (75 MHz, CDCl3) δ 138.95, 128.58, 127.82, 127.78, 86.82, 73.92, 72.66, 
60.68, 35.51, 29.47, 26.11, 20.75, 19.20, 18.20, -4.11, -4.58. 
 
(5,7-anti) methyl 7-[(tert-butyldimethylsilyl)oxy]-5-hydroxy-2E-octenoate 2.3.22 
Compound 2.3.22 was prepared from aldehyde 2.3.21 and methyl crotonate 
2.2.2 in 65% yield in a 1.3:1 anti:syn mixture of diastereomers after purification 
according to the general procedure. 
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Major isomer:  Rf = 0.19 (hexanes/EtOAc 5:1); 
1
H NMR (500 MHz, CDCl3) δ 
7.01 (dtd, J = 9.6, 7.3, 2.3 Hz, 1H), 6.00 – 5.81 (m, 1H), 4.23 (dd, J = 10.5, 4.5 Hz, 
1H), 3.74 (s, 3H), 3.65 (s, 1H), 2.38 (m, 2H), 2.19 (s, 1H), 1.79 – 1.47 (m, 2H), 1.25 
(d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.10 (d, J = 3.8 Hz, 6H). 
Structure Proof: 
 
 
Diol 2.3.22a 
Ester mixture 2.3.22 was deprotected using HF / pyridine to give 2.3.22a. 
Data of the resulting diol was then compared to known spectra for the syn 
diastereomer.
54
 These data were consistent with the minor diastereomer in our 
reaction. The major product in the vinylogous aldol reaction is the anti-diastereomer. 
 
 
(5,7-anti) methyl 7-(benzyloxy)-5-hydroxy-2E-octenoate (2.3.24) 
Compound 2.3.24 was prepared from aldehyde 2.3.23 and methyl crotonate 
2.2.2 in 78% yield in a 3.4:1 anti:syn mixture of diastereomers after purification 
according to the general procedure. 
                                                 
54
 Scott, M. S.; Luckhurst, C. A; Dixon, D. J. Org. Lett. 2005, 7, 5813. 
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Major isomer:  Rf = 0.20 (hexanes/EtOAc 3:1); 
1
H NMR (500 MHz, CDCl3) δ 
7.43 – 7.27 (m, 5H), 6.98 (ddd, J = 15.6, 8.3, 6.5 Hz, 1H), 5.88 (dt, J = 15.7, 1.4 Hz, 
1H), 4.68 (d, J = 11.3 Hz, 1H), 4.41 (d, J = 11.4 Hz, 1H), 3.96 (dd, J = 8.7, 5.2 Hz, 
1H), 3.82 (ddd, J = 12.3, 6.1, 3.1 Hz, 1H), 3.72 (s, 3H), 2.45 – 2.22 (m, 2H), 1.74 – 
1.51 (m, 2H), 1.25 (d, J = 6.0 Hz, 3H). 
Structure Proof: 
 
Diol 2.3.24a 
Ester 2.3.24 was reduced with H2/Pd/C to give diol 2.3.24a. The resulting 
spectra were compared to that of the known syn- and anti-diols.
55
 This data was 
consistent with the major isomer of the vinylogous aldol reaction being the anti-
diastereomer. 
 
 
 
(2E,6E)-methyl-5-hydroxy-7-phenylhepta-2,6-dienoate (2.3.26) 
Compound 2.3.26 was prepared from aldehyde 2.3.25 and methyl crotonate 
2.2.2 in 43% yield after purification according to the general procedure. 
                                                 
55
 Stritzke, K.; Schulz, S.; Nishida, R. Eur. J. Org. Chem. 2002, 3884. 
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Rf = 0.22 (hexanes/EtOAc 3:1); 
1
H NMR (500 MHz, CDCl3) δ 7.40 – 7.25 
(m, 5H), 6.99 (dt, J = 15.6, 7.4 Hz, 1H), 6.60 (d, J = 15.9 Hz, 1H), 6.21 (dd, J = 15.9, 
6.6 Hz, 1H), 5.94 (dt, J = 15.7, 1.4 Hz, 1H), 4.44 (q, J = 6.1 Hz, 1H), 3.71 (s, 3H), 
2.57 – 2.50 (m, 2H), 1.77 (bs, 1H);  13C NMR (75 MHz, CDCl3) δ 166.91, 144.79, 
136.49, 131.45, 131.08, 128.87, 128.19, 126.81, 124.05, 71.79, 51.78, 40.38; HRMS 
(ESI) m/z calc’d for C14H16O3Na [M+Na]
+
: 255.0997; found: 255.1000. 
 
 
Methyl (E)-(anti)-5-Hydroxy-4-methyl-5-phenylpent-2-enoate (2.8.4) 
Compound 2.8.4 was prepared from benzaldehyde 2.3.13 and 2.8.3 according 
to the general procedure. The product was isolated in 95% yield after purification and 
in a 15:1 diastereoselectivity favoring the anti-isomer.  
1
H NMR (500 MHz, CDCl3) δ 7.49 – 7.24 (m, 5H), 7.06 (dd, J = 15.8, 8.2 Hz, 
1H), 5.92 (dd, J = 15.8, 1.1 Hz, 1H), 4.53 (dd, J = 7.5, 2.9 Hz, 1H), 3.75 (s, 3H), 2.79 
– 2.54 (m, 1H), 1.95 (d, J = 3.0 Hz, 1H), 0.94 (d, J = 6.9 Hz, 3H). 13C NMR (75 
MHz): δ 16.1, 44.4, 51.5, 77.9, 121.8, 126.6, 127.8, 128.4, 142.2, 150.8, 166.9. 
 
Alcohol 2.9.3 
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Compound 2.9.3 was prepared from benzaldehyde 2.3.13 and furan 2.9.2 in 
84% yield after purification according to the general procedure. 
1
H NMR (500 MHz, CDCl3) δ 7.45 – 7.26 (m, 5H), 7.08 (d, J = 3.4 Hz, 1H), 
6.18 (d, J = 3.4 Hz, 1H), 5.08 (ddd, J = 8.3, 4.8, 3.3 Hz, 1H), 3.87 (s, 3H), 3.23 – 2.98 
(m, 2H), 2.12 (d, J = 3.2 Hz, 1H). 
 
Alcohol 2.9.4 
Compound 2.9.4 was prepared from valeraldehyde 2.2.1 and furan 2.9.2 in 
72% yield after purification according to the general procedure. 
1
H NMR (500 MHz, CDCl3) ä 7.07 (d, J = 3.4 Hz, 1H), 6.21 (d, J = 3.3 Hz, 
1H), 3.93 (m, 1H), 3.82 (s, 3H), 2.85 (dd, J = 15.1, 4.1 Hz, 1H), 2.75 (dd, J = 15.1, 
8.1 Hz, 1H), 2.09 (bs, 1H), 1.61 – 1.12 (m, 6H), 0.86 (t, J = 7.1 Hz, 3H). 
 
2-Iodobenzaldehyde (2.11.2): 
According to a literature procedure,
56
 to a solution of 2-iodobenzylalcohol 
2.11.2 (1.31 g, 5.60 mmol) in DCM was added PCC (1.33 g, 6.16 mmol). After being 
stirred at room temperature for 2 h, the reaction solvent was removed in vacuum and 
                                                 
56
 Tummatorn, J.; Dudley, G. B. Org. Lett. 2011, 13, 1572. 
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the residue was dissolved with 30% EtOAc/hexane and filtered through a silica gel 
plug. Evaporation gave 1.26 g (97%) of 2.11.3 as a white solid. 
1
H NMR (500 MHz, CDCl3) δ 10.08 (d, J = 0.6 Hz, 1H), 7.96 (dd, J = 7.9, 0.8 
Hz, 1H), 7.89 (dd, J = 7.7, 1.8 Hz, 1H), 7.48 (t, J = 7.5 Hz, 1H), 7.32 – 7.28 (m, 1H); 
13
C NMR (75 MHz, CDCl3) δ 196.03, 140.89, 135.71, 135.37, 130.50, 128.96, 
100.93. 
 
2-(1′-Methylethenyl)-1-iodobenzene 2.11.4 
According to a literature procedure,
57
 a solution of 2-iodobenzaldehyde 2.11.3 
(0.300 g, 1.29 mmol, 0 °C) in THF (6 mL) was treated with a 3 M solution of 
MeMgBr in THF (0.560 mL, 1.68 mmol). After 15 minutes, the reaction mixture was 
quenched with H2O, extracted with Et2O, dried over MgSO4, and evaporated. The 
crude material was purified by flash chromatography (5:1 pentane:Et2O) to give 
2.11.4 (0.298 g, 1.20 mmol, 98%). 
1
H NMR (500 MHz, CDCl3) δ 7.81 (dd, J = 7.9, 1.2 Hz, 1H), 7.58 (dd, J = 7.8, 
1.7 Hz, 1H), 7.39 (td, J = 7.7, 1.0 Hz, 1H), 6.98 (td, J = 7.6, 1.7 Hz, 1H), 5.08 (q, J = 
6.4 Hz, 1H), 1.47 (d, J = 6.4 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 147.4, 139.0, 
128.9, 128.5, 126.2, 97.0, 73.4, 23.7. 
                                                 
57
 Keck, G. E.; Murry, J. A. J. Org. Chem. 1991, 56, 6606. 
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TBS ether 2.11.5 
To a stirring solution of alcohol 2.11.4 (0.278 g, 1.121 mmol) in DMF (6 mL) 
was added imidazole (0.153 g, 2.241 mmol), DMAP (0.027 g, 0.224 mmol) and 
TBSCl (0.253 g, 1.681 mmol).  The mixture was stirred at room temperature for 2 h, 
then 15 mL of water was added.  The mixture was transferred to a separatory funnel.  
The aqueous layer was separated and extracted with ether (2x).  The combined 
organic layers were then washed with water, saturated NaHCO3, brine, dried with 
MgSO4 and filtered.  The solvent was removed in vacuo and the residue was purified 
by column chromatography (hexanes) (2.11.5, 0.378 g, 1.043 mmol, 93%) as a clear 
colorless liquid. 
1
H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 7.9 Hz, 1H), 7.59 (dd, J = 7.8, 1.5 
Hz, 1H), 7.36 (t, J = 7.5 Hz, 1H), 6.94 (td, J = 7.7, 1.7 Hz, 1H), 5.00 (q, J = 6.2 Hz, 
1H), 1.37 (d, J = 6.2 Hz, 1H), 0.92 (s, 3H), 0.07 (s, 1H), -0.02 (s, 1H); 
13
C NMR (75 
MHz, CDCl3) δ 149.00, 139.05, 128.84, 128.68, 127.36, 96.53, 74.82, 26.22, 26.13, 
25.91, 18.46, -4.54, -4.65. 
 
Aldehyde 2.11.6 
nBu4NBr (0.462 g, 1.434 mmol), NaOAc (0.146 g, 1.776 mmol), LiCl (0.030 
g, 0.717 mmol), and Pd(OAc)2 (0.015 g, 0.68 mmol) were added sequentially to a 
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stirred solution of 2.11.5 (0.248 g, 0.683 mmol) and 5-hexen-1-ol (0.085 mL, 0.717 
mmol) in anhydrous DMF (4 mL).  The mixture was heated to 50 
o
C.  After 3 days at 
50 
o
C, the reaction mixture was cooled to room temperature and diluted with EtOAc 
(10 mL) and hexanes (20 mL) resulting in a biphasic organic solution.  The DMF-
containing phase was separated and extracted with hexanes (10 mL).  The combined 
hexanes/EtOAc extracts were washed with deionized water, 1.0 M CuSO4, deionized 
water, 1.0 M NaOH, deionized water, and brine.  After drying over anhydrous MgSO4 
and concentrating under reduced pressure, the crude product was purified by flash 
chromatography (30:1 hexanes:EtOAc) to afford aldehyde 2.11.6 (0.154 g, 0.046 
mmol, 67%). 
1
H NMR (500 MHz, CDCl3) δ 9.79 (t, J = 1.7 Hz, 1H), 7.55 (dd, J = 7.6, 1.3 
Hz, 1H), 7.21 (td, J = 7.5, 1.4 Hz, 1H), 7.16 (td, J = 7.4, 1.6 Hz, 1H), 7.09 (dd, J = 
7.5, 1.2 Hz, 1H), 5.08 (q, J = 6.3 Hz, 1H), 2.69 – 2.53 (m, 2H), 2.46 (td, J = 7.3, 1.7 
Hz, 2H), 1.73 – 1.60 (m, 4H), 1.44 (ddd, J = 18.0, 8.7, 6.1 Hz, 2H), 1.38 (d, J = 6.3 
Hz, 3H), 0.90 (s, 9H), 0.04 (s, 3H), -0.06 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 
202.81, 144.79, 137.44, 128.98, 126.78, 126.36, 126.00, 67.51, 44.09, 32.07, 31.32, 
29.53, 27.28, 26.10, 22.26, 18.46, -4.48, -4.53. 
 
Aldehyde 2.11.7 
To a solution of 2.11.6 (0.150 g, 0.448 mmol) in 1:1 THF/H2O (2 mL) at room 
temperature was added HOAc (3 mL). The solution was stirred at 50 
o
C for 10 hours 
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at which time saturated aqueous NaHCO3 was carefully added until bubbling ceased. 
The mixture was extracted with Et2O (2x) and washed with water and brine. After 
drying over MgSO4 and concentrating under reduced pressure. The crude aldehyde 
2.11.7 (0.094 g, 0.427 mmol, 95%) was used in the subsequent reaction because of 
instability to silica gel chromatography. 
1
H NMR (500 MHz, CDCl3) δ 9.77 (t, J = 1.7 Hz, 1H), 7.54 (dd, J = 7.6, 1.4 
Hz, 1H), 7.26 – 7.19 (m, 2H), 7.14 (dd, J = 7.5, 1.4 Hz, 1H), 5.17 (q, J = 6.4 Hz, 1H), 
2.74 – 2.59 (m, 2H), 2.46 (td, J = 7.3, 1.7 Hz, 2H), 1.72 – 1.58 (m, 5H), 1.50 (d, J = 
6.4 Hz, 2H), 1.47 – 1.37 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 202.91, 143.49, 
138.91, 129.57, 127.56, 126.74, 125.28, 66.39, 44.02, 32.32, 31.66, 29.38, 25.04, 
22.14. 
 
Aldehyde 2.11.9 
Triethylamine (0.253 mL, 1.78 mmol, 4.0 equiv) and DMAP (0.011 g, 0.09 
mmol, 0.2 equiv) were added to a solution of alcohol 2.11.9 (0.099 g, 0.449 mmol, 
1.0 equiv) and crotonic anhydride (0.133 mL, 0.899 mmol, 2.0 equiv) in CH2Cl2 (4.5 
mL) at 0 ºC.  After 2 hours at 0 ºC, the reaction was quenched with saturated 
NaHCO3 (10 mL).  The organic phase was separated, washed with water and brine, 
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash chromatography (gradient, hexanes to 10:1 
hexanes:EtOAc) to provide ester 2.11.9 (0.118 g, 0.409 mmol, 91%).  
163 
 
1
H NMR (500 MHz, CDCl3) δ 9.77 (t, J = 1.7 Hz, 1H), 7.50 – 7.40 (m, 1H), 
7.25 – 7.18 (m, 2H), 7.15 (dd, J = 6.2, 2.8 Hz, 1H), 6.99 (dq, J = 15.4, 6.9 Hz, 1H), 
6.17 (q, J = 6.5 Hz, 1H), 5.88 (ddd, J = 15.5, 3.2, 1.5 Hz, 1H), 2.80 – 2.59 (m, 2H), 
2.45 (td, J = 7.4, 1.7 Hz, 2H), 1.88 (dd, J = 6.9, 1.7 Hz, 3H), 1.74 – 1.58 (m, 4H), 1.55 
(d, J = 6.5 Hz, 3H), 1.43 (dt, J = 7.8, 4.7 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 
202.95, 165.96, 144.98, 139.97, 139.34, 129.63, 127.91, 126.60, 126.02, 123.16, 
68.64, 44.04, 32.58, 31.29, 29.40, 22.54, 22.18, 18.21. 
 
 
Aldehyde 2.11.6a 
nBu4NBr (0.682 g, 2.12 mmol), NaOAc (0.215 g, 2.62 mmol), LiCl (0.045 g, 
1.058 mmol), and Pd(OAc)2 (0.023 g, .101 mmol) were added sequentially to a stirred 
solution of 2.11.5 (0.365 g, 1.01 mmol) and 3-buten-1-ol (0.091 mL, 1.058 mmol) in 
anhydrous DMF (5 mL).  The mixture was heated to 50
o
C.  After 2 days at 50
o
C, the 
reaction mixture was cooled to room temperature and diluted with EtOAc (10 mL) 
and hexanes (20 mL) resulting in a biphasic organic solution.  The DMF-containing 
phase was separated and extracted with hexanes (10 mL).  The combined 
hexanes/EtOAc extracts were washed with deionized water, 1.0 M CuSO4, deionized 
water, 1.0 M NaOH, deionized water, and brine.  After drying over anhydrous MgSO4 
and concentrating under reduced pressure, the crude product was purified by flash 
chromatography (30:1 hexanes:EtOAc) to afford aldehyde 2.11.6a (0.169 g, 0.551 
mmol, 55%). 
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1
H NMR (500 MHz, CDCl3) δ 9.81 (t, J = 1.4 Hz, 1H), 7.56 (dd, J = 7.7, 1.3 
Hz, 1H), 7.25 – 7.20 (m, 1H), 7.17 (td, J = 7.4, 1.5 Hz, 1H), 7.10 (dd, J = 7.5, 1.2 Hz, 
1H), 5.10 (q, J = 6.3 Hz, 1H), 2.76 – 2.57 (m, 2H), 2.54 (td, J = 7.1, 1.4 Hz, 2H), 2.02 
– 1.83 (m, 2H), 1.39 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.05 (s, 3H), -0.05 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 202.21, 145.00, 136.49, 129.05, 126.91, 126.71, 126.22, 
67.55, 43.78, 31.46, 27.32, 26.09, 23.66, 18.45, -4.50, -4.53. 
 
 
Alcohol 2.11.7a 
To a solution of 2.11.6a (0.169 g, 0.551 mmol) in 1:1 THF/H2O (2 mL) at 
room temperature was added HOAc (3 mL). The solution was stirred at 50 
o
C for 10 
hours at which time saturated aqueous NaHCO3 was carefully added until bubbling 
ceased. The mixture was extracted with Et2O (2x) and washed with water and brine. 
After drying over MgSO4 and concentrating under reduced pressure. The crude 
aldehyde 2.11.7a (0.101 g, 0.525 mmol, 95%) was used in the subsequent reaction 
because of instability to silica gel chromatography. 
1
H NMR (500 MHz, CDCl3) δ 9.77 (t, J = 1.4 Hz, 1H), 7.55 (dd, J = 7.7, 1.4 
Hz, 1H), 7.29 – 7.20 (m, 4H), 7.15 (dd, J = 7.5, 1.3 Hz, 1H), 5.19 (q, J = 6.4 Hz, 1H), 
2.77 – 2.65 (m, 3H), 2.54 (td, J = 7.1, 1.4 Hz, 2H), 2.00 – 1.92 (m, 2H), 1.51 (d, J = 
6.4 Hz, 5H); 
13
C NMR (75 MHz, CDCl3) δ 202.40, 143.61, 138.00, 129.71, 127.73, 
127.12, 125.56, 66.43, 43.66, 31.71, 24.98, 24.00. 
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Aldehyde 2.4.5: 
Triethylamine (0.278 mL, 1.98 mmol, 4.0 equiv) and DMAP (0.012 g, 0.10 
mmol, 0.2 equiv) were added to a solution of alcohol 2.11.7a (0.095 g, 0.495 mmol, 
1.0 equiv) and crotonic anhydride (0.146 mL, 0.988 mmol, 2.0 equiv) in CH2Cl2 (4.5 
mL) at 0 ºC.  After 2 hours at 0 ºC, the reaction was quenched with saturated 
NaHCO3 (10 mL).  The organic phase was separated, washed with water and brine, 
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash chromatography (gradient, hexanes to 20:1 
hexanes:EtOAc) to provide ester 2.4.5 as colorless oil (0.072 g, 56%).  
1
H NMR (500 MHz, CDCl3) δ 9.79 (t, J = 1.4 Hz, 1H), 7.44 (dd, J = 7.0, 2.1 
Hz, 1H), 7.26 – 7.18 (m, 2H), 7.18 – 7.13 (m, 1H), 6.99 (dq, J = 15.4, 6.9 Hz, 1H), 
6.16 (q, J = 6.5 Hz, 1H), 5.91 – 5.84 (m, 1H), 2.83 – 2.66 (m, 2H), 2.53 (ddd, J = 8.9, 
3.3, 1.7 Hz, 2H), 2.03 – 1.92 (m, 2H), 1.87 (dd, J = 6.9, 1.7 Hz, 3H), 1.55 (d, J = 6.6 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 202.41, 165.93, 145.08, 140.22, 138.22, 
129.66, 127.96, 126.91, 126.03, 123.04, 68.60, 43.58, 31.79, 23.64, 22.56, 18.17. 
 
TBS Iodobenzyl alcohol (2.11.5b) 
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To a stirring solution of 2-iodobenzylalcohol 2.11.1 (5.0 g, 21.36 mmol) in 
100 mL DMF was added imidazole (2.18 g, 32 mmol, 1.5 equiv), DMAP (0.522 g, 
4.27 mmol, 0.2 equiv) and TBSCl (3.54 g, 23.5 mmol, 1.1 equiv).  The mixture was 
stirred at room temperature for 2 h, then 100 mL of water was added.  The mixture 
was transferred to a separatory funnel.  The aqueous layer was separated and 
extracted with ether (2x).  The combined organic layers were then washed with water 
(2x), dried with MgSO4 and filtered.  The solvent was removed in vacuo and the 
residue was purified by column chromatography (hexanes) (2.11.5b, 5.07 g, 68%) as 
a clear colorless liquid. 
Rf = 0.29 (hexanes); 
1
H NMR: (500 MHz, CDCl3) δ 7.77 (dd, J = 7.9 1.3, 1H), 
7.51 (d, J = 7.7, 1H), 7.37 (t, J = 7.5, 1H), 6.96 (t,  J  = 7.8, 1H), 4.63 (s, 2H), 0.97 (s, 
9H), 0.14 (s, 6H); 
13
C NMR: (75 MHz, CDCl3) δ 143.1, 138.8, 128.7, 128.4, 127.6, 
96.0, 69.6, 26.2, 18.6, -5.1.   
 
 
 
4-[2-(tert-Butyldimethylsilanyloxymethyl)phenyl]butyraldehyde (2.11.6b): 
 
nBu4NBr (1.94 g, 6.03 mmol), NaOAc (0.612 g, 7.46 mmol), LiCl (0.128 g, 
0.301 mmol), and Pd(OAc)2 (0.064 g, 0.281 mmol) were added sequentially to a 
stirred solution of 2.11.5b (1.0 g, 2.87 mmol) and 3-buten-1-ol (0.259 mL, 0.3014 
mmol) in anhydrous DMF (6 mL).  The mixture was heated to 50 
o
C.  After 3 days at 
50 
o
C, the reaction mixture was cooled to room temperature and diluted with EtOAc 
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(10 mL) and hexanes (20 mL) resulting in a biphasic organic solution.  The DMF-
containing phase was separated and extracted with hexanes (10 mL).  The combined 
hexanes/EtOAc extracts were washed with deionized water, 1.0 M CuSO4, deionized 
water, 1.0 M NaOH, deionized water, and brine.  After drying over anhydrous MgSO4 
and concentrating under reduced pressure, the crude product was purified by flash 
chromatography (30:1 hexanes:EtOAc) to afford aldehyde 2.11.6b (0.53 g, 1.83 
mmol, 64%). 
 
1
H NMR (500 MHz; CDCl3):  δ 9.76 (t, 1H, J = 1.5 Hz), 7.42-7.38 (m, 1H), 
7.22-7.17 (m, 2H), 7.14-7.10 (m, 1H), 4.72 (s, 2H), 2.64 (t, 2H, J = 7.7 Hz), 2.48 (dt, 
2H, J = 1.5, 7.3 Hz), 1.96-1.89 (m, 2H), 0.92 (m, 2H), 0.09 (s, 6H).  
13
C NMR (100 
MHz; CDCl3):  δ 202.5, 139.0, 138.7, 129.2, 127.7, 127.5, 126.5, 63.2, 43.7, 31.5, 
26.2, 23.2, 18.7, -5.0.  LRMS (ESI) m/z calc’d for C17H28O2SiNa [M+Na]
+
:  315.2; 
found:  315.1. 
 
Alcohol 2.11.7b: 
To a solution of 2.11.6b (0.20 g, 0.684 mmol) in 1:1 THF/H2O (4 mL) at 
room temperature was added HOAc (5 mL). The solution was stirred for 10 hours at 
which time saturated aqueous NaHCO3 was carefully added until bubbling ceased. 
The mixture was extracted with Et2O (2x) and washed with water and brine. After 
drying over MgSO4 and concentrating under reduced pressure, aldehyde 2.11.7b 
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(0.096 g, 0.539 mmol, 79%) was obtained. The crude product was used as is in the 
next subsequent steps because of decomposition on silica gel. 
 
1
H NMR (400 MHz, CDCl3) δ 9.77 (s, 1H), 7.36 (d, J = 6.9 Hz, 1H), 7.31 – 
7.07 (m, 3H), 4.72 (s, 2H), 2.81 – 2.65 (m, 2H), 2.54 (t, J = 7.0 Hz, 2H), 2.07 (bs, 
1H), 2.01 – 1.89 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 202.77, 139.87, 138.62, 
129.67, 128.93, 128.30, 126.73, 63.34, 43.63, 31.69, 23.67. 
 
Aldehyde 2.4.3 
Triethylamine (0.345 mL, 2.46 mmol, 10 equiv) and DMAP (0.006 g, 0.05 
mmol, 0.2 equiv) were added to a solution of alcohol 2.11.7b (0.043 g, 0.246 mmol, 
1.0 equiv) and crotonic anhydride (0.182 mL, 0.123 mmol, 5.0 equiv) in CH2Cl2 (2.5 
mL) at 0 ºC.  After 2 hours at 0 ºC, the reaction was quenched with saturated 
NaHCO3 (10 mL).  The organic phase was separated, washed with water and brine, 
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash chromatography (5:1 hexanes:EtOAc) to provide a 
colorless oil 2.4.3 (0.0265 g, 0.108 mmol, 44%).  
1
H NMR (300 MHz, CDCl3) δ 9.80 (t, J = 1.5 Hz, 1H), 7.39 (d, J = 7.3 Hz, 
1H), 7.33 – 7.17 (m, 4H), 7.03 (dq, J = 15.5, 6.9 Hz, 1H), 5.89 (dq, J = 15.6, 1.7 Hz, 
1H), 5.23 (s, 2H), 2.73 (dd, J = 8.9, 6.9 Hz, 2H), 2.53 (td, J = 7.3, 1.5 Hz, 2H), 2.05 – 
1.82 (m, 5H); 
13
C NMR (75 MHz, CDCl3) δ 202.21, 145.58, 130.28, 129.74, 128.95, 
126.74, 122.64, 64.15, 43.68, 31.91, 23.66, 18.29. 
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Aldehyde 2.11.6c: 
 
nBu4NBr (3.65 g, 11.34 mmol), NaOAc (1.151 g, 14.03 mmol), LiCl (0.240 g, 
5.67 mmol), and Pd(OAc)2 (0.121 g, 0.540 mmol) were added sequentially to a stirred 
solution of 2.11.4a (1.88 g, 5.40 mmol) and 3-methyl-3-buten-1-ol (0.572 mL, 5.67 
mmol) in anhydrous DMF (11 mL).  The mixture was heated to 50 
o
C.  After 2 days 
at 50 
o
C, the reaction mixture was cooled to room temperature and diluted with 
EtOAc (10 mL) and hexanes (20 mL) resulting in a biphasic organic solution.  The 
DMF-containing phase was separated and extracted with hexanes (10 mL).  The 
combined hexanes/EtOAc extracts were washed with deionized water, 1.0 M CuSO4, 
deionized water, 1.0 M NaOH, deionized water, and brine.  After drying over 
anhydrous MgSO4 and concentrating under reduced pressure, the crude product was 
purified by flash chromatography (40:1 hexanes:EtOAc) to afford aldehyde 2.11.6c 
(0.768 g, 2.506 mmol, 46%). 
1
H NMR (500 MHz, CDCl3) δ 9.68 (dd, J = 2.3, 1.6 Hz, 1H), 7.48 – 7.33 (m, 
1H), 7.24 – 7.15 (m, 2H), 7.13 – 7.04 (m, 1H), 4.73 (dd, J = 13.0, 3.2 Hz, 2H), 2.57 
(qd, J = 13.8, 7.3 Hz, 2H), 2.44 (ddd, J = 15.8, 5.2, 1.4 Hz, 1H), 2.38 (dt, J = 19.8, 6.8 
Hz, 1H), 2.26 (ddd, J = 15.9, 7.6, 2.5 Hz, 1H), 0.98 (d, J = 6.6 Hz, 3H), 0.93 (s, 9H), 
0.10 (s, 6H); 
13
C NMR (75 MHz, CDCl3) δ 202.59, 139.40, 137.48, 130.14, 127.79, 
127.22, 126.64, 63.19, 50.82, 39.62, 29.60, 26.20, 20.45, 18.65, -5.00. 
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Aldehyde 2.11.7c 
To a solution of 2.11.6c (0.260 g, 0.848 mmol) in 1:1 THF/H2O (2 mL) at 
room temperature was added HOAc (3 mL). The solution was stirred for 10 hours at 
which time saturated aqueous NaHCO3 was carefully added until bubbling ceased. 
The mixture was extracted with Et2O (2x) and washed with water and brine. After 
drying over MgSO4 and concentrating under reduced pressure, aldehyde 2.11.7c 
(0.162 g, 0.848 mmol, 99%) was obtained. The crude product was used as is in the 
next subsequent steps because of decomposition on silica gel. 
1
H NMR (500 MHz, CDCl3) δ 9.66 (s, 1H), 7.38 (d, J = 6.5 Hz, 1H), 7.24 (dd, 
J = 6.0, 2.9 Hz, 2H), 7.18 – 7.12 (m, 1H), 4.82 – 4.59 (m, 2H), 2.77 – 2.66 (m, 1H), 
2.59 (dd, J = 13.7, 7.5 Hz, 1H), 2.52 – 2.37 (m, 3H), 2.37 – 2.27 (m, 2H), 1.00 (d, J = 
6.4 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 203.07, 139.01, 138.39, 130.52, 128.93, 
127.89, 126.82, 62.98, 50.79, 39.65, 29.86, 20.38. 
 
Aldehyde 2.4.7 
Triethylamine (0.289 mL, 2.06 mmol, 4.0 equiv) and DMAP (0.013 g, 0.103 
mmol, 0.2 equiv) were added to a solution of alcohol 2.11.7b (0.099 g, 0.515 mmol, 
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1.0 equiv) and crotonic anhydride (0.153 mL, 1.03 mmol, 2.0 equiv) in CH2Cl2 (5 
mL) at 0 ºC.  After 2 hours at 0 ºC, the reaction was quenched with saturated 
NaHCO3 (10 mL).  The organic phase was separated, washed with water and brine, 
dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash chromatography was purified by flash chromatography 
(30:1 hexanes:EtOAc) to provide a colorless oil (0.063 g, 0.242 mmol, 47%).  
1
H NMR (500 MHz, CDCl3) δ 9.70 (dd, J = 2.2, 1.6 Hz, 1H), 7.38 (dd, J = 
7.5, 1.2 Hz, 1H), 7.29 (td, J = 7.4, 1.5 Hz, 1H), 7.24 (td, J = 7.4, 1.4 Hz, 1H), 7.21 – 
7.17 (m, 1H), 7.02 (dq, J = 15.5, 6.9 Hz, 1H), 5.88 (dq, J = 15.5, 1.6 Hz, 1H), 5.32 – 
5.07 (m, 2H), 2.68 (dd, J = 13.9, 7.2 Hz, 1H), 2.62 (dd, J = 13.9, 7.4 Hz, 1H), 2.47 
(ddd, J = 16.0, 5.0, 1.4 Hz, 1H), 2.44 – 2.35 (m, 1H), 2.30 (ddd, J = 16.0, 7.8, 2.4 Hz, 
1H), 1.89 (dd, J = 6.9, 1.7 Hz, 3H), 1.00 (d, J = 6.5 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3) δ 202.43, 166.51, 145.59, 139.26, 134.42, 130.64, 130.32, 128.70, 126.87, 
122.62, 64.05, 50.73, 39.82, 30.04, 20.33, 18.28. 
 
 
6-[2-(tert-Butyldimethylsilanyloxymethyl)phenyl]hexanal 2.11.6d 
nBu4NBr (1.94 g, 6.03 mmol), NaOAc (0.612 g, 7.46 mmol), LiCl (0.128 g, 
3.01 mmol), and Pd(OAc)2 (0.064 g, 0.287 mmol) were added sequentially to a stirred 
solution of 2.11.4a (1.0 g, 2.87 mmol) and 5-hexen-1-ol (0.357 ml, 3.01 mmol) in 
anhydrous DMF (6 mL).  The mixture was heated to 50 
o
C.  After 4 days at this 
temperature, the reaction mixture was to room temperature and diluted with EtOAc 
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(15 mL) and hexanes (30 mL) resulting in a biphasic organic solution.  The DMF-
containing phase was separated and extracted with hexanes (10 mL).  The combined 
hexanes/EtOAc extracts were washed with deionized water, 1.0 M CuSO4, deionized 
water, 1.0 M NaOH, deionized water, and brine.  After drying over MgSO4 and 
concentrating under reduced pressure, the crude product was purified by flash 
chromatography (30:1 hexanes:EtOAc) to afford aldehyde 2.11.6d (0.476 g, 1.48 
mmol, 52%). 
1
H NMR (500 MHz; CDCl3):  δ 9.75 (t, 1H, J = 1.8 Hz), 7.43-7.35 (m, 1H), 
7.20-7.16 (m, 2H), 7.13-7.10 (m, 1H), 4.71 (s, 2H), 2.60-2.55 (m, 2H), 1.69-1.56 (m, 
4H), 1.43-1.36 (m, 2H), 0.92 (s, 9H), 0.08 (s, 6H).  
13
C NMR (100 MHz; CDCl3):  δ 
202.8, 139.7, 138.8, 129.0, 127.4, 127.3, 126.1, 63.2, 44.1, 32.1, 30.7, 29.4, 26.2, 
22.2, 18.6, -5.0.  LRMS (ESI) m/z calc’d for C19H32O2SiNa [M+Na]
+
:  343.2; found:  
343.2. 
 
Alcohol 2.11.7d 
To a solution of 2.11.6d (0.20 g, 0.684 mmol) in 1:1 THF/H2O (3 mL) at 
room temperature was added HOAc (4 mL). The solution was stirred for 10 hours at 
which time saturated aqueous NaHCO3 was carefully added until bubbling ceased. 
The mixture was extracted with Et2O (2x) and washed with water and brine. After 
drying over MgSO4 and concentrating under reduced pressure, the crude product was 
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purified by flash chromatography (3:1 hexanes:EtOAc) to afford aldehyde 2.11.7d 
(0.115 g, 0.557 mmol, 89%). 
1
H NMR (500 MHz, CDCl3) δ 9.77 (d, J = 1.2 Hz, 1H), 7.38 (d, J = 7.3 Hz, 
1H), 7.28 – 7.09 (m, 3H), 4.72 (s, 2H), 2.79 – 2.56 (m, 2H), 2.45 (t, J = 7.3 Hz, 2H), 
1.87 (bs, 1H), 1.66 (qd, J = 15.3, 7.7 Hz, 4H), 1.51 – 1.34 (m, 2H). 
 
 
Aldehyde 2.4.9 
A solution of Et3N (1.04 mL, 7.42 mmol) and DMAP (0.018 g, 0.148 mmol) 
in CH2Cl2 (2 mL) was added to a stirred solution of alcohol 2.11.7d (.153 g, 0.742 
mmol) and crotonic anhydride (0.550 mL, 3.71 mmol) in CH2Cl2 (5 mL) at 0 
o
C.  
After 4 hours at 0 
o
C, the reaction was concentrated under reduced pressure.   EtOAc 
(5 mL) was added, and the organic solution was washed with saturated NaHCO3, 
deionized water, and brine.  The organic phase was dried over anhydrous MgSO4 and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (10:1 hexanes:EtOAc) to provide ester 2.4.9 (0.183 g, 0.667 mmol, 
90%). 
1
H NMR (400 MHz, CDCl3) δ 9.76 (t, J = 1.7 Hz, 1H), 7.39 – 7.31 (m, 1H), 
7.31 – 7.27 (m, 1H), 7.20 (t, J = 6.6 Hz, 2H), 7.08 – 6.94 (m, 1H), 5.87 (ddd, J = 15.5, 
3.3, 1.6 Hz, 1H), 5.19 (s, 2H), 2.72 – 2.60 (m, 2H), 2.43 (td, J = 7.3, 1.7 Hz, 2H), 1.88 
(dd, J = 6.9, 1.7 Hz, 3H), 1.64 (qd, J = 15.4, 7.6 Hz, 4H), 1.47 – 1.34 (m, 2H); 13C 
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NMR (75 MHz, CDCl3) δ 202.81, 166.54, 145.44, 141.55, 133.76, 130.02, 129.64, 
128.80, 126.36, 122.69, 64.21, 44.04, 32.55, 31.25, 29.36, 22.18, 18.25. 
 
 
 
6-[2-(tert-Butyldimethylsilanyloxymethyl)phenyl]-2-methylhexan-3-ol (2.11.8)
58
: 
 
iPrMgBr (3.05 mL, 6.1 mmol, 2.0 M solution in Et2O) was added to a stirred 
solution of aldehyde 2.11.6b (1.08 g, 4.1 mmol) in THF (40 mL) at 0 
o
C.  After 1 
hour, the reaction was quenched with saturated NH4Cl (20 mL).  The organic phase 
was separated, washed with deionized water and brine, dried over anhydrous MgSO4, 
and concentrated under reduced pressure.  The product was purified by flash 
chromatography (10:1 hexanes:EtOAc) to provide a colorless oil 2.11.8 (0.78 g, 
78%). 
 
1
H NMR (400 MHz; CDCl3):  δ 7.42-7.38 (m, 1H), 7.21-7.12 (m, 3H), 4.74 (s, 
2H), 3.42-3.34 (m, 1H), 2.68-2.54 (m, 2H), 1.85-1.40 (m, 5H), 1.31 (d, 1H, J = 5.0 
Hz), 0.93 (s, 9H), 0.91 (d, 3H, J = 4.1 Hz), 0.88 (d, 3H, J = 4.0 Hz), 0.09 (s, 6H).  
13
C 
NMR (100 MHz; CDCl3):  δ 139.7, 138.8, 129.0, 127.3, 126.1, 76.8, 63.2, 34.4, 33.7, 
32.3, 27.3, 26.2, 19.1, 18.6, 17.3, -5.0.  LRMS (ESI) m/z calc’d for C20H36O2SiNa 
[M+Na]
+
:  359.2; found:  359.2. 
 
 
                                                 
58
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But-2-enoic acid 4-[2-(tert-Butyldimethylsilanyloxymethyl)phenyl]-1-
isopropylbutyl ester 2.11.9
58
: 
 
A solution of Et3N (1.665 mL, 11.85 mmol) and DMAP (0.058 g, 0.474 
mmol) in CH2Cl2 (12 mL) was added to a stirred solution of alcohol 2.11.8 (0.798 g, 
2.37 mmol) and crotonic anhydride (.731 g, 4.74 mmol) in CH2Cl2 (12 mL) at 0 
o
C.  
After 4 hours at 0 
o
C, the reaction was concentrated under reduced pressure.   EtOAc 
(10 mL) was added, and the organic solution was washed with saturated NaHCO3, 
deionized water, and brine.  The organic phase was dried over anhydrous MgSO4 and 
concentrated under reduced pressure.  The crude product was purified by flash 
chromatography (30:1 hexanes:EtOAc) to provide a colorless oil (0.80 g, 83%).  
 
1
H NMR (500 MHz; CDCl3):  δ 7.42-7.38 (m, 1H), 7.19-7.14 (m, 2H), 7.12-
7.08 (m, 1H), 6.94 (dq, 1H, J = 6.9, 15.5 Hz), 5.83 (dq, 1H, J = 1.7, 15.5 Hz), 4.86-
4.81 (m, 1H), 4.71 (s, 2H), 2.64-2.50 (m, 2H), 1.86 (dd, 3H, J = 1.7, 6.9 Hz), 1.86-
1.78 (m, 1H), 1.65-1.49 (m, 4H), 0.92 (s, 9H), 0.89 (s, 3H), 0.87 (s, 3H), 0.08 (s, 6H).  
13
C NMR (100 MHz; CDCl3):  δ 166.7, 144.5, 139.3, 138.9, 129.0, 127.2, 127.1, 
126.1, 123.3, 78.0, 63.0, 32.1, 31.8, 31.5, 26.7, 26.2, 18.8, 18.6, 18.2, 17.9, -5.0.  
LRMS (ESI) m/z calc’d for C24H40O3SiNa [M+Na]
+
:  427.32; found:  427.2. 
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But-2-enoic acid 4-(2-hydroxymethylphenyl)-1-isopropylbutyl ester 2.11.10:
58
 
 
TBAF (12.3 mL, 12.3 mmol, 1 M solution in THF) was added to a stirred 
solution of 2.11.9 (2.74 g, 8.2 mmol) in THF (80 mL) at 0 
o
C.  After 45 minutes at 0 
o
C, the reaction was quenched with saturated NH4Cl (20 mL).  The organic phase was 
separated, washed with deionized water and brine, dried over anhydrous MgSO4, and 
concentrated under reduced pressure.  was purified by flash chromatography (10:1 
hexanes:EtOAc) to provide a colorless oil 2.11.10 (99%). 
 
1
H NMR (400 MHz; CDCl3):  δ 7.35-7.32 (m, 1H), 7.25-7.13 (m, 3H), 6.94 
(dd, 1H, J = 6.9, 15.5 Hz), 5.83 (dq, 1H, J = 1.7, 15.5 Hz), 4.88-4.82 (m, 1H), 4.72-
4.62 (m, 2H), 2.77-2.56 (m, 2H), 1.85 (dd, 3H, J = 1.7, 6.9 Hz), 1.85-1.75 (m, 2H), 
1.69-1.48 (m, 4H), 0.88 (s, 3H), 0.86 (s, 3H).  
13
C NMR (100 MHz; CDCl3):  δ 166.9, 
144.8, 140.6, 138.5, 129.6, 128.6, 128.2, 126.4, 123.2, 77.8, 63.3, 32.3, 31.9, 31.5, 
27.3, 18.8, 18.2, 17.8.  LRMS (ESI) m/z calc’d for C18H26O3Na [M+Na]
+
:  313.2; 
found:  313.1. 
 
 
 
 
 
But-2-enoic acid 4-(2-formylphenyl)-1-isopropyllbutyl ester 2.4.12
58
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Dess-Martin periodinane (1.02 g, 2.4 mmol) was added to a stirred solution of 
alcohol 2.11.10 (0.465 g, 1.6 mmol) in CH2Cl2 (16 mL).  The mixture was stirred 
overnight (14 hours) at room temperature.  The reaction was diluted with Et2O (10 
mL), then saturated NaHCO3/Na2S2O3 (15 mL, 1/1 mixture) was added, and the 
reaction was stirred vigorously for 15 minutes.  After the mixture was diluted further 
with Et2O (15 mL), the organic phase was separated and washed with saturated 
NaHCO3, deionized water, brine, dried over anhydrous MgSO4, and concentrated 
under reduced pressure.  The crude product was purified by flash chromatography 
(20:1 hexanes:EtOAc) to provide a colorless oil 2.4.12 (0.42 g, 91%). 
 
1
H NMR (400 MHz; CDCl3):  δ 10.22 (s, 1H), 7.79 (dd, 1H), J = 1.5, 7.7 Hz), 
7.47 (dt, 1H, J = 1.5, 7.5 Hz), 7.34 (dt, 1H, J = 1.0, 7.5 Hz), 7.23 (d, 1H, J = 6.0 Hz), 
6.93 (dq, 1H, J = 7.0, 15.6 Hz), 5.82 (dq, 1H, J = 1.7, 15.5 Hz), 4.86-4.80 (m, 1H), 
3.08-2.93 (m, 2H), 1.86 (dd, 3H, J = 1.7, 7.0 Hz), 1.85-1.75 (m, 1H), 1.68-1.50 (m, 
4H), 0.88 (s, 3H), 0.86 (s, 3H).  
13
C NMR (100 MHz; CDCl3):  δ 192.6, 166.7, 145.3, 
144.7, 134.0, 133.9, 132.1, 131.2, 126.8, 123.2, 77.8, 32.6, 31.8, 31.3, 28.3, 18.8, 
18.2, 17.8.  IR (cm
-1
):  2964, 2875, 1714, 1695, 1658, 1292, 1266, 1188, 754.  HRMS 
(ESI) m/z calc’d for C18H24O3Na [M+Na]
+
:  311.1617; found:  311.1610. 
 
Alcohol 2.11.4e 
To a solution of 2-iodobenzaldehyde 2.11.3 (0.300 g, 1.29 mmol, 0 °C) in 
THF (6 mL) was treated with a 2.0 M solution of i-PrMgCl in Et2O (0.84 mL, 1.68 
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mmol). After 15 minutes, the reaction mixture was quenched with H2O, extracted 
with Et2O, dried over MgSO4, and evaporated. The crude material was purified by 
flash chromatography (10:1 hexanes:EtOAc) to give 2.11.4e (0.052 g, 0.088 mmol, 
7%). 
1
H NMR (500 MHz, CDCl3) δ 7.82 (dd, J = 7.9, 1.2 Hz, 1H), 7.46 (dd, J = 7.8, 
1.7 Hz, 1H), 7.37 (td, J = 7.7, 1.1 Hz, 1H), 6.97 (td, J = 7.7, 1.8 Hz, 1H), 4.71 (d, J = 
5.6 Hz, 1H), 2.12 – 2.00 (m, 1H), 1.68 (s, 2H), 1.00 – 0.96 (m, 7H). 
 
 
Ester 2.11.5e 
Compound 2.11.5e was prepared from 2.11.4e by following the procedure for 
the preparation of 2.11.9 and was purified by flash chromatography (40:1 
hexanes:EtOAc) to provide a colorless oil (0.039 g, 66%).  
1
H NMR (500 MHz, CDCl3) δ 7.82 (dd, J = 7.9, 1.1 Hz, 1H), 7.33 – 7.29 (m, 
1H), 7.26 (dd, J = 7.8, 1.8 Hz, 1H), 7.02 (dq, J = 15.5, 6.9 Hz, 1H), 6.95 (td, J = 7.8, 
1.8 Hz, 1H), 5.92 (dq, J = 15.5, 1.6 Hz, 1H), 5.77 (d, J = 6.0 Hz, 1H), 2.23 – 2.09 (m, 
1H), 1.90 (dd, J = 6.9, 1.7 Hz, 3H), 0.98 (dd, J = 6.8, 5.3 Hz, 6H); 
13
C NMR (75 
MHz, CDCl3) δ 145.29, 143.08, 139.74, 129.35, 128.31, 127.76, 122.85, 98.83, 
83.08, 33.47, 19.45, 18.31, 17.39. 
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Aldehyde 2.11.6e 
nBu4NBr (0.056 g, 0.174 mmol), NaOAc (0.018 g, 0.216 mmol), LiCl (3.7 
mg, 0.087 mmol), and Pd(OAc)2 (2 mg, .008 mmol) were added sequentially to a 
stirred solution of 2.11.5e (0.027 g, 0.083 mmol) and 3-buten-1-ol (0.0075 mL, 0.087 
mmol) in anhydrous DMF (1 mL).  The mixture was heated to 50
o
C.  After 2 days at 
50 
o
C, the reaction mixture was cooled to room temperature and diluted with EtOAc 
(5 mL) and hexanes (10 mL) resulting in a biphasic organic solution.  The DMF-
containing phase was separated and extracted with hexanes (5 mL).  The combined 
hexanes/EtOAc extracts were washed with deionized water, 1.0 M CuSO4, deionized 
water, 1.0 M NaOH, deionized water, and brine.  After drying over anhydrous MgSO4 
and concentrating under reduced pressure, the crude product was purified by flash 
chromatography (15:1 hexanes:EtOAc) to afford aldehyde 2.11.6e (0.012 g, 0.042 
mmol, 50%). 
1
H NMR (500 MHz, CDCl3) δ 9.81 (t, J = 1.6 Hz, 1H), 7.36 – 7.31 (m, 1H), 
7.23 – 7.18 (m, 2H), 7.17 – 7.13 (m, 1H), 6.98 (dq, J = 15.5, 6.9 Hz, 1H), 5.89 (dq, J 
= 15.5, 1.6 Hz, 1H), 5.81 (d, J = 7.6 Hz, 1H), 2.83 (ddd, J = 14.2, 9.7, 6.3 Hz, 1H), 
2.73 (ddd, J = 14.1, 9.6, 6.2 Hz, 1H), 1.02 (d, J = 6.6 Hz, 3H), 0.85 (d, J = 6.9 Hz, 
3H); 
13
C NMR (75 MHz, CDCl3) δ 202.50, 165.89, 144.67, 138.84, 138.34, 129.15, 
127.53, 126.76, 126.24, 122.87, 43.45, 34.07, 31.49, 29.70, 23.21, 19.20, 18.27, 
17.99. 
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Alcohol 2.12.2 
To a stirred solution of 2-bromoiodophenol 2.12.1 (0.227 mL, 1.77 mmol) in 
THF (9 mL) at -25 °C was added i-PrMgCl (2.0 M in Et2O, 0.884 mL, 1.77 mmol). 
The solution was stirred for 45 minutes, crotonaldehyde (0.146 mL, 1.77 mmol) was 
added and the mixture warmed to rt and stirred for 10 minutes. The reaction was 
diluted with water, extracted 2x with Et2O. The combined organic layers were then 
washed with brine, dried with MgSO4 and filtered.  The solvent was removed in 
vacuo and the residue was purified by column chromatography (25:1 hexanes:EtOAc) 
to give alcohol 2.12.2 (0.376 g, 1.654 mmol, 94%) as an off-white semi-solid. 
1
H NMR (500 MHz, CDCl3) δ 7.54 (dd, J = 7.8, 1.5 Hz, 1H), 7.51 (dd, J = 8.0, 
1.0 Hz, 1H), 7.33 (dd, J = 10.9, 4.2 Hz, 1H), 7.11 (td, J = 7.8, 1.6 Hz, 1H), 5.85 – 
5.75 (m, 1H), 5.66 – 5.58 (m, 1H), 5.52 (d, J = 6.5 Hz, 1H), 2.02 (d, J = 2.3 Hz, 1H), 
1.70 (d, J = 6.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 142.41, 132.99, 131.83, 
129.15, 128.46, 128.00, 122.66, 73.77, 29.96, 18.02. 
 
Ketone 2.12.3 
 Dess-Martin periodinane (0.280 g, 0.661 mmol, 1.5 equiv) was added to a 
stirred solution of alcohol 2.12.2 (0.10 g, 0.440 mmol, 1.0 equiv) in CH2Cl2 (4 mL).  
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The mixture was stirred overnight (14 h) at room temperature.  The reaction was 
diluted with Et2O (3.0 mL), then a 1:1 mixture of saturated NaHCO3 and saturated 
Na2S2O3 (5.0 mL) was added, and the reaction was stirred vigorously for 15 minutes.  
After the mixture was diluted further with Et2O (15 mL), the organic phase was 
separated, washed with saturated NaHCO3, deionized water and brine, dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified by flash chromatography (25:1 hexanes:EtOAc) to provide ketone 2.12.3 
(0.099 g, 0.044 mmol, 100%). 
 
1
H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 7.8, 1.7 Hz, 1H), 7.54 (dd, J = 8.0, 
1.2 Hz, 1H), 7.35 (td, J = 7.7, 1.1 Hz, 1H), 7.14 (td, J = 7.7, 1.7 Hz, 1H), 5.83 (dqd, J 
= 13.9, 6.5, 0.9 Hz, 1H), 5.65 (ddq, J = 15.2, 6.5, 1.5 Hz, 1H), 5.55 (d, J = 6.5 Hz, 
1H), 1.73 (ddd, J = 6.5, 1.3, 0.8 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 195.36, 
148.67, 141.27, 133.52, 132.16, 131.26, 129.06, 127.36, 119.51, 18.91. 
 
 
Ketone 2.12.5 
To the TBS alkene 2.12.4 (0.112 g, 0.524 mmol) was added a solution of 9-
BBN in THF (0.5M, 1.05 mL, 0.524 mmol) and stirred for 4 hours. To a sealed tube 
containing a solution of Bromide 2.12.3 (0.097 g, 0.403 mmol), PdCl2(dppf)·CH2Cl2 
(0.033 g, 0.040 mmol) and K2CO3 in freshly distilled, degassed DMF (2 mL) was 
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added the trialkylborane solution. The reaction vessel was sealed, and heated to 50 °C 
for 8 hours. The reaction was then diluted with Et2O then poured into water. The 
product was extracted with Et2O, washed with water four times, and dried over 
MgSO4. The crude product was purified by flash chromatography (40:1 
hexanes:EtOAc) to provide ketone 2.12.5 (0.099 g, 0.273 mmol, 68%). 
1
H NMR (500 MHz, CDCl3) δ 7.36 (td, J = 7.5, 1.4 Hz, 1H), 7.33 – 7.30 (m, 
1H), 7.27 – 7.19 (m, 2H), 6.70 (dq, J = 15.6, 6.8 Hz, 1H), 6.48 (dq, J = 15.7, 1.4 Hz, 
1H), 3.58 (t, J = 6.6 Hz, 2H), 2.72 – 2.61 (m, 2H), 1.95 (dd, J = 6.8, 1.5 Hz, 3H), 1.61 
– 1.40 (m, 4H), 1.40 – 1.27 (m, 4H), 0.89 (s, 9H), 0.04 (s, 6H); 13C NMR (101 MHz, 
CDCl3) δ 147.37, 141.64, 139.18, 133.20, 130.40, 130.21, 128.06, 125.44, 63.52, 
33.45, 33.05, 31.98, 29.64, 26.24, 25.88, 18.80, 18.64, -5.00. 
 
Alcohol 2.12.6: 
To a solution of 2.12.5 (0.25 g, 0.69 mmol) in 1:1 THF/H2O (0.5 mL) at room 
temperature was added HOAc (1 mL). The solution was stirred for 10 hours at which 
time saturated aqueous NaHCO3 was carefully added until bubbling ceased. The 
mixture was extracted with Et2O (2x) and washed with water and brine. After drying 
over MgSO4 and concentrating under reduced pressure, the crude mixture was 
purified by flash chromatography (3:1 hexanes:EtOAc) to give ketone 2.12.6 (0.013 
g, 0.053 mmol, 76%) was obtained.  
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1
H NMR (500 MHz, CDCl3) δ 7.36 (td, J = 7.5, 1.4 Hz, 1H), 7.32 (dd, J = 7.6, 
1.1 Hz, 1H), 7.25 (d, J = 7.4 Hz, 1H), 7.24 – 7.20 (m, 1H), 6.70 (dq, J = 15.6, 6.8 Hz, 
1H), 6.48 (dq, J = 15.6, 1.4 Hz, 1H), 3.62 (t, J = 6.6 Hz, 2H), 2.72 – 2.61 (m, 2H), 
1.95 (dd, J = 6.8, 1.5 Hz, 3H), 1.63 – 1.49 (m, 5H), 1.41 – 1.30 (m, 4H); 13C NMR 
(75 MHz, CDCl3) δ 197.74, 147.39, 141.60, 139.13, 133.14, 130.41, 130.26, 128.11, 
125.47, 63.18, 33.35, 32.89, 31.84, 29.46, 25.65, 18.77. 
 
 
Aldehyde 2.12.7 
 Dess-Martin periodinane (0.043 g, 0.102 mmol, 1.5 equiv) was added to a 
stirred solution of alcohol 2.12.6 (0.17 g, 0.068 mmol, 1.0 equiv) in CH2Cl2 (1 mL).  
The mixture was stirred overnight (14 h) at room temperature.  The reaction was 
diluted with Et2O (3.0 mL), then a 1:1 mixture of saturated NaHCO3 and saturated 
Na2S2O3 (5.0 mL) was added, and the reaction was stirred vigorously for 15 minutes.  
After the mixture was diluted further with Et2O (15 mL), the organic phase was 
separated, washed with saturated NaHCO3, deionized water and brine, dried over 
MgSO4, filtered, and concentrated under reduced pressure.  The crude product was 
purified by flash chromatography (20:1 hexanes:EtOAc) to provide ketone 2.12.7 
(0.016 g, 0.065 mmol, 97%). 
 
1
H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.8 Hz, 1H), 7.39 – 7.35 (m, 1H), 
7.33 (dd, J = 7.6, 1.0 Hz, 1H), 6.49 (dq, J = 15.6, 1.5 Hz, 1H), 2.72 – 2.65 (m, 2H), 
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2.42 (td, J = 7.4, 1.8 Hz, 2H), 1.96 (dd, J = 6.8, 1.5 Hz, 3H), 1.69 – 1.54 (m, 4H), 1.41 
– 1.31 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 203.03, 197.54, 147.36, 141.37, 
139.10, 133.08, 130.45, 130.34, 128.22, 125.59, 44.04, 33.31, 31.66, 29.25, 22.08, 
18.79. 
 
General Cyclization (Intramolecular Vinylogous Aldol) Procedure: 
 
A solution of the substrate (0.5 mmol) in toluene (5 mL) was added to a 
stirred solution of freshly prepared ATPH (1.1 mmol) in toluene (5 mL) at -78
o
C 
(acetonitrile/dry ice bath).  After 20 minutes, the ATPH-substrate solution was added 
dropwise via cannula (1 hour) to a stirred solution of LTMP (1.0 mmol) in THF (5 
mL) and toluene (35 mL) at – 78oC.  After 30 minutes following the addition, 
saturated NH4Cl (25 mL) was added, and the biphasic mixture was stirred vigorously 
for 20 minutes while warming to ambient temperature.  The mixture was filtered 
through a small pad of Celite, which was washed with Et2O (50 mL).  The organic 
phase of the filtrate was separated and washed with brine, dried over anhydrous 
MgSO4, and concentrated under reduced pressure.  Purification of the crude product 
was achieved with flash chromatography (10:1 hexanes:EtOAc then 3:1 
hexanes:EtOAc) where 2,6-diphenylphenol was also recovered in good yield. 
Preparation of ATPH:  Me3Al (0.55 mL, 1.1 mmol, 2.0 M solution in hexanes) 
was added to a stirred solution of 2,6-diphenylphenol (0.813 g, 3.3 mmol) in toluene 
(5 mL) at room temperature.  After 30 minutes, the ATPH solution was cooled to -
78
o
C and used as described in the cyclization procedure. 
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Preparation of LTMP:  nBuLi (0.67 mL, 1.0 mmol, 1.50 M solution in 
hexanes) was added to a stirred solution of TMP (0.21 mL, 1.25 mmol) in THF (5 
mL) at -78
o
C.  After 30 minutes and immediately before the cannulation step in the 
cyclization procedure, the solution was diluted with cooled toluene (35 mL). 
 
 
 
 
14-Hydroxy-8-isopropyl-5,6,7,8,13,14-hexahydro-9-oxabenzo-(E)-cyclododecen-
10-one 2.4.13: 
 
Compound 2.4.13 was prepared from 2.4.12 in 86% yield after purification 
using the general cyclization procedure.  We could not detect any diastereomeric 
material by 
1
H NMR.  
1
H NMR (400 MHz; CDCl3):  δ 7.52 (br d, 1H, J = 6.2 Hz), 7.23-7.13 (m, 
2H), 7.05 (br d, 1H, J = 7.6 Hz), 6.82 (ddd, 1H, J = 5.4, 10.9, 16.0 Hz), 5.49 (br d, 
1H, J = 15.7 Hz), 5.08 (br d, 1H, J = 9.4 Hz), 4.63 (ddd, 1H, J = 3.0, 6.7, 10.0 Hz), 
3.00-2.91 (br m, 1H), 2.64-2.52 (br m, 2H), 2.42 (br q, 1H, J = 10.9 Hz), 2.20-2.04 
(br m, 1H), 2.03-1.98 (br d, 1H, J = 1.8 Hz), 1.92-1.74 (m, 2H), 1.54-1.42 (br m, 1H), 
1.08-0.96 (br m, 1H), 0.94 (d, 3H, J = 2.8 Hz), 0.92 (d, 3H, J = 2.9 Hz).  
1
H NMR (T 
= 59
o
C, 500 MHz; CDCl3):  δ 7.52 (d, 1H, J = 7.6 Hz), 7.21 (dt, 1H, J = 1.3, 7.8 Hz), 
7.16 (dt, 1H, J = 1.5, 7.2 Hz), 7.06 (d, 1H, J = 7.7 Hz), 6.78 (ddd, 1H, J = 5.6, 10.7, 
16.1 Hz), 5.55 (d, 1H, J = 15.9 Hz), 5.11 (dt, 1H, J = 2.8, 10.3 Hz), 4.64 (ddd, 1H, J = 
3.0, 6.6, 10.0 Hz), 3.00-2.92 (m, 1H), 2.69-2.55 (m, 2H), 2.45 (q, 1H, J = 10.8 Hz), 
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2.17-2.04 (m, 1H), 1.91-1.76 (m, 3H), 1.56-1.45 (br m, 1H), 1.16-1.06 (br m, 1H), 
0.96 (d, 3H, J = 3.3 Hz), 0.94 (d, 3H, J = 3.3 Hz).  
13
C NMR (100 MHz; CDCl3):  δ 
167.8, 144.4, 140.8, 139.7, 127.8, 126.7, 125.7, 124.9, 83.1, 70.5, 43.1, 32.3, 31.5, 
31.0, 25.4, 19.1, 18.6.  IR (cm
-1
):  3431, 2962, 2875, 1712, 1645, 1247, 1034, 1003, 
760.  HRMS (ESI) m/z calc’d for C18H24O3Na [M+Na]
+
:  311.1617; found:  
311.1606. 
 
Macrolactone 2.4.4 
 Compound 2.4.4 was prepared from 2.4.3 in 81% yield after 
purification using the general cyclization procedure.  We could not detect any 
diastereomeric material by 
1
H NMR. 
1
H NMR (500 MHz, CDCl3) δ 7.32 – 7.23 (m, 1H), 7.17 (dd, J = 11.6, 4.3 Hz, 
2H), 7.05 (ddd, J = 16.2, 9.1, 7.3 Hz, 1H), 5.92 (d, J = 15.8 Hz, 1H), 5.36 (d, J = 12.9 
Hz, 1H), 5.20 (d, J = 12.9 Hz, 1H), 3.85 (dd, J = 14.5, 8.0 Hz, 1H), 2.81 (dt, J = 12.5, 
6.3 Hz, 1H), 2.54 (td, J = 12.7, 5.3 Hz, 1H), 2.43 (td, J = 11.9, 3.8 Hz, 1H), 2.25 (dt, J 
= 12.2, 8.4 Hz, 1H), 1.82 – 1.46 (m, 3H), 1.40 – 1.29 (m, 1H), 1.29 – 1.18 (bs, 1H); 
13
C NMR (75 MHz, CDCl3) δ 146.84, 142.36, 131.00, 130.18, 128.85, 126.21, 
123.47, 71.54, 67.86, 42.14, 35.88, 33.21, 29.88. 
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Macrolactone 2.4.8 
Compound 2.4.8 was prepared from 2.4.7 in 90% yield and ~2.5:1 dr after 
purification using the general cyclization procedure.   
Major isomer:
 1
H NMR (500 MHz, CDCl3) δ 7.33 – 7.19 (m, 3H), 7.17 – 7.10 
(m, 1H), 6.82 (ddd, J = 16.1, 9.6, 6.7 Hz, 1H), 5.95 (d, J = 15.9 Hz, 1H), 5.42 (d, J = 
13.2 Hz, 1H), 5.14 (d, J = 13.3 Hz, 1H), 3.78 (dd, J = 15.2, 8.8 Hz, 1H), 2.89 (dt, J = 
11.9, 6.1 Hz, 1H), 2.63 (dd, J = 12.9, 3.4 Hz, 1H), 2.38 – 2.25 (m, 2H), 2.19 (dt, J = 
11.1, 9.0 Hz, 1H), 1.73 – 1.65 (m, 1H), 1.36 (dd, J = 13.3, 10.8 Hz, 1H), 0.98 (d, J = 
6.4 Hz, 3H); Mixture of isomers: 
13
C NMR (75 MHz, CDCl3) δ 145.70, 134.39, 
132.86, 131.22, 129.66, 129.34, 128.13, 127.92, 126.96, 126.60, 123.93, 121.81, 
70.67, 68.46, 67.82, 67.12, 46.36, 42.12, 41.60, 41.34, 32.91, 19.82. 
 
 
Macrolide 2.4.10 
Compound 2.4.10 was prepared from 2.4.9 in 80% yield after purification 
using the general cyclization procedure.  We could not detect any diastereomeric 
material by 
1
H NMR. 
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1
H NMR (500 MHz, CDCl3) δ 7.31 (dd, J = 7.1, 4.8 Hz, 2H), 7.23 (d, J = 7.3 
Hz, 1H), 7.18 (t, J = 7.4 Hz, 1H), 6.87 (ddd, J = 15.8, 8.5, 7.3 Hz, 1H), 5.87 (d, J = 
15.8 Hz, 1H), 5.30 (d, J = 12.1 Hz, 1H), 5.08 (d, J = 12.1 Hz, 1H), 3.69 (dd, J = 10.4, 
3.9 Hz, 1H), 2.66 – 2.43 (m, 3H), 2.27 (dt, J = 11.7, 9.8 Hz, 1H), 1.76 – 1.34 (m, 6H); 
13
C NMR (75 MHz, CDCl3) δ 165.79, 145.81, 143.46, 133.28, 131.20, 130.17, 
129.29, 125.97, 124.14, 71.91, 66.66, 41.70, 34.71, 33.11, 31.89, 27.66, 26.19. 
 
Macrolide 2.4.6  
Compound 2.4.6 was prepared from 2.4.5 in 79% yield and 2:1 dr after 
purification using the general cyclization procedure.   
Major diastereomer: 
1
H NMR (500 MHz, CDCl3) δ 7.26 – 7.12 (m, 4H), 6.94 
(ddd, J = 16.3, 9.6, 6.6 Hz, 1H), 5.98 – 5.86 (m, 2H), 3.70 (dd, J = 13.9, 7.1 Hz, 1H), 
3.00 – 2.91 (m, 1H), 2.79 – 2.71 (m, 1H), 2.71 – 2.60 (m, 1H), 2.39 – 2.21 (m, 2H), 
1.91 – 1.75 (m, 3H), 1.60 (d, J = 6.8 Hz, 3H). 
 
Macrocycle 2.4.11 
Compound 2.4.11 was prepared from 2.11.7 in 94% yield and 4:1 dr after 
purification using the general cyclization procedure.   
189 
 
Major diastereomer: 
1
H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 7.7 Hz, 1H), 
7.35 – 7.26 (m, 1H), 7.26 – 7.17 (m, 2H), 6.91 (ddd, J = 16.2, 9.7, 6.7 Hz, 1H), 6.10 
(q, J = 6.5 Hz, 1H), 5.90 (d, J = 15.8 Hz, 1H), 3.65 (qd, J = 7.6, 3.9 Hz, 1H), 2.61 – 
2.50 (m, 2H), 2.32 – 2.20 (m, 2H), 1.74 (d, J = 6.5 Hz, 3H), 1.55 – 1.29 (m, 8H); Both 
diastereomers: 
13
C NMR (75 MHz, CDCl3) δ 166.26, 144.99, 144.54, 143.07, 136.89, 
131.56, 130.50, 129.39, 128.72, 128.22, 126.73, 125.98, 125.93, 124.91, 124.67, 
100.23, 74.94, 71.98, 70.63, 70.44, 41.81, 41.53, 34.70, 34.24, 33.83, 32.69, 31.70, 
31.58, 27.78, 27.66, 26.23, 25.60, 22.19, 18.55. 
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Chapter 3 
The Design and Synthesis of Ligands for the Characterization of RNA by NMR  
 
3.1 Introduction 
 
The role of RNA in cellular processes recently underwent an expansion with 
the realization that many non-coding RNAs are not simply “transcriptional noise” but 
carry specific, often regulatory, functions. These discoveries continue to shape 
science’s perception of RNA’s role in biological functions and a better understanding 
of the functions of these RNAs will be greatly facilitated by improved methods for 
studying their structure and dynamics in solution.  
NMR is currently the only method available for generating high-resolution 
structures of proteins and nucleic acids in solution. There have been tremendous 
advances in NMR methods that now make it possible to determine both the local and 
global structures of increasingly larger biomolecules.
59
 However, the specific 
physical properties of RNAs still present significant challenges for NMR solution 
structure determinations. First, the density of protons in RNA is relatively low 
compared to proteins; thus, the amount of information gained from a spectrum is also 
relatively low. Second, RNA often forms extended structures which are difficult to 
characterize using exclusively short-range Nuclear Overhauser Effect (NOE) 
interactions. Third, the functional sites of RNAs are often dynamic with many 
functionally important conformational changes occurring on relatively long 
                                                 
59
 Rule, G.S.; Hitchens, T. K.; Fundamentals of Protein NMR Spectroscopy; Springer: Nordrecht, 
The Netherlands, 2006. 
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timescales, greatly broadening and complicating the spectra. Finally, since RNAs are 
built from only four residues and a common sugar, there is a high degree of spectral 
overlap in the NMR data.  
 
Residual Dipolar Couplings 
 
One important advance in macromolecular NMR in the last decade has been 
the development of general methods for measuring Residual Dipolar Couplings 
(RDCs) of molecules in solution.
60
 RDCs provide valuable information on both the 
long-range structure and dynamics of macromolecules; however, these couplings 
normally average to zero in isotropic solution. Thus, measurement of RDCs requires 
partial alignment of the molecule relative to the magnetic field in order to be 
observed. The observed RDCs for a rigid molecule can be described by the equation 
where γi is the gyromagnetic ratio of nucleus i, r is the distance of the P-Q 
internuclear vector, S is the generalized order parameter, Aa and Ar are the axial and 
rhombic components of the alignment tensor, and θ and φ are the polar coordinates 
describing the orientation of the internuclear vector relative to the principle axis 
system of the alignment tensor (Equation 3.1).
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DPQ ∝ γPγQ S(1 / r3)[Aa(3cos2θ - 1) + (3/2)Ar sin2θcos(2φ)] 
Equation 3.1 
  
                                                 
60
 (a) Tjandra, N.; Bax, A. Science 1998, 278, 1111. (b) Bax, A.; Kontaxis, G.; Tjandra, N. Methods 
Enzym. 2001, 339, 127. 
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External techniques to induce anisotropy in RNA in solution and subsequently 
measure RDCs were the first to be developed. These processes involved adding Pf1 
bacteriophages or liquid crystalline bicelles to the sample.
61
 When placed in a 
magnetic field, these disk-on-rod-like structures will align because of their 
anisotropic magnetic susceptibility. This induces a sterically uniform environment for 
the RNAs which will then align in the least sterically encumbering manner. The 
advantages of this method are the media will not bind nucleic acids and the media are 
stable to differing buffers and temperatures. However, the technique is limited 
because of the small degree of alignment.  
 
 
 
Figure 3.1 External methods of inducting anisotropy 
 
One approach that has been successfully used for alignment in proteins is the 
incorporation of so-called paramagnetic tags, which consist of a paramagnetic 
lanthanide atom bound to a strong chelating group site-specifically attached to a 
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 (a) Hansen, M.R.; Mueller, L.; Pardi, A. Nature Struct. Biol., 1998, 5, 1065. (b) Hansen, M.R.; 
Hanson; P.; Pardi, A. J. Biomol. Struct. Dynam., 2000, 365. (c) Hansen, M.R.; Hanson, P.; Pardi, A. 
Methods Enzym. 2000, 317, 220. (d) Tjandra, N., Tate, S., Ono, A., Kainosho, M. and Bax, A. J. Am. 
Chem. Soc., 2000, 122, 6190. 
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biomolecule.
62
 In proteins, this can be done in 3 different ways: tagging an N- or C-
terminal extension; extension by a peptide that is recognized by a metal binding 
protein such as CaM; or attaching a paramagnetic tag to the protein of interest, 
preferably via a cysteine residue (Figure 3.2).  
 
Figure 3.2 Paramagnetic tagging of proteins 
 
3.2  Synthesis of Ligands 
 
Ligand Design Considerations  
 
We have studied analogous techniques for tagging RNA molecules with 
chelating groups that bind paramagnetic metals with very high affinities. By 
connecting a chelating group to the 5’ end of RNA, different alignment tensors can 
then be induced by coordinating different paramagnetic lanthanide ions to the 
chelator.
62
 These paramagnetic labels can also be used to extract additional long-
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 (a) Rodriguez-Castaneda, F.; Haberz, P.; Leonov, A.; Griesinger, C. Magn. Reson. Chem. 2006, 
44 Spec No, S10. (b) Allegrozzi, M.; Bertini, I.; Janik, M. B. L.; Lee, Y.M.; Lin, G. H.; Luchinat, C. J. 
Am. Chem. Soc. 2000, 122, 4154. 
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range structural and dynamic information by analysis of pseudocontact shifts.
62
 Our 
goal is to develop efficient methods for applying these powerful paramagnetic 
tagging techniques to NMR studies of RNAs.  
In our initial strategy, we considered several important design elements. First, 
the coordination strength of the chelator to the lanthanide is important because 
reversibility in binding is not conducive to the measurement of RDCs. The lanthanide 
itself is also a consideration, and we felt that one with a large magnetic susceptibility 
such as dysprosium would be a good initial candidate. The third important feature is 
to have as short of a linker as possible since longer linkers can lead to smaller degrees 
of alignment and less residual dipolar coupling. We also wished to use enzymatic 
synthesis of RNA in the presence of this chelator. In order to accomplish this, the 
recognition sites of the enzyme require a guanidine base, charge on the phosphate, 
and the 2’-hydroxyl to be present and these elements must also be present in the final 
chelator compound (Figure 3.3).   
 
Figure 3.3  Design Considerations  
 
In our initial studies, we wished to examine how we would incorporate the 
ligand into the nucleotide and therefore chose to synthesize compounds with the 
general motif of 3.4.1. Structures of this type would have at least six sites of 
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coordination to the metal (four carboxylates and two amines) and could foreseeably 
bind essentially irreversibly under the experimental conditions.  The different linkers 
to be studied would be amenable to the proposed methods of incorporation to the 
nucleoside such as phosphorimidazolide coupling via an aliphatic amine, an 
azide/alkyne click-to-chelate strategy, and phosphoramidite coupling.    
 
 
Figure 3.4 First Generation Linker Framework Strategy 
 
We recognize that while there is symmetry around the nitrogens in each of the 
proposed compounds above, once complexed to a metal a chiral complex is formed. 
After tethering to a chiral biomolecule, two diastereomeric compounds would result. 
Because diastereomeric compounds have different physicochemical properties this 
would result in a doubling of the resonances observed by NMR. This complicates the 
spectrum and makes extraction of RDC information difficult, hence would not be an 
effective chelator for us.
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 One possible solution to this would be to prepare an 
inherently chiral chelator that would selectively bind as a single isomer. However, for 
the initial studies, we focused on the preparation and incorporation of linkers into 
achiral polyamine carboxylates.  
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Figure 3.5 The chirality issue 
  
Ligand Synthesis 
 
The synthesis of the model chelators bearing different linkers is described 
below (Scheme 3.1). Starting with 1,3-diamino-2-propanol 3.1.1, the primary amines 
were tetra-alkylated and the secondary alcohol was oxidized to the ketone via the 
Swern oxidation. The resulting ketone 3.1.3 could then undergo a rearrangement with 
tosylmethyl isocyanide (TosMIC), giving primary nitrile 3.1.4 which could be 
reduced to the primary amine 3.1.5 using Pt2O under H2. Ketone 3.1.3 could also be 
utilized in a Horner-Wadsworth-Emmons olefination with 3.1.6 to give α,β-
unsaturated primary amide 3.1.7. Reduction of this compound with Pd/C/H2 provided 
the amide of interest, 3.1.8. Alcohol 3.1.2 could also be subjected to a Mitsunobu 
reaction, resulting in secondary azide 3.1.9. The azide itself could be studied for 
incorporation into the nucleoside but it was also reduced with Pd/C/H2 to study 
incorporation of the resulting secondary amine 3.1.10. Finally, chelator 3.1.14 was 
prepared for study by first mono-Boc protecting triamine 3.1.11. The remaining 
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amines were tetra-alkylated as before and the Boc protecting group was removed with 
acid.  
 
Scheme 3.1 Synthesis of First Generation Chelators 
 
 The inherent difficulties in the synthesis of a lanthanide complex of a single 
diastereomer prompted us to explore an alternative wherein the stereochemistry at the 
metal center is controlled by a chiral, non-racemic ligand.  After studying the 
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incorporation of molecules of various functionality into nucleosides (data not shown) 
it was determined that the azide functionality would be most readily linked by a click 
reaction.
63
 We, therefore, designed an inherently chiral chelator that would selectively 
bind as a single isomer with an azide linker, the synthesis of which is shown below 
(Scheme 3.2.3). 1,3-diamino-2-propanol 3.1.1 was tetra-alkylated with chiral amide 
3.2.1 in excellent yield. The alcohol was then converted to the desired azide linker by 
a Mitsunobu reaction as before giving desired compound 3.2.3.  
 
 
Scheme 3.2 Synthesis of 3.2.3 
 
It is well known that lanthanide ions can promote the cleavage of RNA 
(Figure 3.6).
64
 In order for these lanthanide complexes to be useful as a means of 
inducing RDCs, the complexes must have a high degree of stability and/or inertness 
to dissociation under the NMR experimental conditions. In the case of 3.2.3, there are 
as many as 7 sites of coordination to the metal but lanthanides are known have up to 
11 sites of coordination available.  
                                                 
63
 Mindt, T. L.; Struthers, H.; Brans, L.; Anguelov, T.; Schweinsberg, C.; Maes, V.; Tourwé, D.; 
Schibli, R. J. Am. Chem. Soc. 2006, 128, 15096. 
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 (a) Morrow, J. R.; Buttrey, L. A.; Berback, K. A. Inorg. Chem. 1992, 31, 16. (b) Amin, S.; 
Morrow, J. R.; Lake, C. H.; Churchill, M. R. Angew. Chem. Int. Ed. Eng. 1994, 33, 773. (c) Morrow, J. 
R.; Buttrey, L. A.; Shelton, V. M.; Berback, K. A. J. Am. Chem. Soc. 1992, 114, 1903. (d) Chin, K. O. 
A.; Morrow, J. R. Inorg. Chem. 1994, 33, 5036. (e) Tsubouchi, A.; Bruice, T. C. J. Am. Chem. Soc. 
1995, 117, 7399. 
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Figure 3.6 Hydrolysis of RNA phosphate backbone by metal catalysis 
 
In order to determine the stability of RNA in the presence of our complex, we 
monitored the interaction of our complex with a model RNA. Unfortunately, we 
found extensive degradation of RNA in preliminary studies conducted in the labs of 
our collaborator, Professor Art Pardi (Figure 3.7).  
 
 
Figure 3.7 Degradation studies on RNA 
200 
 
We suspected that the cause of instability of RNA towards our complex was 
due to the presence of an open coordination site, and sought to design a chiral ligand 
that would occupy as many sites of coordination on the metal as possible. Knowing 
that cyclic chelating ligands are among the most thermodynamically stable and 
kinetically inert lanthanide III complexes, we prepared 3.3.4 and 3.3.5 in order to try 
to prevent the degradation of the RNAs. Cyclen 3.3.1 was tris-alkylated with chiral 
amide 3.2.1. Degradation studies were carried out after methylating the remaining 
nitrogen and metallating with both dysprosium and thulium.  Unfortunately, RNA 
degradation studies on the complex revealed that cleavage still occurs and we were 
faced with the need to develop a more chemically inert complex (Scheme 3.3).  
 
Scheme 3.3.  Third Generation Ligand Strategy and Model of 3.3.4  
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Among the many factors that can promote cleavage of RNA by lanthanides is 
the charge on the metal center. Therefore, we sought to design a complex that is 
overall neutral. We considered the same thermodynamically stable cyclic structure, 
but with carboxylate ligands in the place of amides. We prepared complex 3.4.5 by 
the route described below (Scheme 3.4). Cyclen was mono-protected with a formyl 
group, after which the remaining three amines were alkylated with 3.4.2. No 
racemization was detected at the stereocenters in 3.4.3. The benzyl esters and formyl 
group were then removed under acidic reducing conditions to provide 3.4.4. Finally, 
metalation of the chelator with DyCl3 gave complex 3.4.5.  Gratifyingly, subsequent 
degradation studies revealed that there was no detectable hydrolysis of the RNA.  
 
 
Scheme 3.4 Synthesis of Complex 3.4.5 
 
With a successful model substrate in hand, we focused on functionalizing the 
final amine with a linker for attachment to a GMP nucleotide for enzymatic 
incorporation into RNA. Unfortunately, we were unable to alkylate the remaining 
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secondary nitrogen after an exhaustive study. Our current progress on this fourth 
generation ligand strategy is shown in Scheme 3.5. We anticipate coupling to GMP 
via the free hydroxyl 3.5.5 with phosphoramidite chemistry or by the azide via a click 
reaction of 3.5.3 and 3.5.7. Full disclosure of RNA characterization is anticipated 
soon.  
 
 
 
Scheme 3.5  Fourth Generation Ligand and Nucleoside Coupling Partner Strategy 
 
 
3.3 Experimental 
 
N-formylcyclen 3.4.1 
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Cyclen (5 g, 29 mmol) and N,N-dimethylformamide dimethylacetal (3.92 mL, 
30.5 mmol) were dissolved in toluene (70 mL) and put into a flask equipped with a 
distillation apparatus under a nitrogen atmosphere. The methanol/toluene azeotrope 
formed was distilled until complete elimination of toluene had occurred. The resulting 
yellow oil (2a) was dried overnight at 70 ºC. It was then cooled to 0 ºC and a 
water/methanol mixture (1:1 v/v; 25 mL) was added dropwise. The mixture was 
warmed to room temperature and stirred for 24 h. The solvents were evaporated and 
the residue was re-dissolved in a minimum amount of acetonitrile, which was 
subsequently evaporated; this procedure was repeated twice to completely eliminate 
water, Addition of ether to the yellow oil precipitated a white solid (5.58 g, 95% 
yield). 
1
H NMR (400 MHz, CDCl3) δ 8.17 (s, 1H), 3.56 (t, J = 5.3 Hz, 2H), 3.52 – 
3.47 (m, 2H), 2.86 – 2.76 (m, 6H), 2.72 – 2.65 (m, 6H). 
 
 
L-benzyl 2-(trifly1oxy)propionate 3.4.2 
According to a variation of a literature procedure, a solution of benzyl lactate 
3.4.2a (5.0 g, 27.7 mmol) and pyridine (2.7 mL, 33.3 mmol) in CH2Cl2 (45 mL) at 0 
ºC was treated with triflic anhydride (8.61 g, 30.5 mmol) in CH2Cl2 (45 mL) for 1 h. 
After removal of the pyridinium triflate salt by filtration, the crude product was 
purified by silica gel chromatography (5:1 hexanes/CH2Cl2 to obtain benzyl 2-
(trifly1oxy)propionate 3.4.2 (6.91 g, 22.13 mmol, 80%).  
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Rf = 0.2 (5:1 hexanes/CH2Cl2); 
1
H NMR (500 MHz, CDCl3) δ 7.43 – 7.34 (m, 
2H), 5.31 – 5.24 (m, 1H), 1.72 (d, J = 7.0 Hz, 1H). 
 
1,4,7-Tris(benzyIoxycarbonyl)methyl-10-formyl-1,4,7,10-tetraazacyclododecane 
3.4.3 
To a stirred solution of N-formylcyclen 3.4.1 (0.668 g, 3.34 mmol) and 
diisopropylethylamine (2 mL, 11.68 mmol) in MeCN (17 mL) at 0 ºC was added L-
benzyl 2-(trifly1oxy)propionate 3.4.2 (3.23 g, 10.34 mmol) in MeCN (10 mL). The 
solution was stirred for 3 hours and allowed to warm to RT. The crude product was 
obtained after removal of the solvent was extracted with water and CHCl3. The 
organic layers were combined and dried over magnesium sulfate. Removal of the 
solvent afforded an orange residue. This crude product was purified by silica gel 
chromatography (1:1 hexanes/EtOAc) to obtain tribenzyl ester 3.4.3 (0.564 g, 0.821 
mmol, 25 %). 
1
H NMR (500 MHz, CDCl3) δ 7.97 (s, 1H), 7.40 – 7.28 (m, 15H), 5.14 – 5.09 
(m, 6H), 4.23 – 4.15 (m, 1H), 3.85 – 3.73 (m, 1H), 3.68 – 3.61 (m, 2H), 3.52 (p, J = 
7.2 Hz, 2H), 3.17 (dt, J = 14.3, 4.8 Hz, 1H), 2.92 (ddd, J = 14.0, 10.2, 3.7 Hz, 1H), 
2.88 – 2.52 (m, 9H), 2.44 – 2.34 (m, 2H), 1.26 – 1.20 (m, 9H); 13C NMR (75 MHz 
CDCl3): δ 14.94, 15.06, 15.16, 42.03, 47.32, 48.76, 49.37, 49.56, 50.13, 50.99, 52.66, 
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55.58, 58.76, 60.02, 65.83, 65.94, 66.05, 128.07, 128.15, 128.25, 128.44, 128.48, 
135.68, 135.77, 135.80, 162.71, 173.02, 173.12, 173.17. 
 
 
Tricarboxylic Acid 3.4.4 
The tribenzyl ester 3.4.3 (0.138 g, 0.201 mmol) was hydrogenated overnight 
in 30% aqueous methanol containing 2 M HCl (1.5 mL of methanol and 0.5 mL of 2 
M HCl) in the presence of Pd/carbon (10% Pd, 0.021 g, 0.020 mmol). The catalyst 
was filtered off and evaporation of the filtrate gave an off-white solid crude material 
3.4.4. 
1
H NMR (500 MHz, D2O) δ 4.36 – 4.27 (m, 1H), 4.05 – 3.95 (m, 1H), 3.81 – 
3.53 (m, 2H), 3.41 (dd, J = 27.8, 13.6 Hz, 1H), 3.30 (t, J = 13.1 Hz, 1H), 3.14 (d, J = 
5.6 Hz, 5H), 3.12 – 2.94 (m, 6H), 2.86 (dd, J = 32.8, 12.8 Hz, 4H), 2.68 (t, J = 11.1 
Hz, 1H), 2.60 – 2.44 (m, 2H), 1.41 (d, J = 7.0 Hz, 3H), 1.11 (d, J = 5.9 Hz, 6H). 
 
 
Compound 3.5.1  
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To a stirred solution of 3.4.3 (0.113 g, 0.165 mmol) in MeOH (1.3 mL) was 
added 2 M HCl in H2O (0.46 mL, 0.928 mmol). The solution was stirred overnight 
and then concentrated in vacuo. The residue was dissolved in CHCl3 and saturated 
solution of K2CO3 was carefully added to the vigorously stirred solution until 
effervescence ceased. The organic phase was separated, and the aqueous phase was 
extracted with CHCl3. The combined organic phases were washed with water and 
brine, dried over MgSO4, filtered, and concentrated under reduced pressure.  The 
crude product was purified by flash chromatography (3% MeOH in CHCl3) to 
provide 3.5.1 (0.109 g, 0.165 mmol, 100%). 
 
1
H NMR (400 MHz, CDCl3) δ 7.39 – 7.28 (m, 15H), 3.74 (q, J = 7.1 Hz, 1H), 
3.55 (q, J = 7.1 Hz, 2H), 2.95 (bs, 2H), 2.83 (q, J = 9.7 Hz, 8H), 2.56 (d, J = 9.1 Hz, 
4H), 2.43 (d, J = 18.8 Hz, 2H), 1.32 (d, J = 7.2 Hz, 6H), 1.25 (d, J = 7.0 Hz, 3H). 
 
 
 
Compound 3.5.2
 
 
To a stirred solution of 3.5.1 (0.049 g, 0.074 mmol) and pyridine (0.030 mL, 
0.369 mmol) in CH2Cl2 (1.5 mL) at 0 ºC was added chloroacetyl chloride (0.024 mL, 
0.295 mmol). The cold bath was lowered and the solution allowed to warm to room 
temperature. After 30 minutes, the reaction was diluted with CHCl3. The reaction was 
quenched with saturated NaHCO3 and extracted (3x) with CHCl3. The organic layers 
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were combined, dried over magnesium sulfate, filtered and concentrated under 
reduced pressure. The crude product was purified by silica gel chromatography (1% 
MeOH in CHCl3) to obtain 3.5.2 (0.0246 g, 0.033 mmol, 46 %). 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.28 (m, 15H), 5.19 – 5.03 (m, 6H), 
4.53 – 4.41 (m, 1H), 4.02 – 3.90 (m, 2H), 3.75 – 3.61 (m, 3H), 3.57 – 3.46 (m, 2H), 
3.34 (dt, J = 11.7, 5.3 Hz, 1H), 3.07 – 2.51 (m, 10 H), 2.42 (dt, J = 5.2, 2.3 Hz, 1H), 
2.37 – 2.28 (m, 1H), 1.23 (dt, J = 7.1, 2.3 Hz, 9H). 
 
 
Azide 3.5.3 
 To a stirred solution of 3.5.2 (0.044 g, 0.059 mmol) in DMF (1.2 mL), was 
added sodium azide (7.7 mg, 0.118 mmol) and the reaction mixture was stirred 
overnight at room temperature. The solvent was removed under vacuum, and the 
residue was dissolved in EtOAc. The organic layer was washed three times with 
water and once with brine and then dried over MgSO4 and evaporated under reduced 
pressure. The residue was purified by flash chromatography (2:1 hexanes/EtOAc) to 
give the title compound 3.5.3 (0.044 g, 0.059 mmol, 100%). 
 
1
H NMR (500 MHz, CDCl3) δ 7.40 – 7.28 (m, 15H), 5.18 – 5.04 (m, 6H), 
4.29 (bs, 1H), 3.81 – 3.69 (m, 3H), 3.69 – 3.58 (m, 2H), 3.51 (dq, J = 20.6, 7.0 Hz, 
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2H), 3.22 – 3.12 (m, 1H), 2.95 – 2.54 (m, 10H), 2.43 (d, J = 13.4 Hz, 1H), 2.35 (d, J = 
13.9 Hz, 1H), 1.34 – 1.15 (m, 9H). 
 
 
 
Alkynyl Phosphoramidite 3.5.7 
 
 To a stirred solution of 2-cyanoethyl N,N-diisopropylchlorophosphoramidite 
3.5.6 (1.0 g, 4.23 mmol) in THF (10 mL) at 0 ºC was added ethynylmagnesium 
bromide  (0.5 M solution in THF, 8.45 mL, 1 equiv.). After 1 hour, the reaction was 
diluted with Et2O and quenched with saturated NaHCO3.  The organic phase was 
separated, washed with water and brine, dried over MgSO4, filtered, and concentrated 
under reduced pressure.  The crude product was purified by flash chromatography 
(15:1 hexanes:EtOAc) to provide 3.5.7 (0.794 g, 3.51 mmol, 83%). 
 
1
H NMR (500 MHz, CDCl3) δ 3.96 – 3.82 (m, 2H), 3.83 – 3.62 (m, 2H), 3.13 
(d, J = 1.7 Hz, 1H), 2.65 (t, J = 6.6 Hz, 2H), 1.23 (d, J = 6.8 Hz, 6H), 1.20 (d, J = 6.7 
Hz, 6H); 
13
C NMR (75 MHz, CDCl3) δ 117.62, 92.55 (d, J = 7.7 Hz), 84.81 (d, J = 
17.9 Hz), 61.13 (d, J = 17.9 Hz), 49.10 – 47.63 (m), 25.63 – 23.33 (m), 20.55 (d, J = 
7.5 Hz); 
31
P NMR (122 MHz, CDCl3) δ 96.68.  
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